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I. 
Throughout all ages, men and women have incessantly pursued every means to increase, 
preserve and recapture their sexual capacity, or to stimulate the sexual desire of selected 
members of the opposite or same sex. One of the most recurrent methods has been the use of 
aphrodisiacs. Herbal medicines are a major source of aphrodisiacs and have been used world-
wide for thousands of years by different cultures and civilizations. Traditional herbs represent 
an extraordinary reservoir of active ingredients which are still present in about 25% of all 
prescriptions of modern “Western” medicine. Phytochemicals have evolved from traditional 
medicinal plants to modern scientific medicine, giving support to the empirical knowledge of 
“alternative” healing. A deeper understanding of phytochemistry, pharmacognosy and 
ethnopharmacology should therefore be encouraged to support the production of new and safe 
pharmacologically active compounds with minimal undesired toxic effects.  
Nowadays, the commercialization of new synthetic “love drugs”, e.g. Viagra®, Cialis® and 
Levitra®, has fascinated the public interest and has led to a reassessment of classical 
aphrodisiacs and to the search for new ones. The resurgence of “old” herbal remedies that 
arouse sexual activity and the use of new exotic preparations has coincided with an increase in 
poisonings associated with the use of these aphrodisiacs. The practice of self-medication by an 
increasing number of patients, the incessant aggressive advertising of these herbal aphrodisiacs, 
the invasion of the medicinal market with uncontrolled dietary supplements and the absence of 
real directives amplifies the potential health hazards to the community. 
With the aim of evaluating the potential risks of commercialized aphrodisiac products on 
consumer health, the first part of the present work was to develop a new analytical method to 
detect and quantify yohimbine in these herbal remedies. Yohimbine is the active principle of 
Pausinystalia yohimbe PIERRE ex BEILLE (Rubiaceae), a classical aphrodisiac which has been 
recently revalued for its pro-sexual properties and extensively commercialized without any 
surveillance. 
The second part of this work is focused on the phytochemical and pharmacological 
investigation of Erythroxylum vacciniifolium Mart. (Erythroxylaceae), a plant used in Brazilian 
traditional medicine as an aphrodisiac and tonic, and locally known as catuaba. The 
phytochemical and pharmacological aspects consist in the detection, isolation and 
characterization of new natural compounds of potential therapeutic interest, especially for the 
treatment of male erectile dysfunction. 
 
  
II. Introduction 
 
Introduction 
 
   
II. 
7
1.  Aphrodisiacs: the eternal dream 
Throughout all times and at all social and cultural levels, one of the leading forces that has 
driven humanity to triumphant achievements, exultant productivity, and personal satisfaction, is 
the amatory concept. The proverbial belief that the world is conditioned by love is not an 
unfounded saying. The idea of love as the instrument of creation and human perpetuity is not a 
merely mechanical conception. In the first century B.C., the ancient Roman poet Lucretius (99-
55 B.C.) began his epic philosophical poem De Rerum Natura (On the Nature of the Universe) 
with a justly famous invocation to Venus, the poet’s symbol for the forces of cohesion, 
integration and creative energy in the universe. The Lucretian Venus is associated with the 
figure of love, the unifying or binding energy, presented by the poet as a kind of life principle 
(Lucretius and Giussani, 1967). In the name of the goddess, terrible and wicked crimes have 
been committed, men have defied uncontrolled dangers, have renounced magnificence, power, 
and possessions, confirming the quasi virtue of “All for love”. 
Therefore, it is not surprising that man has incessantly pursued every means, every obscure 
aid, to maintain his amorous faculties. Erotic vigor, in all its varying manifestations, has become 
for man a prior interest, and woman the complement in this function. Thus we can consider that 
human history, from past to present, is run by the two harmonizing principles of creation and 
survival, male and female, permeating the creative arts, painting, sculpture, music, literature and 
simpler doings of ordinary life. 
The eternal dream of man and woman have always been the possibility of increasing, 
preserving and recapturing their sexual capacity, or of stimulating the sexual desire of selected 
members of the opposite or same sex by various means. One of the most recurrent methods has 
been the use of aphrodisiacs. These products, causing or increasing sexual desire or arousing 
sexual response, may simply be exotic food or drinks, rare herbal compounds or 
pharmaceuticals, amulets or psychic manipulations. Even putatively innocuous foods can be 
used as aphrodisiacs by suggesting or resembling sex organs (asparagus, oysters, etc.). Human 
sexual arousal is a complicated phenomenon, but simple conditioning stimuli of different genres 
can act as potent aphrodisiacs. 
From a purely biological point of view, maintaining or increasing amorous capabilities can 
have varying importance between the two sexes, due to their basic physiological inequality. In 
nature, the only requirement for a successful sexual encounter is that the male should be able to 
achieve penetration and ejaculation. But from a social point of view, both partners are looking 
for sexual pleasure and satisfaction. Women are then biologically disadvantaged in the 
achievement of the satisfaction, as we are designed so that the male climaxes before the female 
in order to propagate the species. The chance of getting pregnant would be by far reduced if 
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female was the first to reach sexual pleasure. On the other hand, women have the significant 
advantage of being able to achieve multiple orgasms and probably more pleasure than man. 
Different from other animals, the civilized man has the time and opportunity to treat sex as a 
pleasurable activity rather than as an essential act for the propagation of the species. However, it 
is not just for pleasure that man has always hunted for substances to increase his sexual 
activities.  
Sexual potency is part of the male ego, and the anxiety and the humiliation that are associated 
with a declining sexual ability are common to all cultures.  That is why the popularity of 
aphrodisiacs has not shown any sign of decline throughout history. In ancient as in current times, 
in oriental and western cultures, virility has always been one of the central and most desirous 
characteristics of the human male. During the course of centuries, the cult of the phallus has 
assumed divine proportions, as it is considered the symbol of creation and life. Its representation, 
as farce or transcendent service, is omnipresent in ancient and modern arts. Images of the Greek 
god Priapos (the protector of gardens and domestic animals and fruits, son of Dionysus and 
Aphrodite) with large ithyphallic genitals were placed in the fields and gardens to ensure 
fruitfulness and protection. He was imported into Rome from Lampascus where Pausanias 
reported that he was supreme among all gods. The Roman Priapus was far more popular than 
his Greek version. He is portrayed wearing a long dress that leaves the genitals uncovered 
(Figure 0-1). The Romans placed a satyr-like statue of him, painted red and with an enormous 
phallus, in gardens as some kind of scarecrow, but also to ensure fruitfulness. 
 
 
 
 
Figure 0-1 
Priapus, the Roman patron god of gardens, vinicultures, sailors and fishermen. 
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The celebration of virility and glorification of manhood have also been testified throughout all 
ages by other cultures and ethnic groups: in ancient Babylonia as well as in India (Caves of 
Ajanta), in the medieval period (Courts of Love) and in contemporary times, in Mayan and 
Incan civilizations as well as in Polynesian and Cameroonian tribes, and so forth.  
Sexual virility still covers an important role in contemporary society, as shown by the 
omnipresence of insistent commercials and flourishing businesses based on this theme. The 
wide diffusion of a new means of communication at the end of last century, the Internet, has 
contributed to the extension of this kind of commerce all over the world in varying degrees. 
Aphrodisiacs of all varieties and from the most remote origins become accessible to everyone, 
increasing in some way the popular curiosity and demand for these “magic potions”. Moreover, 
the arrival of  new synthetic “love drugs”, e.g. Viagra®, Cialis® and Levitra®, has captivated the 
public imagination and  has led to a reassessment of “old” aphrodisiacs and to the search for 
new ones (Drewes et al., 2003). 
2. Definition 
Aphrodisiacs take their name from Aphrodite (“Αφροδιτη”; etymology: “foam-born”) 
(Figure 0-2), the Greek goddess of love, and have been used throughout all times with the 
purpose of increasing desire and drive associated with the sexual instinct. According to Hesiod, 
Aphrodite was born when Uranus (the father of the gods) was castrated by his son Cronus. 
Cronus threw the severed genitals into the ocean which began to churn and foam about them. 
From the aphros (“sea foam”) arose Aphrodite, and the sea carried her to Cythera (Figure 0-3). 
Aphrodite loved and was loved by many gods and mortals. Among her mortal lovers, the most 
famous was perhaps Adonis. Some of her sons are Eros, Anteros, Hymenaios and Aeneas (with 
her Trojan lover Anchises). She is accompanied by the Graces. Her priestesses were not 
prostitutes but women who represented the goddess and sexual intercourse with them was 
considered just one of the methods of worship. Aphrodite was originally an old-Asian goddess, 
similar to the Mesopotamian Ishtar (the ancient Sumero-Babylonian goddess of love and 
fertility) and the Syro-Palestinian goddess Ashtart. To the Romans she was Venus, the 
irresistibly beautiful goddess of love. Venus is the daughter of Jupiter, and some of her lovers 
include Mars and Vulcan, modeled on the affairs of Aphrodite. Venus’ importance rose, and 
that of her cult, through the influence of several Roman political leaders. The dictator Sulla 
made her his patroness, and both Julius Caesar and the emperor Augustus named her the 
ancestor of their family (Oswalt, 1969). 
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Figure 0-2 
Aphrodite, known as the Venus de Milo (Venus of Melos), Greece, second century B.C. (Marble statue, 
Louvre, Paris). 
 
 
 
 
Figure 0-3 
“The birth of Venus”, Sandro Botticelli ca. 1482 (Tempera on canvas, Uffizi, Florence). 
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The Oxford English Dictionary defines an aphrodisiac as “A drug or preparation inducing 
venereal desire”. Venereal desire is often described as the sexual appetite, and can be 
understood as a desire for sexual stimulation. However, the increase of the appetite is not 
essentially associated with an equivalent increase in the capacity to satisfy that sexual desire. 
Aphrodisiacs can be classified according to their mode of action into two categories. The first 
type of aphrodisiac acts specifically to increase the libido (i.e., sexual desire). And the second 
category of aphrodisiac takes action by increasing the ability to indulge in sexual activity (i.e., 
increasing potency). In theory, an aphrodisiac is strictly an agent which arouses or increases 
sexual desire, but in practice anything which increases the capacity for sexual enjoyment will 
tend to increase the appetite and can be considered as an aphrodisiac. There seems to be no limit 
to the credulity of man in his pursuit of aphrodisiacs, and it has been possible to compile a 
catalogue of over 500 animal, vegetable, and mineral substances which have, at some time, been 
evocated for their aphrodisiac properties (Taberner, 1985b).  References to such substances 
have crept into holy texts from the Kāma Sūtra and the Bible to the Koran and the literature 
from Shakespeare and Ovid to Gilbert and Sullivan plays in the twentieth century (Wedeck, 
1963). 
3. Aphrodisiacs in history: the ancient traditions 
The first report discussing sexual pathological disorders dates back 3,000 to 4,000 years, 
when medical information was passed from one generation to the next through oral poems 
among the Hindu population (Herman, 1969).  These poems were finally inscribed around 2,000 
to 1,000 B.C. and one of them (Samhita of Sushruta) already reported the pursuit for substances 
to enhance sexual experience (Sandroni, 2001). The written traditions, preserved in particular 
cultures and occasionally passed on to other cultures through commerce and other ways, are the 
source of our knowledge about aphrodisiacs. The diffusion of this knowledge from Egyptians to 
the Arabs and Greek and so to the Romans was partially interrupted during the Middle Ages 
because it was considered heretical. Throughout the Renaissance these persecutions came to an 
end and the intensification of travel and exploration introduced new knowledge to Europe, 
notably from China, India and the New World. Common aspects have often emerged among 
different cultures and ethnical groups in the use of plants as aphrodisiacs, even though the 
application of this knowledge has always had a large magical component (Taberner, 1985a). 
 
The Hindu tradition. Among the numerous classical works in Sanskrit literature on the 
subject of love, the most famous remain the Anunga Runga, written by the poet Kullianmull in 
the fifteenth century, and the Kāma Sūtra, composed by Vātsyāyana some time between the first 
and fourth centuries A.D. This latter is still celebrated and translations of the book are read 
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widely all over the world. There is a short chapter in the Kāma Sūtra which explains the 
methods for “attracting others to oneself”, including magic rituals, natural remedies of different 
potencies and general advise (Vâtsyâyana et al., 2000). Some local plants and animals used as 
ingredients for the recipes have not been identified yet due to their indecipherable Sanskrit 
names, increasing the mystery concerning the Hindu aphrodisiacs.  
Most of the methods reported in the Kāma Sūtra to increase the sexual vigor of a man include 
milk and honey. These have always been recognized as food able to produce endurance and 
energy, as already described by Greek and Roman writers. These two main ingredients, the 
immediate source of energy for employing in physical activity, are often combined with 
generative organs of animals, considered in organotherapy as the basis of sexual potency. Many 
other recipes are described in the Kāma Sūtra but the ingredients are not likely to have anything 
more than a physiological effect upon sexual desire. The use of highly nutritious food 
substances (ghee, milk, eggs and honey) in these recipes could have an explanation. In a society 
where the normal diet tends to be deficient in proteins and essential vitamins, the addition of 
extremely nutritious supplements would increase the physical vigor and treat a loss of sexual 
appetite due to a deficient diet. These pseudo-aphrodisiacs bring no benefits to individuals on 
equilibrated diets and sometimes their over-use can even be damaging. 
More directly acting sexual stimulants are described in the seventh part of the Kāma Sūtra 
which is dedicated to the occult practices (Aupanishadika). The components of these stimulant 
mixtures involve principles used as aphrodisiacs by other cultures. A mixture of powdered 
thorn-apple seeds, black pepper (Piper nigrum L., Piperaceae), long pepper (Piper longum L., 
Piperaceae) and honey, applied on the penis before coitus, is reputed to make a woman subject 
to the man’s will. The four principles have a specific function in the aphrodisiac mixture which 
has a completely rational basis for its action. The thorn-apple seeds (Datura stramonium L., 
Solanaceae) contain atropine and scopolamine, which are potent tropane alkaloids inducing an 
initial excitement followed by sedation and hallucinations. These two constituents are adsorbed 
through the mucous membranes of both the penis and the vagina, and have a central nervous 
system action producing behavioral effects in both partners (Hostettmann, 2000). The peppers 
have a counter-irritant or rubefacient action, increasing the blood flow around the area of 
application. In the man, this local inflammation helps the development and maintenance of an 
erection, while, in the woman, the irritation of the clitoris increase the sexual desire. Another 
rubefacient plant, ginger (Zingiber officinale Rosc., Zingiberaceae), is described in the Kāma 
Sūtra and employed by man to increase potency. The honey is used for an easier application of 
the mixture and as a useful lubricant. 
During the Middle Ages, other plants of the Solanaceae family such as Atropa belladonna L., 
Hyoscyamus niger L. and Mandragora officinarum L., were used in Europe for the same 
hallucinogenic effects as thorn-apple. The mandrake was considered a potent aphrodisiac and a 
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magical plant at the same time. Its active part was the root, which could resemble the figure of a 
man (the closer this resemblance, the more powerful the root). The root was an expensive 
ingredient in magic potions since its collection required a dangerous procedure. On pulling the 
plant from the ground it was supposed to give vent to a shriek that was instantaneously fatal to 
anyone within earshot. To overcome this danger, the collectors of mandrake tied a dog to the 
plant and, after retiring to a safe distance, would call the animal. Medieval witches used 
mandrake, belladonna and henbane for their pleasure. They applied an ointment of these plants 
to the moist membranes of the vagina using broomsticks as applicators. This ointment is what 
allowed witches to fly on their broomsticks to their Sabbaths (Hostettmann, 2000). 
 
The China and Far-east tradition. The Chinese civilization is one of the oldest in the 
world and its herbal tradition is well-established as confirmed by the pharmacopoeia of Emperor 
Shen Nung written about 3,000 B.C. This pharmacopoeia already described the virtues of potent 
preparations, including Indian hemp, the opium poppy and aconite, and is the basis of modern 
Chinese herbal medicine. In China, this type of health care system is much more developed than 
Western medicines for social and economic reasons. The Far-east tradition devotes a particular 
attention to substances which generally promote longevity and particularly restore sexual vigor. 
One of the most celebrated drugs is the ginseng root (Panax ginseng C.A. Mey., Araliaceae) 
which has been used for centuries in China, Tibet, Korea, Thailand, Cambodia, Laos, Myanmar, 
Vietnam, and India, where it is reputed to possess the same properties as the mandrake root 
(Mandragora officinarum L., Solanaceae). As for the mystical mandrake, the shape of the 
ginseng root is similar to the human form and consequently it should be universally beneficial to 
the body. In fact, the etymology of the name of the plant comes from the Greek language “cure-
all” (panax: pana = all; axos = cure), and from the Mandarin language “man-like” (ginseng: 
Anglicization of the Chinese jin-chen). In Asia ginseng can be bought in different forms 
(powder, pills, ointments, tinctures and teas) and is recommended among many other things as 
an aphrodisiac with the power of rejuvenation. Only recently has ginseng use penetrated to the 
West. It has turned into a famous preparation for its adaptogen properties and is subject to 
extensive scientific and medical investigation. The aptitude of ginseng to increase sexual desire 
or potency has not been demonstrated yet, but it is considered as an aphrodisiac as well because 
of its non-specific “tonic” effect on the body (Gillis, 1997). 
In addition to the humanoid roots, Chinese herbal medicine frequently uses deer antlers and 
other parts of animals as aphrodisiacs. Organotherapy is widespread in Far-east tradition and the 
price of many of these items can be very high. The ancient Chinese used animal genitals as a 
method to increase potency. Tiger and deer penises are still considered a delicacy today. Even 
the nomadic tribes like the Tartars believed firmly in the effectiveness of animal genitalia for 
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making aphrodisiacs. They ate the penis of a stallion rather than its testicles because they 
believe in the efficacy of natural products which merely resemble the penis. 
The Near-east tradition. The translations of the early wedge-shaped tablets found by 
archeologists in Arabian regions reveals that the Babylonians and Assyrians practiced magic 
rituals to protect themselves against malign spirits and to increase fertility in woman and 
potency in man. The later Arabic tradition in aphrodisiacs is partially influenced by this earlier 
knowledge. The Egyptians also practiced magic and the herbalists served also as priests. Many 
plants used by these healers had beneficial properties recognizable even today, but these 
properties were understood as the presence of spirits in the plant rather than being due to some 
active substances. The Egyptian Papyrus Ebers, a medical Egyptian document dated 1,600 B.C., 
lists prescriptions for various ailments, including impotence. In the latter, baby crocodiles’ 
hearts were mixed with wood oil to the appropriate consistency, and this then smeared onto the 
man’s penis to restore potency (Shah, 2002). 
 
The Greek tradition. Akin to the Arab tradition, the Greek knowledge in aphrodisiacs also 
derived from the writings of the earlier Mediterranean civilizations. As a result, the magic and 
supernatural had a great importance in curative practices. The magic love charms of the 
sorceresses Medea and Circe are just an example of the significance of these practices in Greek 
mythology. Bizarre ceremonies, associating complex mixtures and the solicitation of gods, were 
served by priests to cure sexual dysfunctions. These rituals illustrate that irrational human 
activity can be found throughout the world among tribes and cultures at all level of development, 
and even contemporary educated man is not immune to these kinds of activities. 
 
The Roman tradition. Even though the Romans produced a developed civilization based 
on complex laws, the pre-Christian Empire has never been regarded as an exactly ideal example 
of a society with high moral standards. We contemplate this period as an epoch of violence and 
sexual excess, and the orgy is still considered as a particularly Roman event. This moral laxity 
provided the widespread use of a multitude of recipes for love potions, philters and aphrodisiacs 
of all type. Instructions for the preparation of aphrodisiacs were reported in Natural History by 
Pliny the Elder (23-79 A.D.) (Plinius Secundus, 1991). He collected the aphrodisiac recipes 
from earlier Roman and Greek traditions and described them in his work even if some were 
dubious. A strong element of magic pervades many of these recipes, whereas others are simply 
herbal mixtures. Pliny the Elder wrote of rocket (Brassica eruca L., Cruciferae) and nettle 
(Urtica dioica L., Urticaceae) which, among other things, were believed to have aphrodisiac 
properties. The nettle was used externally for its potent rubefacient action and could serve a 
useful purpose in sexual stimulation. In fact, the fine hairs on the nettle leaves contain a high 
concentration of acetylcholine and histamine which produce an inflammatory process. Another 
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counter-irritant aphrodisiac, but far more dangerous, described by Pliny was the cantharides or 
Spanish fly (Lytta vesicatoria L., Meloidae). Aristotle (384-322 B.C.) was the first person to 
describe blister beetles as an aphrodisiac. Livia, the Emperor Tiberius’s mother, purportedly 
slipped powdered cantharides into the food of other members of the imperial family to stimulate 
them into committing sexual indiscretions that could later be used against them. 
Xiphion spp. (Iridaceae) and Orchis spp. (Orchidaceae) were also recommended herbs. They 
were believed to have aphrodisiac properties because their root tubers resembled a pair of 
testicles. In fact, the word “orchid” is derived from the Greek language for testicle. 
The Roman tradition included also several plants used to decrease the sexual desire, the 
anaphrodisiacs. Among other plants, the one most frequently employed for this purpose was the 
Caecilian lettuce (Lactuca sp., Asteraceae) which was considered to have the power of 
quenching amorous propensities. 
 
The Arab tradition. The Arab civilization, which reached its peak around Baghdad in the 
thirteenth century, was extremely developed in medicine, chemistry, astronomy and philosophy. 
Its knowledge was slowly bought back to West Europe by crusaders returning from the Holy 
Wars. Among the different medical books returned, specific texts containing advice in sexual 
matters, prescription for sexual disorders, and lists of aphrodisiac drugs and recipes, have 
miraculously survived the religious intolerance of the Dark Ages. The best-known book on the 
subject is certainly The Perfumed Garden, written in the sixteenth century by Shaykh Umar ibn 
Muhammed al-Nefzawi and translated by Sir Richard Burton. This book contains contemporary 
and much earlier references to prescriptions for sexual disorders, and it is probably the most 
widely known book of sex instruction. Some of its recipes can be even traced to the original 
Galenic writings (“On the Secrets of Women” and “On the Secrets of Men”). The aphrodisiac 
mixtures included different drugs, depending on the purpose or the sex of the consumer. For 
example, drugs that excited the sexual desire of women were: aged olive oil, orchids, garden 
carrot seed, turnip seed, ash of the leaf of the oleander, dry alum, magpie excrement, powdered 
willow leaves, and piths of fine dates. 
In Arab tradition, the use of hot spices applied to the sexual organs as rubefacients was 
frequent. Macerated cubeb-pepper or cardamom grains or, alternatively, a mixture of pyrether, 
ginger and ointment of lilac were recommended by the author of The Perfumed Garden. In 
another chapter, rubefacients were also recommended for increasing the dimensions of small 
members. The immoderate use of all the known aphrodisiacs and of the strongest hot spices by 
different Arab populations was presumably due to their apprehension for a premature impotence 
as a result of the excesses to which polygamy led. 
The Arabs were also talented chemists; they were the first to use distillation techniques and 
were able to use alcohol to dissolve substances insoluble in water. This knowledge helped them 
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in the preparation of perfumes and essences from plants which had an important function in 
increasing the pleasure obtainable through sex. The title of The Perfumed Garden was probably 
attributed to the importance of this aspect of sensual pleasure.  
4. Assessing the effects of potential aphrodisiacs 
Behind the vast mythological component of aphrodisiacs, there also is an honest biological 
basis for human sexual arousal and a scientific explanation for why many of these compounds 
give people an effect. Despite the massive popularity of aphrodisiacs throughout history, the 
medical and scientific community has always been skeptical about them and has tended to 
conclude that no such substances, in the classical sense, exist. The puritanical values of western 
culture have turned a blind eye and have only recently begun to explore even medically 
diagnosed sexual dysfunctions. Consequently, investigations into both sexual stimulation and 
the effects of specific substances on sexual arousal are limited. Most data collected on the 
activities of drugs and food has arisen from information published about side effects of drugs 
designed for other purposes or in the specific area of male erectile dysfunction.  
Several conceptual and methodological difficulties should be noted in these types of medical 
investigation. One of the main problems in proving the existence of substances which can 
increase sexual desire is the inability of accurately measuring the level of desire. Physiologists 
have developed methods to measure objectively the level of sexual arousal, but sexual desire 
can really only be assessed subjectively by the individual, and factors such as conditioning can 
become vital (Taberner, 1985a). Measurement approaches can usually vary from one study to 
another, as certain investigators try to assess drug effects on subjective measures of sexual 
interest or desire, while others emphasize changes in physiological or hormonal indices of 
sexual response (Rosen and Ashton, 1993). 
Supplementary problems involve the potentially confounding results of drug dosage levels 
and duration of use, characteristics of the patient, and the social and medical context in which a 
specific drug is taken (Crowe and George, 1989). The conclusions of these investigations are 
often based upon anecdotal reports or case studies, although the obvious role of reporting biases 
on the part of patients and physicians (Buffum, 1982). Nonspecific effects of curing with some 
therapeutic drugs have not been adequately studied even if such remedies are known to enhance 
sexual performance as a result of improved health or psychological well-being of the individual. 
Furthermore, the use of double blind controls cannot be overemphasized, because of the 
significant placebo effect or positive expectations effect of studies in this area (Sonda et al., 
1990; Susset et al., 1989). Finally, the sexist bias in this research is evident, as pharmacological 
effects on female sexuality have been almost completely neglected by most investigators. 
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5. Aphrodisiacs that increase potency (allow or sustain 
erection) 
An increase in sexual desire caused by aphrodisiacs is not necessarily associated with a 
corresponding increase in the ability to satisfy this appetite. Drugs that increase the capacity in 
sexual activity often have a use in clinical medicine to restore the capability of a patient who has 
suffered from some pathological disorder which has resulted in organic impotence.  
5.1. Erectile dysfunction 
Many people believe that impotence is a disorder associated with modern civilization. 
However, preoccupation with potency has been present through the ages (Shah, 2002). 
The term “impotence” is derived from the Latin word impotentia, which literally translated 
means lack of power. It has traditionally been used to signify the inability of the male to attain 
and maintain erection of the penis sufficiently long to permit satisfactory sexual intercourse. 
This term, together with its pejorative implications, has often generated confusion in both 
clinical and basic science investigations, so it was recently replaced by the more precise term 
“erectile dysfunction” (NIH, 1993). 
For years, psychological factors were implicated as the main cause of impotence, but during 
the last decade there has been an important change in the management of sexual dysfunction. 
This revolution was essentially due to the improved understanding of erectile physiology and to 
the development of new and effective medical therapies. The number of men affected by 
erectile dysfunction has reached approximately 10 to 20 million in the United States (NIH, 
1993). Even though the loss of erectile function is not an inevitable consequence of normal 
aging, it becomes more frequent with age. Recent investigations reveal that up to 70% of 70 
years old males have some dysfunction and 50% have moderate or severe problems (Colpo, 
1998). 
In most men, erectile dysfunction is thought to be the consequence of organic deterioration, 
especially circulatory insufficiency (Krane et al., 1989). The usual origin is an organic factor or 
disease, such as hypertension, hypercholesteremia, vascular and heart diseases, diabetes mellitus, 
surgery and trauma, side effects of medications or neurodegenerative disorders, and the use of 
tobacco. Psychological problems also give an important contribution to the weakening of sexual 
performance, diminishing self-esteem, and disrupting personal relationships (Feldman et al., 
1994). 
An erection is a hemodynamic balance between inflow and outflow of blood within two 
chambers, called the corpora cavernosa (Figure 0-4). These cavities, which run the length of the 
organ, are filled with spongy tissue, and surrounded by a membrane, called the tunica albuginea. 
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The spongy tissue contains smooth muscles, fibrous tissues, spaces, veins, and arteries. Erection 
begins with sensory and mental stimulation. Impulses from the brain and local nerves cause the 
muscles of the corpora cavernosa to relax, allowing blood to flow in and fill the open spaces. 
The blood creates pressure in the corpora cavernosa, making the penis expand. The tunica 
albuginea helps to trap the blood in the corpora cavernosa, thereby sustaining erection. Erection 
is reversed when muscles in the penis contract, stopping the inflow of blood and opening 
outflow channels. The relaxing of the muscles of the corpora and penile arterial vessels is 
mediated by nitric oxide (NO), which is synthesized in the nerve terminals innervating these 
muscles. Any problem in blood inflow and outflow can be the origin of erectile dysfunction. 
 
 
 
 
Figure 0-4 
Transverse section of the penis. 
 
 
 
Normal neurologic innervations of an intact vascular tree and normal sexual desire are 
essential factors for a man to achieve an erection. When one or more of these factors fails or is 
deteriorated, an erectile dysfunction can be developed by the individual. Since 90% of all 
patients with impotence have a physiologic problem, that is where most of the treatment options 
are focused (Colpo, 1998). Current treatments of erectile dysfunction include oral medication, 
intracorporal injections, intraurethral applications, vacuum pumps, and penile prostheses. 
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5.2. Oral medication 
Three oral medications are well-known for their ability to cause and sustain an erection: 
Spanish fly, yohimbine and the phosphodiesterase inhibitors. Spanish fly is an ancient natural 
aphrodisiac which has fallen into disuse for the treatment of erectile dysfunction because of its 
numerous toxic effects. Yohimbine is an indole alkaloid extracted mainly from an African plant 
(Pausinystalia yohimbe PIERRE ex BEILLE, Rubiaceae) which has recently been the focus of 
new public interest. As more and more information is gained on the mechanism underlying 
penile erection, more drugs are being developed to treat erectile dysfunction. The most 
promising of these synthetic medications are the phosphodiesterase inhibitors which are 
effective in treating both organic and psychological impotence. 
5.2.1. Yohimbine 
Yohimbine is an indole alkaloid (Figure 0-5) with a competitive antagonist activity selective 
for the α2-adrenergic receptor (Murburg et al., 1991). 
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Figure 0-5 
Structure of yohimbine. 
 
It comes from the bark of the West African tree Pausinystalia yohimbe PIERRE ex BEILLE 
(Rubiaceae) (Synonym: Corynanthe yohimbe) and it was first isolated in 1896. The bark of the 
tree is traditionally used in African and West Indian medicine as an aphrodisiac with the ability 
to increase sexual potency and virility. Afrodex®, a drug containing yohimbine hydrochloride, 
methyl testosterone and Strychnos nux-vomica L. (Loganiaceae), was claimed to have 
aphrodisiac powers and remained on the African market until 1973 (Sonda et al., 1990). 
Renewed interest in yohimbine for erectile dysfunction has prompted several new investigative 
trials, including chemical ones. Some indications are that in certain cases yohimbine can 
improve sexual performance (Ernst and Pittler, 1998), but generally it has limited efficacy. The 
American Urological Association in its clinical guidelines recently states that “… yohimbine 
Introduction 
 
   
II. 
20 
does not indicate a significant role in the treatment of organic erectile dysfunction… reported 
benefits have been modest and there is a pronounced placebo effect” (Montague et al., 1996). 
Despite studies which show that yohimbine is generally well tolerated with few and benign side 
effects, other reports illustrate its potential risks on certain individuals. Common adverse effects 
of yohimbine include increased blood pressure, tachycardia, anxiety, and manic reactions 
(Grossman et al., 1993; Gurguis and Uhde, 1990; Holmberg and Gershon, 1961; Lacomblez et 
al., 1989; Onrot et al., 1987; Price et al., 1984; Teloken et al., 1998). This drug is still used for 
men with a psychological component to their erectile dysfunction, or for those who absolutely 
refuse any other type of therapy. Most men receive prescriptions for this medication, but it is 
available over the counter at health food stores or it is sold on the Internet. For more chemical 
and pharmacological details on yohimbine, see chapters III.1.2 and III.1.3. 
5.2.2. Spanish fly 
Spanish flies or cantharides are the common names for a variety of blister beetles, usually 
black or bronze-green, mostly elongate and cylindrical (18 to 25 mm), belonging to the family 
Meloidae (order Coleoptera). Cantharides is generally specified as the Eurasian Lytta 
vesicatoria L. (syn. Cantharis vesicatoria) (Figure 0-6), or as other genera, particularly 
Mylabris and Epicauta. The beetles are most commonly found in southern Europe, Africa, and 
Asia. Adult beetles are phytophagous, feeding especially on plants of the families 
Amaranthaceae, Asteraceae, Leguminosae, and Solanaceae. Some American species are pests, 
devastating potato, tomato, beet and clover crops. The larvae, on the other hand, are considered 
beneficial because they feed on grasshopper eggs. When disturbed, the beetles release an 
irritating substance called cantharidin (3α,7α-dimethylhexahydro-4,7-epoxyisobenzofuran-1,3-
dione) from the joints between their leg segments. 
 
 
Figure 0-6 
Lytta vesicatoria L. (syn. Cantharis vesicatoria), Meloidae. 
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Preparations containing the dried beetles have been official in most European and American 
Pharmacopoeias, and still linger on in veterinary medicine as blistering and wart-removing 
agents. The beetles for these preparations are collected before sunrise, while unable to use their 
wings, by shaking them from the trees on to cloth spread underneath. 
The main active principle of cantharides is cantharidin (Figure 0-7), a crystalline lactone, of 
which good specimens of the beetle yield from 0.4 to 1.1%. It exists in the beetles mainly in the 
free state, but a varying proportion is combined in the form of the potassium salt of 
cantharidinic acid. Cantharidin is a vesicant and a mucosal irritant causing intraepidermal 
blisters. It was formerly topically used as counter-irritant and internally as diuretic and for 
impotence. Due to its numerous toxic effects, cantharidin has fallen into disuse for most 
legitimate medical purposes. The toxic dose in humans can be as little as 3 mg and the fatal dose 
is only 32 mg (Taberner, 1985b). Cantharides also contain 10 to 15% of fat. 
 
 
O
CH3
CH3 O
O
O CH3
CH3 O
O
O
OH
OH
cantharidin cantharidinic acid
 
Figure 0-7 
Structures of cantharidin and cantharidinic acid. 
 
 
Humans were quick to attribute aphrodisiac properties to cantharidin. As far back as the third 
century B.C., Aristotle had already described the properties of blister beetles, and Pliny the 
Elder (23-79 A.D.) reported the aphrodisiac virtues of these insects in his work Natural History. 
Tacitus, in his Annals of Imperial Rome, mentioned that cantharides were available and used by 
the Emperor Tiberius’s mother, Livia, to stimulate the sexual appetite of other members of the 
imperial family. During the kingdom of Louis XIII (1610-1643), a preparation containing 
cantharides was commercialized by the minister Armand Jean du Plessis (Cardinal de 
Richelieu) under the famous name of “bombons à la cantharide du Cardinal” (Hostettmann, 
2000). Madame de Pompadour apparently used tincture of cantharides to regain and maintain 
the sexual attentions of King Louis XV. In 1772, the Marquis de Sade, the infamous French 
writer of novels and short stories characterized by a preoccupation with sexual violence, was 
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tried in court for poisoning several prostitutes. He had, in secret, given them cantharides in the 
hope that it would arouse them sexually. 
The aphrodisiac reputation of cantharides probably rests upon the ability to cause irritation of 
the urethra with resultant vascular congestion and inflammation of the erectile tissue in male or 
female genitalia, a sensation that may be interpreted as enhanced sexuality by some (Till and 
Majmudar, 1981). Besides its long and colorful history, perpetuated by a reputation as an 
aphrodisiac, cantharides and their active principle cantharidin are famous for their toxicity as 
punctuated by numerous reports of poisoning (Fisch et al., 1978; Harrisberg et al., 1984; Karras 
et al., 1996; Marcovigi et al., 1995; Polettini et al., 1992; Tagwireyi et al., 2000; Till and 
Majmudar, 1981). Many of the toxic effects of cantharides are directly related to the vesicant 
properties of cantharidin. It causes blistering of mucus membranes upon contact: hemorrhagic 
mucositis of the mouth, esophagus, and stomach is a frequent cause of death from the drug. 
Gross genitor-urinary hemorrhage is another common occurrence and results from tubular 
necrosis and glomerular damage as well as from blister formation in the lower urinary tract. 
Some references mention cases of persistent erection or priapism, which may be extremely 
painful, particularly if urination becomes impossible (Karras et al., 1996). 
Unfortunately, the myth of Spanish fly as an aphrodisiac has outlived its medical utility. It is 
debatable as to whether or not commercial preparations of Spanish Fly sold in western sex-
shops and through the mail actually contain cantharidin. The high toxicity may well prevent 
many producers from really adding cantharidin to “love potions”. Such products are usually 
labeled “placebo” and any cantharidin that is present is contained in homeopathic dilutions. 
However, other preparations containing cantharidin in concentrations capable of causing severe 
toxicity are available illicitly on the black market or from countries where the controls are less 
stringent.  
There is another potential risk of cantharidin poisoning in African countries where beetles are 
considered delicacies and where ingestions of frogs or birds which have eaten the beetles may 
also cause toxicity (Eisner et al., 1990). 
5.2.3. Phosphodiesterase inhibitors 
As information is progressively gained on how the relaxation process takes place in the penis, 
more drugs are being developed to treat erectile dysfunction. The phosphodiesterase type 5 
(PDE5) inhibitors are new drugs which affect local regulation of erectile function by 
potentiating the effects of nitric oxide (NO). 
The first developed and consequently the most famous is sildenafil (Figure 0-8), the active 
principle of the oral pill Viagra®, produced by the Pfizer Corporation, and approved by the FDA 
in early April 1998. This active compound is effective in treating both organic and 
psychological impotence (Boolell et al., 1996). 
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Figure 0-8 
Structures of three phosphodiesterase type 5 inhibitors. 
 
 
As already explained in previous chapters, penile erection is a hemodynamic process 
involving relaxation of smooth muscle of the corpus cavernosum and its associated arterioles. 
This relaxation process results in an increased flow of blood into the trabecular spaces of the 
corpora cavernosa (Andersson and Wagner, 1995). Smooth muscle relaxation is mediated by 
NO which, on sexual stimulation (visual or otherwise), is released in the nerve terminals of 
parasympathetic non-adrenergic, non-cholinergic neurons in the penis and also by the 
endothelial cells of blood vessels and corpora cavernosa (Burnett et al., 1992). NO activates 
guanylate cyclase which increases the conversion of guanosine triphosphate (GTP) to cyclic 
guanosine monophosphate (cGMP). This latter provides the signal which leads to relaxation of 
smooth muscle of the corpus cavernosum and the penile arterioles. The erection caused by this 
relaxation ceases after a while because cGMP is hydrolyzed to guanosine 5’-monophosphate 
(GMP) by cyclic nucleotide phosphodiesterase (PDE) isozymes (Beavo, 1995). Of the PDE 
isozyme families known, only PDE5 and PDE6 are specific for cGMP as a substrate. PDE3 and 
PDE4 are specific for cyclic adenosine monophosphate (cAMP), and PDE1 and PDE2 
hydrolyze both cGMP and cAMP. Therefore, substances that inhibit cGMP hydrolysis increase 
the cGMP signal, enhancing the relaxation of smooth muscles in the corpus cavernosum and 
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facilitating penile erection. Sildenafil is a potent inhibitor of the cGMP-specific PDE5 found in 
corpus cavernosum (Figure 0-9). 
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Figure 0-9 
Action of sildenafil (Viagra®) in erectile dysfunction (Drewes et al., 2003). 
 
 
Sildenafil has to be taken 1 hour before desired intercourse and then, ½ to 1 hour later, the 
sexual stimulation must be performed to bring on the erection. If no stimulation occurs, nothing 
will happen. Side effects can include facial flushing, mild headaches, diarrhea and mild 
disturbance of the vision (blue haze). Sildenafil has not to be administrated to patients with 
heart problems taking nitrate medications because of the severe potentiation of vasodilatory 
effects. 
Two other potent, selective, reversible PDE5 inhibitors, tadalafil (Cialis®) and vardenafil 
(Levitra®) (Figure 0-8), respectively produced by  Lilly-ICOS and Bayer Pharmaceutical 
Company, are under regulatory review in Europe, the United States and other countries. In both 
chemical and PDE subtype selectivity profiles, tadalafil differs markedly from sildenafil and 
vardenafil. Tadalafil is approximately 780 times more selective for PDE5 than PDE6 while 
vardenafil and sildenafil are, respectively, only 2.9 and 6.8 times more selective (Brock, 2002). 
Although these in vitro selectivity ratios cannot be extrapolated to clinical findings with each 
PDE5 inhibitor, color visual disturbances occur in up to 11% of sildenafil patients, in a small 
minority of vardenafil patients and in only 0.1% tadalafil patients. Compared with sildenafil and 
vardenafil, tadalafil also exhibits a prolonged plasma residence (t½ 17.5 hrs) and prolonged 
therapeutic response. 
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5.2.4. Alternative herbal remedies 
The commercialization of the synthetic “love drug” Viagra® has not only captivated the public 
imagination, but has led to the reconsideration of classical natural aphrodisiacs for their use to 
combat impotence, and to the search for a new natural product which can truly compete with 
Viagra®. Since the reassessment of “old” natural products such as yohimbine and cantharidin 
has not given new significant results, investigators have directed their researches at aphrodisiacs 
used in various traditional medicines.  A lot of work has been done to trace their history, to 
examine herbs as folklore traditional healing, and to summarize the latest scientific research on 
their many benefits and the ways potential hazards, if any, can be avoided (Adimoelja, 2000). 
 
Vuka-vuka. With the explosion of web-based sales, it is now possible to buy herbal remedies 
from around the world, including vuka-vuka, the “African natural Viagra®”. This traditional 
preparation originates from Zimbabwe and has become famous worldwide after a programme of 
the American CNN in 1998. In Zimbabwe, vuka-vuka  is a popular drug used by a high 
proportion of men. In Ndebele, one of the languages of Zimbabwe, vuka-vuka means “wake-up, 
wake-up”. The aphrodisiac preparations are sold at different markets in Harare (Mbara market) 
and Bulawayo by traditional healers. There are two forms of vuka-vuka, one an herbal remedy 
and the other a concoction containing cantharidin extracted from Mylabris spp. This latter has 
already been the cause of several health problems in Zimbabwe and can be potentially 
dangerous for tourists attracted by experimenting with new aphrodisiacs. The herbal preparation 
has different constituents, depending on the traditional healer who formulates it. In general, 
three drugs are common to all mixtures and have equal amounts: the root bark of Mondia 
whiteii Skeels (Asclepiadaceae), the roots of Albizzia antunesiana Harms (Leguminosae), and 
the stem bark of Ozoroa insignis Delile (Anacardiaceae). Three other plants are traditionally 
used in the formulation of vuka-vuka, but they are not always present: the stem or root bark of 
Pouzolzia hypoleuca Wedd. (Urticaceae), the roots of Elephantorrhiza goetzi Harms 
(Leguminosae), and the stem bark of Cassia singueana Delile (Leguminosae). The efficacy of 
these plants in the cure of impotence have not been demonstrated yet. 
 
Tribulus terrestris. Tribulus terrestris L. (Zygophyllaceae) is an annual creeping herb 
growing on roadsides and hills in China, Japan, Korea, the western part of Asia, the southern 
part of Europe and Africa. It has long been used in the traditional Chinese and Indian systems of 
medicine for the treatment of various ailments and is popularly claimed to improve sexual 
function in man. Several researchers have presented evidence that protodioscin, a compound 
present in the Tribulus terrestris L. extract, can improve sexual desire and enhance erection 
(Adaikan et al., 2000; Adimoelja, 2000). The activity of the plant has been clinically proved 
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(Miller, 1988). It is considered as a neurosteroid which acts centrally as a γ-aminobutyric acid 
antagonist to facilitate sexual function. The mechanism of the increase of DHEA after a 
constant administration of the extract of Tribulus terrestris L. still needs some clarification, 
however some studies provide evidence for the claimed role of this plant as an aphrodisiac in 
traditional medicine (Adaikan et al., 2000; Adimoelja, 2000; Gauthaman et al., 2002). 
 
Maca. Lepidium meyenii Walp. (Brassicaceae), commonly known in South America as maca, 
is a nutritionally valuable Peruvian plant and is traditionally used in the Andean region for its 
supposed properties to improve energy, fertility in both sexes and male potency (Cicero et al., 
2001; Muhammad et al., 2002). Maca is a crop which is found only in a very restricted area of 
central Peru, in the agro-ecological zone above 4000 m where low temperature and strong winds 
limit other crops. It can be successfully cultivated outside its current natural habitat giving 
edible and high nutritive (especially proteins and minerals) subterranean parts (hypocotyl). 
There is no reliable scientific evidence to confirm a positive effect of maca on an increase of 
sexual performance, but recent studies have shown that oral administration of a lipidic extract 
from L. meyenii increases the number of complete introductions and the number of sperm-
positive females in normal mice and decreases the erection latency in male rats with erectile 
dysfunction (Cicero et al., 2001; Zheng et al., 2000). Besides this scientific evidence, further 
systematic approaches are needed to find which constituent of the plant is responsible for the 
observed effect on the sexual performance parameters. 
 
Catuama and muira-puama. Catuama® is a Brazilian herbal medicine recommended for 
certain disorders, including physical and mental fatigue, neuromuscular asthenia and general 
weakness (Antunes et al., 2001). Catuama® consists of a mixture of crude hydroalcoholic 
extracts of four medical plants: Paullinia cupana H.B. et K. (Sapindaceae; guaraná), Trichilia 
catigua A. Juss. (Meliaceae; catuaba), Zingiber officinale Rosc. (Zingiberaceae; ginger), and 
Ptychopetalum olacoides Benth. (Olacaceae; muira-puama).The individual components have 
also been used, separately, for centuries, to cure different complications. However, more 
recently, it is the combination of the four plants that has been promoted as an aphrodisiac. 
Latest investigations have shown that Catuama® relaxes various arterial vessels by a mechanism 
involving the release of nitric oxide (NO) (Calixto and Cabrini, 1997). This relaxing activity 
was attributed to active principles present mainly in P. cupana, T. catigua and Z. officinale. 
Since relaxation of corpus cavernosum is a key step in penile erection, the effects of Catuama® 
and the extracts of single plants were examined on isolated rabbit corpus cavernosum 
preparations using a bioassay cascade (Antunes et al., 2001). In these experiments, Catuama® 
and each of its plant constituents showed dose-dependent relaxation of the rabbit isolated corpus 
cavernosum. T. catigua extract caused a prolonged and sustained relaxation, while the other 
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extracts produced short-lived relaxations. Of the four extracts assayed, P. cupana was the most 
effective in causing relaxation of smooth muscle. 
The wood and bark of  Ptychopetalum olacoides Benth. and Ptychopetalum uncinatum 
Anselmino (Olacaceae) make up the herbal remedy known in Brazil as muira-puama. These 
plants have been traditionally used for different purposes, including the treatment of erectile 
dysfunction (Drewes et al., 2003). Even though more investigations are needed to prove the 
efficacy of muira-puama, a human trial carried out by a French group showed the herbal 
remedy to be effective in improving libido and treating sexual impotency (Waynberg, 1990). 
It has to be noted that the vernacular name of T. catigua, catuaba, is the name given to a 
popular herbal medicine from Brazil. Plants of different genera have been referred to as catuaba, 
and these have been attributed with aphrodisiac and tonic properties (see chapter IV.1.1). 
 
5.3. Intracorporal injections and intraurethral applications 
In the early 1980s, treatment of erectile dysfunction took a whole new turn with the discovery 
of vasoactive drugs which injected into the penis could produce a rigid erection. The most 
common agents used today include papaverine, prostaglandin, and phentolamine, either alone or 
in combinations with each other (Figure 0-10). In general, 75% of men with erectile 
dysfunctions have a good response to injection therapy. However, patients must be carefully 
instructed in the method of penile injections in order to avoid complications. 
 
Papaverine. Papaverine is a potent direct smooth muscle relaxant isolated from the white 
poppy, Papaver somniferum L. (Papaveraceae). This plant yields opium, the dried latex of the 
immature poppy capsule, a mixture of twenty-six alkaloids, including morphine, codeine, 
laudanine, thebaine, and papaverine. It is the earliest known painkiller and archeological 
evidence suggests that opium poppies were grown as a medical and psychoactive  drug during 
the Neolithic and Bronze Ages. 
Virag was the first to discover that an injection of papaverine in the corpus cavernosum 
produced erections by causing arterial vasodilatation and smooth muscle relaxation (Virag, 
1982). Since that time, other substances have been identified. The most dangerous complication 
that can occur with papaverine injections is priapism (Lomas and Jarow, 1992). This is a full, 
firm erection that lasts more than 4 hours, becoming quite painful and if not detumesced can 
cause permanent damage. Other complications can include scarring, bleeding, and bruising at 
the injection site, pain, and infection (Colpo, 1998). Scarring may occur as a result of repeated 
injections in a small area or by the acidity of the injection solutions. Because of the high 
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incidence of these side effects, the use of papaverine as a single agent has fallen out of favor. It 
is commonly used in a tri-mix combination, including prostaglandin and phentolamine. 
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Figure 0-10 
Structures of papaverine, phentolamine, and prostaglandin E-1. 
 
 
Prostaglandin. Prostaglandin (PGE-1) is a naturally occurring agent that induces smooth 
muscle relaxation. It is released by the prostate during ejaculation and, as an injectable agent, 
has the advantage of being metabolized quickly within the penis. This decreases the incidence 
of priapism and scarring. Used as a single agent, PGE-1 has the disadvantage of causing penile 
pain, which occurs in up to 30% of patients (Schramek et al., 1990). 
A related substance of prostaglandin, alprostadil, is used as an intraurethral drug. This drug, in 
a pellet form, is inserted into the end of the penis through an applicator and absorbed through 
the urethral wall into the corpora, causing an erection 10 min later. This is an innovative system 
because it is simple and non-invasive. However, some disadvantages, such as burning of the 
urethra upon application, pains similar to that of prostaglandin injections, possible light-
headedness or syncope after application, erections which are not so rigid and cost of the 
medication,  can discourage patients from using this intreurethral medication (Colpo, 1998). 
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Phentolamine. Phentolamine in an α-adrenergic antagonist that modulates the sympathetic 
nervous system. Its employment as a single agent is very erratic. When used in combination 
with papaverine and PGE-1, phentolamine potentiates the effect of these latter and reduces their 
incidence of pain (Govier et al., 1993). 
6. Aphrodisiacs that increase sexual desire 
The aphrodisiacs discussed in this chapter are oral pharmacological agents with potential to 
directly influence the motivational and/or pleasure components of sexual response. In general, 
these types of aphrodisiacs act at the level of the central nervous system (CNS) by changing 
specific neurotransmitters or specific sex hormone concentrations. Some of them can be 
effective in both sexes, although those acting through an increase in hormone concentration are 
often sex-specific. 
The role of neurotransmitters and hormones has been extensively investigated and there is 
growing evidence that some of them may have positive effects on sexual performance. Certain 
neurotransmitters and peptides such as dopamine, oxytocin and adrenocorticotrophic hormone 
(ACTH), have facilitatory effects on sexual behavior while γ-aminobutyric acid (GABA), 
endogenous opioids and norepinephrine appear to be inhibitors. The complex role of 
neurotransmitters in the control of sexual behavior has led researchers to investigate a broad 
range of receptor agonists (stimulating agents) and antagonists (blocking agents). Some of the 
traditional aphrodisiacs also work via peripheral and central neurotransmitter action. The 
alkaloid yohimbine, for example, stimulates the peripheral and central nervous system by acting 
on α-adrenoceptors (Feuerstein et al., 1985). 
 
Dopamine agonists. The neurotransmitter dopamine also stimulates copulatory behavior. 
There is considerable evidence for prosexual effects of dopamine agonists in various nonhuman  
species, but the first indication of these affecting humans came from early studies of 
dopaminergic drugs in the treatment of Parkinson’s disease. In fact, soon after L-dopa became 
clinically available, a number of clinical reports appeared of hypersexuality in patients receiving 
drug treatment (Rosen and Ashton, 1993). In 1978, E. Brown and coworkers reported that four 
out of seven men taking L-dopa had increased sexual interest or activity. Based on intensive 
neurologic and psychiatric assessments before and after treatment, they concluded that sexual 
drive changes were unrelated to improved physical or mental health in these patients (Brown et 
al., 1978). 
Clinical studies on L-dopa and other dopaminergic drugs such as apomorphine, nomifensine 
and bupropion have shown increased sexual desire and arousal in patients with erectile 
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dysfunction or inhibited sexual desire. Interestingly, clinical work on nomifensine and 
bupropion, two atypical antidepressant agents, was conducted on both male and female patients 
and were found to be active in both sexes (Rosen and Ashton, 1993). Even though these studies 
have reported positive results, the high rate of adverse side effects limits the clinical usefulness 
of these drugs as well as other dopaminergic agents of this type. Despite this, some 
entrepreneurial individuals in the US and Europe are making a lot of money out of the 
supposedly aphrodisiac effects of L-dopa. 
 
α-Adrenergic drugs. The most famous active principle having a prosexual effect and 
acting as a α-adrenergic antagonist, is certainly yohimbine (see chapter III.1.3). Even though 
different studies suggest that yohimbine treatment has the capacity to positively affect sexual 
desire and performance, at least in some subjects other studies report that more than half of all 
patients have shown little or no benefit from the drug. Based upon investigations of yohimbine’s 
effects on mounting behavior in male rats, Clark and coworkers suggested that α-adrenoceptor 
stimulation directly increases libido (Clark et al., 1984). Unfortunately, these results failed to be 
confirmed by another study carried out by Chambers and Phoenix on rhesus monkeys 
(Chambers and Phoenix, 1989). 
 
Serotonergic drugs. Serotonin is generally viewed as an inhibitory neurotransmitter in the 
control of sexual drive (Foreman and Wernicke, 1990). However, several serotonergic drugs 
such as trazodone, clomipramine, and fluoxetine, have been reported to enhance sexual activity. 
Trazodone, for example, a well known antidepressant, inhibits serotonin re-uptake and several 
clinical trials have reported increased libido in male and female patients treated with the drug. 
Changes in sexual desire are apparently unrelated to the antidepressant effects of the drug. 
Nevertheless, despite potential benefits these drugs have serious side effects (sedation, blurred 
vision, dry mouth, fatigue, constipation, headaches) and some patients may find prolonged 
erectile stimulation embarrassing. 
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7. The commercial accessibility of aphrodisiacs and their 
dangers 
The long pathway from advertising aphrodisiacs as magic-religious charms to witchdoctors, 
herbalism, pseudo-scientists and Viagra® is a fascinating one. Throughout the ages, quacks have 
used aphrodisiacs to exploit vulnerable victims, 30% of whom through the power of suggestion 
have achieved sexual success from potions, powders and sexual pomades (Renshaw, 1978). 
All through history, pseudo-healers and charlatans have sought success in marketing what 
they claim to be sex-potions and they have often succeeded in selling their miracle drugs. 
Herbal medicine is an ancient and respected science which has led to the discovery of many of 
the effective drugs used clinically today. Ancient herbal texts have also provided the basis of 
modern medicine. The genuine herbalists have always had complete faith in the value of their 
treatment and their objective has been at all times to help their patients. In opposition, the 
quacks have unashamedly attempted the exploitation of their clients by offering remedies which 
they know to be ineffective and selling them at inflated prices. Preparations which are claimed 
to increase sexual desire or virility are clearly going to provide lucrative benefits for these 
charlatans who trade upon the credulity and ignorance of their clients. Taberner in his eminent 
book on aphrodisiacs clearly reported this conception about herbalism and quackery: 
“There is a grey area between herbalism and quackery into which many of the reputated 
aphrodisiac preparations fall. The simplest means of differentiating between the two is to 
consider the intent of the seller as being the important criterion. Once a herbal remedy has been 
shown conclusively to be a little or no worth, then it becomes quackery to continue to sell it 
with that knowledge.” (Taberner, 1985a). 
In the 21st century, obsession with sexual performance is an international phenomenon and 
many entrepreneurs try to obtain large profits from it as shown by the widespread trade of all 
sexually related products, including aphrodisiacs. Quackery is still a common practice in our 
time and charlatans have gained new means of spreading their impostures. While in the past, 
advertising aphrodisiacs was primarily by word of mouth, today internet advertising, radio 
airtime, and commercial-packed television broadcasts are potent means for marketing 
“wonderful” sex-remedies. The power and the high responsibility of these media in the 
divulgation of dubious health claims and in the commercial promotion of certain drugs, is 
illustrated by the explosion of the Viagra® phenomenon in 1998. Led by an immense marketing 
strategy orchestrated by the manufacturing company Pfizer and with the aid of news coverage, 
Viagra® has become one of the best-selling drugs in modern medical history. The wide media 
attention for Viagra® has created a new massive public interest in aphrodisiacs and remedies for 
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erectile dysfunction, especially in the so-called herbal alternative products. Although many of 
these products sold are labeled as “natural”, this does not ensure the product’s safety or efficacy. 
Many of the reputed aphrodisiacs described in this work could be safe drugs or dangerous 
poisons. In fact, there is no real distinction between a drug and a poison; many clinically used 
drugs can be toxic at doses only slightly above the recommended therapeutic dose. There is also 
a widespread and unfortunate misconception that a drug of natural origin must intrinsically be 
good and cannot cause any poisoning, but people often forget that the most deadly venoms are 
from nature. It is quite likely that many cases of accidental self-poisoning arise from this 
erroneous idea. 
Toxic and lethal cases involving individuals who seek new sexual experiences using chemical 
and herbal aphrodisiacs are constantly reported throughout the world. Upon exposure, the 
clinical toxicity may vary from mild to severe and may even be life-threatening.  
During February 1993-May 1995, the New York City Poison Control Center was informed 
about the onset of illness in five previously healthy men after they ingested a substance 
marketed as a topical aphrodisiac; four of the men died (MMWR, 1995). The deceased died 
from cardiac dysrhythmia due to inappropriate use of the purported aphrodisiac which was 
found to contain bufadienolides, naturally occurring cardioactive steroids that have digoxin-like 
effects. The product marketed as an aphrodisiac was sold under names such as “Stone”, “Love 
Stone”, “Black Stone”, and “Rock Hard” and was available in grocery stores and smoke shops 
and from street vendors. In addition to bufadienolides, the active ingredients of these 
aphrodisiacs, extracted from the Bufo toad (Bufo marinus L.) skin and glands, contained 
bufotenin and its O-methylated derivative, a putative hallucinogen congener of serotonin. The 
same cardioactive steroids have been found as the active ingredients in Chan Su, a Chinese 
patent medicine used as a topical anesthetic and cardiotonic agent. Cardioactive steroids, 
including bufadienolides, have a narrow therapeutic index, and unintentional therapeutic 
intoxication is well documented. 
As already reported in the previous chapter, the aphrodisiac “Spanish fly” is another well-
documented source of  poisoning in different countries (Fisch et al., 1978; Harrisberg et al., 
1984; Karras et al., 1996; Marcovigi et al., 1995; Polettini et al., 1992; Tagwireyi et al., 2000; 
Till and Majmudar, 1981). 
Due to increased morbidity and mortality, poisonings associated with the use of herbal 
remedies have raised universal attention in the last few years (Deng, 2002). But unfortunately, 
in daily practice, many cases of herbal poisoning were not diagnosed or treated correctly, and 
therefore, more information about the toxicology of herbal products is urgently needed. Lack of 
regulation, easy accessibility, contamination, adulteration and toxic potential are some of the 
dangers deemed to be associated with aphrodisiac poisoning. Of these factors, contamination, 
adulteration and natural toxic substances are three main risk factors connected with the 
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aphrodisiac product itself, which may potentially cause poisoning. Herbal aphrodisiacs may be 
contaminated with pesticides, moulds and/or heavy metals in the botanical product, and by 
minerals and/or prescription drugs in the final medicines. Herbs may also be adulterated with 
western medicines, such as steroids, hormones, CNS stimulants, etc. Recently, the FDA issued a 
warning on an all-natural herbal product claiming to increase the sexual experience for both 
men and women, and found to contain Viagra® (Mitka, 2003). The incriminated product, 
Vinarol®, was sold over the counter and through the Internet, at a cost that ranged from $6 to 
$10 per tablet. A spokeswoman of the company which commercialized Vinarol® claimed either 
employee tampering was responsible, or a shipment of herbs from China was already tainted 
with sildenafil. 
Since herbal poisoning can result from contamination, adulteration or natural toxins, 
qualitative and quantitative analyses to delineate the incriminating components should be 
undertaken. Scientific research conducted to investigate the biological activity, safety, and 
efficacy of aphrodisiacs would be of great benefit to patients and the health community. 
  
  
III. Qualitative and quantitative determination of 
yohimbine in authentic yohimbe bark and 
commercial aphrodisiacs 
  
Qualitative and quantitative determination of yohimbine in authentic 
yohimbe bark and commercial aphrodisiacs 
   
III. 
37
1.  Introduction 
1.1. Yohimbe: the revival of an old aphrodisiac 
Since its commercialization, Viagra has focalized huge media attention and created massive 
public interest in the availability of so-called aphrodisiacs and remedies for erectile dysfunction. 
This interest has had a knock-on effect and has led to a resurgence of sales in more  easily-
available herbal supplements‡ (LaFrance et al., 2000), in particular those containing yohimbe 
(Sunderland et al., 1999). The importance of this phenomenon has been reported, but also 
extended by the existence of thousands of websites pretending to have discovered miraculous 
natural mixtures able to increase sexual desire (Figure 0-1).  
One of the main recurrent ingredients of these commercialized products is the dried bark of 
Pausinystalia yohimbe PIERRE ex BEILLE (Rubiaceae) (Synonym: Corynanthe yohimbe) (Betz 
et al., 1995), a tree native to the coastal forests of Central Africa and distributed from Southeast 
Nigeria to the Congolese Mayombe region. P. yohimbe is a fast-growing tree but does not reach 
a great diameter (max. of ca. 50 cm) and has been referred to as “common”. This bark has long 
been considered an aphrodisiac and it is extensively used by local populations as part of 
traditional health care systems. The pygmies and bushmen of West African tropical zones 
certainly knew of the yohimbe power at an early date. Bantu-speaking tribe members were also 
aware of the faculty of this tree and they used decoctions made from its bark for marriage 
ceremonies and ritual orgies (Rätsch, 1997). Yohimbe is traditionally employed among other 
indications as a local anesthetic, sympatholytic, hypertensive drug in small doses, as well as 
hypotensive and hallucinogen in large doses, but the most common use remains as an 
aphrodisiac (Lewis and Elvin-Lewis, 1977; Oliver-Bever, 1986). In addition to its extensive 
indigenous use, the bark of yohimbe has been exported for many years to Europe, where the 
                                                
‡
 Most people think that dietary supplements and herbs are closely regulated to ensure that they are safe, 
effective, and truthfully advertised. Herbal supplements are considered foods, not drugs, by the US Food 
and Drug Administration (FDA) and, therefore, are not subject to the same testing, manufacturing, and 
labeling standards and regulations as drugs. Until 1994, the FDA had disallowed health claims of any 
kind on herbal supplements. The passage of the Federal Dietary Supplement and Health Education Act 
(DSHEA) in late 1994 started to reverse this trend and severely limited the FDA’s ability to regulate these 
products. In January 2000, the FDA updated the laws governing the labeling of herbal supplements, so 
consumers now can see labels that explain how herbs can influence different actions in the body. 
However, herbal supplement labels still cannot say anything about treating specific medical conditions, 
because they are not subject to clinical trials or to the same manufacturing standards as prescription or 
traditional over-the-counter drugs. 
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drug is both prescribed in western medicine and sold in herbal markets. Its interest outside the 
African continent was first recorded in Germany, where yohimbine, the main alkaloid of the 
drug and also known as aphrodine, quebrachine or corynin, was isolated for the first time by 
Spiegel in 1896 (Morales, 2000). Recent advancements in the development of yohimbe-based 
remedies have led to an increased demand for the export market. 
 
 
 
Figure 0-1 
Results obtained in a search for aphrodisiacs on the Internet by a generic search engine. 
 
 
Exploitation of P. yohimbe bark currently takes place in Cameroon and, to a lesser extent, 
Southeast Nigeria from wild populations (Sunderland et al., 1999). Around 100 tons of bark are 
annually supplied by Plantecam (Cameroon), a subsidiary of Groupe Fournier, which is the 
exclusive supplier to Europe. Outside contractors, registered local businesses who have Forestry 
Department licenses to exploit medicinal plants, take advantage of all the P. yohimbe bark 
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supplied to Plantecam. Plant material from companies or individuals without valid licenses is 
not accepted by Plantecam; however the issue of licenses does not necessarily control the means 
of exploitation, and Plantecam themselves admit that “… 98% of the trees exploited are 
probably felled”. The majority of P. yohimbe bark are collected by BaKola (pygmy) harvesters 
without any permits or authorization, carried to the roadside and illegally sold to contractors 
(Figure 0-2). Despite current levels of exploitation, the yohimbe tree presently grows 
abundantly and there does not seem to be a problem of regeneration. However, although the 
current regenerative capacity of the species is not yet compromised, the considerable over-
exploitation in certain areas will ultimately affect the regenerative potential of P. yohimbe 
(Sunderland et al., 1999). 
 
 
 
Figure 0-2 
Exploited bark of P. yohimbe in Southern Cameroon. Photo T. Sunderland. 
 
 
1.2. Chemical components of Pausinystalia yohimbe 
Authentic bark of yohimbe contains up to 5.9% of total alkaloids, depending on  the age of the 
plant and the height at which the bark has been collected (Paris and Letouzey, 1960). During the 
rainy season, the alkaloid amount of the bark can increase by about 1% (Paris and Letouzey, 
1960). The profile of alkaloids in the bark of yohimbe was reported as: yohimbine (17α-
hydroxy-yohimban-16α-carboxylate, syn.: quebrachine), 0.8%; β-yohimbine (syn.: amsonine), 
0.03%; and  pseudoyohimbine (syn.: yohimbene), 0.04% (Le Hir et al., 1953). Another study on 
two other bark samples gave the following results: yohimbine, 1.15 and 2.24%; α-yohimbine 
(syn.: corynanthidine, isoyohimbine, mesoyohimbine, and rauwolscine), 0.46 and 0.39%; 
pseudoyohimbine, 0.36 and 0.02%; ajmalicine (syn.: δ-yohimbine, raubasine, vinceine, and 
vincaine), 0.08 and 0.04%; and dihydrositsirikine, 0.12 and 0.39% (van der Meulen and van der 
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Kerk, 1964). Additional minor alkaloids have also been isolated: alloyohimbine (syn.: 
dihydroyohimbine), corynanthine (syn.: rauhimbine), corynantheine and dihydrocorynanthine 
(Kutney and Brown, 1966; Le Hir et al., 1953). Some structures of these molecules are 
illustrated in Figure 0-3. The references for the synonyms are given in the book of M. Hesse 
(Hesse, 1964).   
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Figure 0-3 
Structures of principal indole alkaloids of P. yohimbe. 
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1.3. Pharmacological effects of yohimbine 
From a pharmacological point of view, yohimbine is a competitive antagonist selective for the 
α2-adrenergic receptor (Murburg et al., 1991). Its α2-antagonist activity is 20 to 500 times 
stronger than its α1-activity, and also depends on the specific tissue (Steers et al., 1984). The 
sympathetic outflow increases as a result of the blockade of the presynaptic α2-adrenergic 
receptors as well as by potentialization of the release of norepinephrine from nerve endings 
(Figure 0-4). This leads to an activation of  α1 and β1 receptors in the heart and in the peripheral 
vasculature with a consequent rise in blood pressure (Goldberg et al., 1984). On the other hand, 
blockade of the postsynaptic α2-adrenergic receptors induces an inhibition of the 
sympathomimetic reactions. Yohimbine is considered a “dirty drug” because, in addition to its 
effects in the sympathetic system it exhibits other important actions, including dopamine 
receptor antagonism, monoamine oxidase (MAO) and cholinesterase inhibition, and 5-
hydroxytryptamine receptor antagonist and agonist activity (Goldberg and Robertson, 1983). 
The drug is metabolized with rapid plasma clearance, exhibiting a biological t½ of 36 minutes, 
and is not eliminated in the urine (Owen et al., 1985; Owen et al., 1987). 
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Figure 0-4 
Drug actions on the sympathetic nervous system. Drugs may affect synthesis, storage, release, uptake, 
and receptors. Yohimbine blocks the presynaptic α2-adrenergic receptors. (MAO, monoamine oxidase; α-
MeNE, α-methylnorepinephrine; NE, norepinephrine) 
 
Qualitative and quantitative determination of yohimbine in authentic 
yohimbe bark and commercial aphrodisiacs 
   
III. 
42 
As mentioned in chapter 1.1, yohimbine has been used in the past as an aphrodisiac and 
erectogenic drug. However, even if this drug is pharmacologically characterized, its efficacy in 
the treatment of sexual dysfunction has never clearly been demonstrated. The positive effect of 
yohimbine on sexual activity in male rats is well defined (Clark et al., 1984, 1985), but 
unfortunately the situation is not nearly as clear for man (Morales, 2000). According to the 
literature (Feuerstein et al., 1985), the activity of yohimbine in the peripheral and central 
nervous system should not be restricted to the noradrenergic system but also extended to the 
serotonergic system. A possible mechanism for the improvement in erectile function of patients 
treated with yohimbine was established after the identification and characterization of functional 
α2-adrenergic receptors in human corpus cavernosum (Traish et al., 1997). On the other hand, 
according to recent data (Sonda et al., 1990) the central nervous system activity of yohimbine 
appears to be predominant for a sexual response. From a therapeutic point of view, it was 
suggested that this duality may in fact be beneficial for yohimbine activity even though the use 
of non-selective drugs is generally precluded (Morales, 2000). Until now, only a dozen 
controlled studies (Hollander and McCarley, 1992; Jacobsen, 1992; Kunelius et al., 1997; 
Morales et al., 1982; Price and Grunhaus, 1990; Riley, 1994; Rowland et al., 1997; Sonda et al., 
1990; Susset et al., 1989; Vickers et al., 1993; Vogt et al., 1997) have been reported and some 
of them are statistically insufficient for a definitive conclusion. In all these studies, 
administration of a daily dose of 18-42 mg of yohimbine often divided in three single doses, 
demonstrated only modest effects on psychogenic erectile dysfunction (Reid et al., 1987) and a 
marginal efficacy in selected cases of organic impotence (Morales et al., 1987). A 2- to 3- 
weeks latency between onset of daily yohimbine administration and this light erectile function 
improvement was observed. Some authors (Teloken et al., 1998) studied the effects of  a large 
daily single dose (100mg) of yohimbine compared to placebo, and concluded that the drug 
“promotes no improvement in patients with organic erectile dysfunction”. The American 
Urological Association guidelines on treatment of organic erectile dysfunction recently stated 
that “the outcome data for yohimbine clearly indicate a marked placebo efficiency” and that 
“based on the data to date, yohimbine does not appear to be effective for organic erectile 
dysfunction and, thus, it should not to be recommended as treatment for the standard patient” 
(Montague et al., 1996). Besides these results, two different meta-analyses (Carey and Johnson, 
1996; Ernst and Pittler, 1998) demonstrated that yohimbine is superior than placebo in the 
treatment  of erectile dysfunction. 
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1.4. Side effects and contraindications of yohimbine 
Despite studies which show that yohimbine is generally well tolerated with few and benign 
side effects (Morales et al., 1987; Riley, 1994; Sonda et al., 1990; Susset et al., 1989; Vogt et 
al., 1997), other reports illustrate its potential risks on certain individuals. Common adverse 
effects of yohimbine include elevated systolic blood pressure and heart rate as well as anxiety, 
irritability and tremor, headache, mild antidiuretic activity (stimulation of antidiuretic hormone 
release), nausea, increased perspiration, salivation, lacrimation, and papillary dilatation 
(Grossman et al., 1993; Gurguis and Uhde, 1990; Lacomblez et al., 1989; Onrot et al., 1987; 
Price et al., 1984; Teloken et al., 1998). Yohimbine was also reported to induce a generalized 
erythrodermic skin eruption, progressive renal failure and lupus-like syndrome (Sandler and 
Aronson, 1993). Furthermore, a daily dose of 15 mg can provoke bronchospasms (Landis and 
Shore, 1989). Treatment with yohimbine is contraindicated in patients taking psychotropic 
medications and tyramine-containing food because of its potential effects on cholinergic and 
adrenergic activities (Arky, 1998). Description of a hypertensive crisis due to an herbal 
treatment of impotence suggested that these medications are a potential cause of toxicity (Ruck 
et al., 1999). The German Commission E monograph recommended that the P. yohimbe bark 
should not be taken by patients with renal disease, noting increases in blood pressure. 
With regard to these data, detection and quantification of yohimbine in the commercialized 
products have to be considered imperative, in order to evaluate the potential risks of aphrodisiac 
products on consumer health. 
1.5. Previous detection and quantification methods 
Thin-layer chromatographic methods for identifying yohimbine in authentic yohimbe bark 
have been reported in the literature (Wagner and Bladt, 1996). More sensitive methods using 
HPLC coupled with UV spectrophotometry, amperometric or fluorescence detection have been 
employed to determine and quantify this compound (Chiba and Isii, 1990; Diquet et al., 1984; 
Goldberg et al., 1984; Le Verge et al., 1992; Owen et al., 1985). A more selective analysis of 
yohimbine using the LC-MS-MS technique has been recently published (Reimer et al., 1993). 
All these methods have been employed to analyze clinical samples from persons using mono-
substance medication (yohimbine), but they were not sensitive and selective enough for the 
investigation of multibotanical products (Betz et al., 1995). A  GC method to analyze dietary 
supplements containing complex plant mixtures including yohimbe bark was thus developed. A 
nitrogen phosphorous detector (NPD) was used to quantify total alkaloids and identification of 
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yohimbine was established by comparison of GC-EI-MS spectra with the reference mass 
spectrum obtained for the yohimbine standard (Betz et al., 1995).  
The present study describes a rapid qualitative and quantitative method for the analysis of 
yohimbine in commercialized aphrodisiacs by HPLC-UV-MS with atmospheric pressure 
chemical ionization (APCI) and electrospray ionization (ESI). The optimized experimental 
conditions allowed a considerable reduction of the time of analysis and simplified the 
preparation procedure. The precision and reproducibility of the MS analysis was improved by 
adding deuterium labeled yohimbine as internal standard (Auriola et al., 1991a, b). The HPLC-
MS method proved to be more sensitive when compared to HPLC-UV. The selectivity of the 
MS detection has been improved by a MSn analysis of the yohimbine chromatogram peaks. 
2. Results and Discussion 
2.1. General procedures 
Aphrodisiac products were purchased from different sources found on the Internet (see 
chapter VI.1.1). Figure 0-5 illustrates an example of herbal aphrodisiacs obtained by internet 
resellers and analyzed in this study. 
 
 
 
Figure 0-5 
Aphrodisiac products obtained from Internet retailers and analyzed for their yohimbine content. 
 
 
Extractions. The extraction procedures for authentic yohimbe bark and aphrodisiac products 
are reported in chapter VI.1.1. 
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Sample preparation. The residues of extractions were dissolved in 50.0 mL of an 
acetonitrile (2 mM Et3N): water (50:50) solution containing codeine (1 mM) for UV detection 
and deuterium-labeled yohimbine (0.4 mM) for MS detection as internal standards. The 
deuterium-labeled yohimbine ([methyl-2H]-labeled yohimbine) was obtained by esterification of 
yohimbinic acid with [2H]-methanol in acidic conditions (see chapter VI.1.12). 
 
Preparation of standard solutions. Pure reference substance yohimbine HCl was 
dissolved in an acetonitrile (2 mM Et3N): water (50:50) solution containing codeine (1 mM) and 
deuterium-labeled yohimbine (0.4 mM) as internal standards in a 100-mL volumetric flask. 
Dilutions were prepared from this solution to establish a calibration curve in the range of 47.4-
1896.5 ng on-column (n=7). A volume of 10 µL was injected. 
 
Chromatography. HPLC instrumentation and conditions are reported in chapter VI.2.2. 
Separation was performed on a Nucleosil 100-5 C18 AB column (125 x 2 mm i.d., 5 µm; 
Macherey-Nagel, Düren, Germany) equipped with a pre-column of the same material (8 x 3 mm 
i.d., 5 µm) using a water (2 mM Et3N) : acetonitrile (2 mM Et3N)  gradient of 80:20 to 70:30 in 
2 min, followed by an isocratic elution of 70:30 for 6 min, a gradient elution of 70:30 to 55:45 
in 6 min and to 0:100 in 6 min. The total analysis time was 35 minutes, including column 
washing and stabilization. The flow-rate was set to 0.3 mL/min and detection to 280 nm. 
 
LC-API-MS. LC-APCI-MS and LC-ESI-MS instrumentation and conditions are reported in 
chapter VI.2.3. MSn experiments were performed by programming dependent scan events. The 
first event was a full MS scan (MS1); during the second event the main ion recorded was 
isolated and selectively fragmented in the ion trap (MS2), whilst the third event (MS3) 
represented the isolation and selective fragmentation of the most important ions recorded in the 
MS2. The collision energy was set to 30 eV. To confirm the fragmentation way of yohimbine 
and its epimers, a 10 µg/mL solution of the corresponding standards was examined by flow 
injection analysis (FIA) using the APCI-MSn conditions described for the LC-APCI-MS 
analyses. The standard solution injection flow was 5 µL/min and was diluted before the APCI 
interface by addition of  a 40:60 acetonitrile (2 mM Et3N):water (2 mM Et3N) solution 
performed with a HP-1100 (Hewlet Packard, Palo Alto, CA, USA) binary pump (0.2 mL/min) 
by means of a T junction (Waters, Milford, MA, USA). 
2.2. Validation requirements 
The validation of the analytical test method was carried out to ensure that the analytical 
methodology was accurate, specific, reproducible and robust over the specified range that the 
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analyte was analyzed. Analytical method validation has received considerable attention in the 
literature and regulatory agencies but unfortunately, there is no single source of final guidelines 
on it (Shabir, 2003). In this study, guidelines from the International Conference on 
Harmonization (ICH, 1995, 1997) were used to perform the validation. 
Before undertaking the task of method validation, some preliminary work was performed (i.e., 
analytical equipment qualification, stability of analytical solutions and system suitability test). 
The analytical system itself was evaluated for its adequate design, maintenance, calibration, and 
testing. Before performing any validation experiments, the installation, operational and 
performance qualification was estimated. Afterwards, the HPLC system was tested for its 
suitability, which is the capability of providing data of acceptable quality. In addition, to 
generate reproducible and reliable results, the stability of sample solutions, standards, reagents 
and mobile phases was determined. 
According to the ICH, the characteristics used to “quantify” the performance of the analytical 
method included the following: 
 
Accuracy. Accuracy is the measure of the exactness of an analytical method, or the 
closeness of agreement between the value which is accepted either as a conventional, true value 
or an accepted reference value and the value found. For the assay of the drug products, accuracy 
was evaluated by analyzing mixtures spiked with known quantities of components (technique of 
standard additions). In general, this approach is used if it is not possible to prepare a blank 
sample matrix without the presence of the analyte. Accuracy criteria for the assay method were 
that the mean recovery would be 100 ± 2% at each concentration over the range of 70-130% of 
the target concentration. To document accuracy, the ICH guideline on methodology 
recommends collecting data from a minimum of nine determinations over a minimum of three 
concentration levels covering the specified range (i.e., three concentrations, three replicates 
each). 
 
Precision. Precision is the measure of the degree of repeatability of an analytical method 
under normal operation and is usually expressed as the percent relative standard deviation 
(RSD) for a statistically significant number of samples. The precision includes repeatability, 
intermediate precision and reproducibility. The repeatability is the results of the method 
operating over a short time interval under the same conditions (intra-assay precision). This 
implies the use of the same operator, equipment and reagents. It was calculated from nine 
determinations covering the specified range of the procedure (i.e., three levels, repeated three 
times each). The intermediate precision is the measurement of day-to-day method variations due 
to random events within the same laboratory. The reproducibility is the measure of the precision 
of the method when changing all of the possible variables, i.e. different operators, reagents, 
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instruments, times and laboratories. It is normally acceptable if it is no more than two or three 
times greater than the repeatability. 
 
Specificity. The specificity is the ability of the method to measure one species of analyte in 
the presence of other elements or compounds. To measure the specificity of the HPLC methods, 
the analyte peak purity and resolution from the nearest eluting peak was calculated. Once 
acceptable resolution was obtained for the analyte, the chromatographic parameters, such as 
column type, solvent system, flow-rate and detection mode, were considered set. 
 
Limit of detection. The limit of detection is the indication of the minimum analyte 
concentration in a sample that can be detected, not quantitated. It is a test that specifies whether 
or not an analyte is above or below a certain value. It was measured as a concentration at a 3:1 
signal-to noise ratio and an appropriate number of samples were analyzed at this limit to 
validate the level. 
 
Limit of quantitation. The limit of quantitation is the indication of the minimum analyte 
concentration in a sample that can be measured with acceptable precision and accuracy under 
the stated operational conditions of the method. The limit of quantitation was set to a signal-to-
noise ratio of 10:1. Afterwards, the precision and the accuracy were determined at this 
concentration to confirm the validation of the method. 
 
Linearity and range. The linearity identifies the range of concentrations over which the 
method response is proportional to the amount of analyte. The straight-line over the range does 
not necessarily extrapolate to the origin but would normally be expected to do so. A correlation 
coefficient of >0.999 is generally considered as evidence of acceptable fit of data to the 
regression line. Range is the interval between the upper and lower levels of analyte (inclusive) 
that have been demonstrated to be determined with precision, accuracy and linearity using the 
method as written. The minimum recommended range for assay is from 80-120% of the target 
concentration. 
 
Robustness. Robustness is the capacity of a method to remain unaffected by small 
deliberate variations in method parameters. The robustness was considered early in the method 
development and was evaluated by varying column temperature (±1 to 5°C), percent organic 
solvent  (± 2% acetonitrile content in mobile-phase), pH of buffer in mobile phase (up to ± 0.5 
pH units), flow-rate (± 0.1 mL/min), etc. These changes were within the limits that produce 
acceptable chromatography and were incorporated in the method procedure. 
Qualitative and quantitative determination of yohimbine in authentic 
yohimbe bark and commercial aphrodisiacs 
   
III. 
48 
ICH recognizes that is it not always necessary to evaluate every analytical performance 
parameter and indicates which one is needed depending on the type of method and its intended 
use (Table 0-1). 
 
 
Table 0-1 
ICH validation characteristics. 
Analytical performance 
characteristics Identification  Impurity testing  Assay 
   Quantitative Limit tests   
Accuracy No  Yes No  Yes 
Precision       
Repeatability No  Yes No  Yes 
Intermediate precision No  Yes No  Yes 
Specificity Yes  Yes Yes  Yes 
Limit of detection No  No Yes  No 
Limit of quantitation No  Yes No  No 
Linearity No  Yes No  Yes 
Range No  Yes No  Yes 
 
 
2.3. Method development 
Extraction procedures. A number of extraction methods have been described, relating 
almost entirely to subsequent analysis of the extract by HPLC, which is the predominant final 
analytical method. The extraction method reported by Betz et al. (1995) was chosen because of 
its application to commercial yohimbe products. In general, the extraction was carried out by 
grinding the authentic bark or aphrodisiac products, making them alkaline with 30% NH4OH 
and extracting them in CHCl3. Extraction procedures varied slightly from those proposed by 
Betz et al. (1995) and therefore had to be validated. Figure 0-6 graphically shows the decreasing 
of yohimbine in authentic yohimbe bark with the increasing number of extractions. The 
measurements were made in triplicate and they showed that after the fourth extraction the 
quantity of yohimbine remaining was negligible. For commercial aphrodisiacs, the extraction 
procedures were adapted to the specific dosage form. 
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Figure 0-6 
Graph representing the quantity of yohimbine in authentic yohimbe bark after a certain number of 
extractions (solvent: alkaline CHCl3; extraction time: 1.5 hr; temperature: 23°C; replicates: n = 3). 
 
 
HPLC-API-MS. In order to analyze the alkaloid extract of multibotanical samples, a LC-MS 
method was optimized through the development of a fast and robust LC chromatographic 
separation and detection of yohimbine with two different ionization interfaces. The reversed-
phase chromatographic separation of the alkaloid extract was restricted by the compatibility 
with the LC-MS ionization conditions. The basic properties of alkaloids lead indeed to 
protonated molecules under acidic and neutral conditions, increasing their polarity and 
decreasing their affinity to the lipophilic-stationary phase. Moreover charged molecules were 
responsible for hydrogen bonding and ionic interactions with deprotonated silanol groups 
leading to additional retention and peak tailing. Tailing is extremely undesirable when 
separating complex mixtures of compounds due to loss of resolution, and also due to the effects 
it has on quantitative results. In fact, integrators may not be able to establish the end of a tailing 
peak with sufficient precision and accuracy. An answer to those problems was to work with a 
basic solvent system or use acid buffers with ion pair reagents which have high affinities for 
protonated alkaloids and RP phase.  A highly efficient HPLC method for the separation of 
indole alkaloids (including yohimbine and its epimers) has  already been developed 
(Gerasimenko et al., 2001), but the use of a high concentration of phosphate buffer (39 mM) 
and hexanesulphonic acid (2.5 mM) as ion pair reagent was not compatible with the LC-APCI-
MS and LC-ESI-MS interfaces. The use of triethylamine (Et3N) (2 mM) allowed a good 
separation of the alkaloids on reversed phase and this buffer did not appear to interfere with 
yohimbine ionization under experimental LC-MS conditions. Due to their limited stability, 
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conventional RP stationary phases were not recommended to be run with mobile phases at pH > 
8 for extended periods of time. Cleavage of the siloxane bonding by hydrolysis, or dissolution 
of the silica would rapidly lead to a considerable loss in column performance. Moreover, older 
“classical” RP supports, which are made from lower purity silica than more recent phases, 
seemed to give worse separation results. It is possible that the poorer performance may be 
attributed to their high metal content, i.e. iron and aluminum which can become incorporated 
into silica structure, increasing the acidity of neighboring silanol groups.  To solve this problem, 
a new base-deactivated Nucleosil® 100-5 C18 AB column was employed. The polymer-coated 
octadecyl packing material features an outstanding shielding of the silica matrix due to its 
chemically cross-linked C18 modification and is inert towards basic substances. The carbon 
content of 25% is considerably higher than for monomerically coated standard C18 phases 
(Figure 0-7). This special surface bonding technology of Nucleosil® 100-5 C18 AB increases the 
stability to hydrolysis in alkaline media when compared to conventional RP phases and allows 
the use of enlarged pH range from 1 to 11. Moreover, this special phase has a particularly large 
steric selectivity. 
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Figure 0-7 
Representation of a conventional RP phase and a base deactivated RP phase. 
 
 
The response in all LC-MS techniques is highly dependent upon pH. Knowing the pKa value 
of yohimbine (7.26 at 23°C) allowed us to predict its state of ionization as a function of pH. LC-
MS ionization of yohimbine was compared using two different interfaces -APCI and ESI. APCI 
requires the sample to be vaporized, favoring vaporization of neutral species in a liquid phase 
because of their higher volatility in comparison with charged species. In the present analysis, 
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adjusting the pH to a basic value with Et3N aided yohimbine and other alkaloids in their 
volatilization. With APCI, ions were observed in both positive and negative modes, but the 
negative ion mode failed to give a stable and reproducible MS response. Furthermore, peak 
intensity observed in the negative mode with APCI ionization was weak. On the other hand, 
adjusting the pH to favor charged molecules can be helpful for desorption techniques such as 
ESI. The desorption process is thus favored for charged species in comparison with neutral 
species, due to repulsion with other like-charged ions. Figure 0-8 illustrates the regions that 
favor desorption in contrast to vaporization at different pH values. 
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Figure 0-8 
Favored pH regions for ESI and APCI: desorption and vaporization. Relative abundance of yohimbine 
(B0) and its conjugate acid (BH+) at various pH values. Yohimbine pKa: 7.23 at 23°C. 
 
 
In our case, the ideal pH for LC separation (>10.23 at 23°C; 3 units more than yohimbine 
pKa) was not optimal for an ESI interface. A post-column removal of buffer or neutralization 
could be a solution to this problem but unfortunately it was not suitable for quantitative analysis, 
because it affected the precision. Surprisingly, ions measured in the positive mode were found 
to give a stable, reproducible and highly sensitive MS response. This observation was probably 
due to the redox reactions of water that take place in the metal capillary of ESI in the positive 
ionization mode. A recent study (Van Berkel et al., 1997) reported that the pH of  the spraying 
solution may decrease by at least 4 pH units with the ESI interface due to electrolytic oxidation 
of water in the positive mode. The pH changes were promoted when using a metal spray 
capillary and increased as the flow rate decreased and/or the ESI current increased. 
The LC method with Et3N buffer was finally retained using both APCI-MS and ESI-MS 
techniques for qualitative and quantitative analysis of the different extracts. The pH minimum  
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was set to 10.23 at 23°C in order to have yohimbine quantitatively in its basic form. The two 
API were performed in the positive ion mode. In order to improve the quantitative analysis 
precision, codeine and isotopically-labeled yohimbine were added simultaneously as internal 
standards during preparation of the sample. Quantitation is based on the response ratio of the 
compound of interest (yohimbine) to the internal standard (codeine or yohimbine-d3) versus the 
response ratio of a similar preparation of the reference standard. The internal standard method is 
appropriate for complex sample preparation procedures (e.g., multiple extractions), low 
concentrations of sample (sensitivity being an issue), and wide range of concentrations expected 
in the sample for analysis. Codeine was chosen as internal standard because of its chemical 
character and the similarity of its UV properties to yohimbine: it possesses a chromophore that 
shows a maximum of absorbance at 280 nm. In addition, using the LC conditions described 
before, the peak of codeine was in general well separated from peaks of other substances. The 
inconvenience of this UV active internal standard was the lack of selectivity, which in 
multibotanical products could be determinant. The use of deuterium-labeled yohimbine as 
internal standard for the MS analysis appeared to be a more elegant method to avoid variations 
in sample preparation, injection and in particular ionization parameters. Moreover, the MS 
response of yohimbine began to fluctuate during a sequence with more than 50 injections, 
especially with the ESI interface.  
Under the optimized conditions, qualitative analysis of the chloroform extract of authentic 
yohimbe bark was performed in the full scan mode (m/z 100-800) to estimate its content and 
determine the specificity of the method. Figure 0-9 shows MS and UV chromatograms of this 
extract with respective spectra of the target analyte. 
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Figure 0-9 
Representative LC-UV-APCI-MS analysis of the authentic yohimbe bark extract containing the internal 
standards codeine and yohimbine-d3 (1277 ng on column). Column: Nucleosil 100-5 C18 AB (125 x 2 
mm i.d., 5 µm) with a pre-column of the same material (8 x 3 mm i.d., 5 µm). Eluents: water (A) and 
acetonitrile (B) with 2 mM Et3N. Gradient: 20-30% B in 2 min, isocratic elution at 30% B for 6 min, 30-
45% B in 6 min and 45-100% B from 14-20 min were applied. Flow rate: 0.3 mL/min. UV detection at 
280 nm. MS conditions: capillary temperature: 150°C; vaporizer temperature: 360°C; corona needle 
current: 6.0 µA; sheath gas (nitrogen) pressure: 90 psi; in-source CID: –15 eV. 
 
 
In the LC-UV-MS analysis, yohimbine and its deuterium-labeled analogue were observed at a 
retention time of 13.63 min and their UV spectra showed a maximum of absorbance at 280 nm. 
Codeine gave the same maximum of absorbance and a retention time of 6.28 min. The MS 
spectrum of the yohimbine peak showed two protonated ions [M+H]+ at m/z 355.4 and 358.4 
corresponding to protonated yohimbine and its protonated trideuterated analogue, respectively. 
Significantly, a protonated ion [M+H]+ was also seen for both molecules in the MS spectrum at 
m/z 356.4 and 359.5, related to their respective isotopes.  
The selectivity of the developed method was tested by analyzing three chloroform extracts of 
aphrodisiac products by LC-UV-MSn. The fragmentation patterns of the yohimbine and codeine 
peaks in these extracts were identical to those of the respective pure compounds, indicating the  
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absence of other molecules having the same retention times and UV spectra. Figure 0-10  
illustrates the UV and MS chromatograms of one of these extracts (aphrodisiac product 9; see 
Table VI-1) and the fragmentation pattern of the yohimbine peak. 
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Figure 0-10 
LC-UV-APCI-MS3 analysis of the extract of aphrodisiac product 9. (Same conditions as described in 
legend for Figure 0-9. The collision energy was set to 30%). 
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2.4. Detection and quantification 
In order to increase the sensitivity of the developed method, qualitative and quantitative 
determination of yohimbine was performed by single ion monitoring (SIM) detection of [M+H]+ 
ions at m/z 355.4 and 358.4 with a spectral window of ± 0.6 Da (Figure 0-11). 
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Figure 0-11 
Single ion monitoring (SIM) detection of yohimbine and its trideuterated analogue. (Same conditions as 
described in legend for Figure 0-9. Detection at m/z 355.4 and 358.4 with a spectral window of ± 0.6 Da). 
 
 
Consistent parameters of quantification were determined for UV and MS methods (Table 0-2). 
The calibration curves were established by injecting in triplicate seven samples of pure 
yohimbine in the 47.4-1896.5 ng (4.74-189.65 µg/mL) range. Linear regression was determined 
by calculating the ratio of the areas of yohimbine and its internal standard as a function of 
concentration. Excellent correlation coefficients  were obtained by UV (r2 = 0.9997), APCI (r2 > 
0.9997) and ESI (r2 > 0.9998) methods. The detection limits for the qualitative analysis were 
evaluated using a signal-to-noise ratio, by comparing the measured signals of pure standard 
solutions of known concentrations with those of blank samples. A signal-to-noise ratio of 3:1 
was considered acceptable and gave detection limits of 0.6 ng  on column (60 ng/mL) for UV 
detection and 0.03 ng  on column (3 ng/mL) for API techniques. The quantitation  limits were 
also calculated using the same approach but considering a typical signal-to noise ratio of 10:1. 
The minimum concentration at which the analyte could be quantified was established at 2.0 ng  
on column (200 ng/mL) for UV detection and 0.1 ng  on column (10 ng/mL) for API methods. 
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In order to estimate the precision of the methods, the repeatability was evaluated by 
successively injecting 15 standards with a concentration covering the linearity range (3 
concentrations, 5 replicates each). The RSD showed a good repeatability for each technique. 
The intermediate precision was measured as for the repeatability but at different days and gave 
good precision results (RSD < 2%). Accuracy was established after determination of  precision, 
linearity and specificity, and performed across the specified range. It was measured as the 
percent of analyte recovery, after spiking authentic yohimbe bark and products with 70, 100 and 
130% of  yohimbine (three concentration levels, three replicates each) before the extraction 
procedure. Recovery of target analyte from the authentic yohimbe bark was excellent (Table 
0-2). 
 
 
Table 0-2 
Validation results of HPLC-UV, HPLC-APCI-MS and HPLC-ESI-MS methods for the detection and 
quantitative determination of yohimbine in aphrodisiac products. 
 LC- UV LC-APCI-MS LC-ESI-MS 
    
Accuracy 
(recovery 70-130%; 
3 levels, n = 3) 
 
99.5% ± 0.92%  102.7% ± 2.10%  103.1% ± 3.12%  
Precision       
Repeatability 
(3 levels, n = 5) 
91.8 ng (0.85%) 
950.0 ng (0.47%) 
1882.3 ng (0.35%) 
 
 89.3 ng (2.63%) 
961.2 ng (0.45%) 
1886.4 ng (0.74%) 
 88.3 ng (0.54%) 
966.1 ng (1.26%) 
1906.4 ng (0.20%) 
 
Intermediate precision 
(3 levels, n = 5) 
91.7 ng (0.19%) 
949.9 ng (0.56%) 
1883.0 ng (0.41%) 
 
 90.4 ng (1.01%) 
958.7 ng (0.39%) 
1885.1 ng (0.59%) 
 90.0 ng (0.74%) 
953.8 ng (0.66%) 
1899.5 ng (0.34%) 
 
Specificity YES YES YES 
Limit of detectiona  
 
0.6 ng  on column 
(60 ng/mL) 
 
0.03 ng  on column 
(3 ng/mL) 
0.03 ng  on column 
(3 ng/mL) 
Limit of quantitationa  
 
2.0 ng  on column 
(200 ng/mL) 
 
0.1 ng  on column 
(10 ng/mL) 
0.1 ng  on column 
(10 ng/mL) 
Linearity 
(7 levels, n = 3) 
   
Slope: 0.001240 0.0008131 0.0007787 
y-intercept : 1.96 0.02896 0.01018 
r2 : 0.9997 0.9997 0.9999 
Range 47.4-3793.0 ng on column 
(4.74-379.30 µg/mL) 
 
47.4-1896.5 ng on column 
(4.74-189.65 µg/mL) 
47.4-1896.5 ng on column 
(4.74-189.65 µg/mL) 
a
 Determination of limits based on a signal-to-noise approach. 
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Recoveries of yohimbine from the different matrices of aphrodisiac products varied with 
galenical forms. They were between 94.5 and 81.4% for gelatin capsules, 99.2 and  80.7% for 
tablets, 98.3 and 85.9% for liquid products, and  97.3 and 96.1% for powders or solids. This 
fluctuation of recoveries may have been due to the irreversible absorption of yohimbine by the 
matrix of different preparations. Herbal aphrodisiacs were in most cases multibotanical 
preparations containing a multitude of substances which could interact with each other. 
Furthermore, in many of these preparations amino acids (i.e., L-arginine), hormones (e.g., 
DHEA), vitamins and minerals were added which could bind to alkaloids. In addition, use of 
excipients such as fillers, binders, lubricants, colorants and aromas could be the cause of 
physical interactions with yohimbine. In order to increase these recovery results, different 
extraction procedures could be adopted for each commercial product, but this would definitely 
complicate and lengthen the entire quantification method. Finally, a single extraction procedure 
was retained but possible variations in the results were considered. 
Although the validation of each method showed good results, the quantification of yohimbine 
in authentic bark of yohimbe and aphrodisiac products gave different responses depending on 
the technique employed. The LC-UV method revealed that the authentic bark of yohimbe 
contained 1.303 ±0.014% (m/m)  of yohimbine, while 5.42 ±0.15% (m/m) and 11.51 ±0.21% 
(m/m) were obtained with the LC-APCI-MS and LC-ESI-MS techniques, respectively. The 
recoveries of the spike of yohimbe samples with 70, 100 and 130% of  the quantity of 
yohimbine determined  by UV detection showed the same percent increments for both API and 
UV methods. 
Calculation of consistent recovery (Table 0-2) demonstrated that the high quantity of 
yohimbine measured in the authentic yohimbe bark by the API technique was due to another 
substance possessing the same molecular mass and retention time. The LC-APCI-MSn analysis 
of the yohimbine peak showed  an [M+H]+ ion at m/z 355.4 and a characteristic fragmentation 
that excluded the presence of any other substances except isomers. In order to confirm similar 
ways of fragmentation of yohimbine and its isomers, a FIA-APCI-MSn analysis of yohimbine, 
α-yohimbine and corynanthine was performed (Table 0-3). The three epimers showed similar 
MS2 fragmentation patterns and equivalent relative abundances of main fragments. On the other 
hand, fragmentation of the three main MS2 protonated molecules (m/z 224.4, 212.4 and 114.4) 
exhibited equal fragment peaks but with different relative abundances. This phenomenon is 
well-known and numerous investigations concerning stereochemical effects displayed on mass 
spectra have been reported (Mandelbaum, 1983; Splitter and Turecek, 1994).  
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In order to investigate an eventual stereochemical discrimination during ionization, the same 
amount (500 ng on column) of standards (yohimbine, α-yohimbine and corynanthine) was 
injected under identical LC-UV-APCI-MS and LC-UV-ESI-MS conditions. The LC-UV 
chromatograms showed peaks of identical UV profile and absorbance for the three isomers but 
α-yohimbine had a retention time  of 17.86 min. Thus, α-yohimbine did not interfere with the 
other two epimers that had the same retention time (13.63 min). APCI- and ESI-SIM traces (m/z 
355.4) of yohimbine and corynanthine revealed a significant difference between their peak 
intensities. With the same quantity of injected standard, corynanthine showed with both APCI-
MS and ESI-MS ionization intensities 3.8 and 4.2 times higher than those of yohimbine, 
respectively. This phenomenon probably took place during the ionization and could be the result 
of a stereochemical discrimination between the two isomers in the volatile phase. Epimeric 
differentiation was noted from the change of the relative abundances of the protonated 
molecules as well as from fragment ions. The difference of ionization intensities obtained by the 
two API techniques was possibly due to the softer ionization mode of ESI with respect to APCI. 
As a consequence of this observation, the presence of minimal quantities of other yohimbine 
isomers with similar characteristics to corynanthine could also influence the analysis. As 
reported earlier, yohimbe bark contains different amounts of yohimbine isomers depending on 
the analyzed batch. Examined aphrodisiac products showed 0.5 to 30% of variations in the 
calculated yohimbine amount between the UV and API-MS methods. This dissimilarity 
demonstrated the impossibility of employing LC-API-MS methods for a multibotanical 
preparation containing authentic yohimbe bark or its extracts. On the other hand, the UV and 
API-MS responses were found to be very consistent for multibotanical preparations containing 
only yohimbine and no other epimers, for example after spiking of herbal preparation with pure 
yohimbine. As consequence of all these observations, it was decided to use the LC-UV-APCI-
MSn method for the quantification of yohimbine, due to the non-discriminative UV detection in 
conjunction with the high selectivity of the APCI-MSn technique. Even if APCI-MSn could 
make a stereochemical discrimination in yohimbine epimer ionization, the fragmentation 
patterns of the different isomers would be the same making it possible to detect compounds 
contaminating the yohimbine peak. The use of this method was not affected by the presence of 
epimers with same retention time as yohimbine, because of their relatively small quantities. 
Moreover, their residual presence has not a significant pharmacological influence as they have 
similar effects. Corynanthine also is an α2-adrenoceptor inhibitor but much less potent than 
yohimbine (Howe and Yaksh, 1986). 
Results of the analysis of aphrodisiac products are presented in Table 0-4. Products 1-5, 19 
and 20 were not commercialized as aphrodisiacs containing yohimbine and absence of trace 
amounts of this compound  confirmed the declaration on product labels. Products 6 and 7 were 
aphrodisiacs bought from Zimbabwe supposedly containing yohimbe bark. The fact that P. 
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yohimbe is a plant native to West Africa and not to the East of this continent, was source of 
doubt about the presence of this plant in the aphrodisiac preparations. The qualitative analysis 
showed total absence of yohimbine in these two products, corroborating the suspicion 
previously articulated. Products 8 to 18 were commercialized as aphrodisiacs containing 
yohimbe bark or yohimbe extract, but in general, as illustrated in Table 0-4, the product labels 
lacked precision about their yohimbine content. Some labels declared that the product contained 
yohimbe without specifying if it was the authentic bark or an extract of it. Other labels did not 
indicate the type of extracts (aqueous, organic, alkaline, etc.) and their yohimbine percentage. 
Product 10 did not declare yohimbe on the label, and even worse, product 18 was sent from the 
producer without a label on the bottle, justifying this by informing that customs did not allow 2 
ingredients into the country. Only two products (9 and 11) declared explicitly the amount of 
yohimbine (4 mg and  2.7 mg per tablet, respectively)  but this did not correspond to the 
quantity experimentally found (5.8 mg ± 1.1 and 1.24 mg ± 0.14, in that order). 
Seven products examined in this study showed relatively low yohimbine levels, going from 
0.504 mg ± 0.080 to 1.24 mg ± 0.14 per unit. Such quantities would probably cause a modest 
health risk; in fact the maximal dose prescribed by directions on labels went from 1.18 mg ± 
0.19  to 3.52 mg ± 0.66 of yohimbine per day. Even though the potential health risks caused by 
these aphrodisiacs containing yohimbine are low, this does not mean that the use of these 
products is completely safe. In effect, these commercial products were analyzed only for their 
yohimbine content and not for other dangerous compounds. Anyway, the presence of low 
quantities of active principle in these herbal medications did not lead to the therapeutic effect 
sought. This could be the cause of unnecessary frustrations and economic costs for the patient. 
Despite these results, four analyzed aphrodisiac products (9, 12, 14 and 18) showed a yohimbine 
amount that could pose severe health risks. Although the quantity of yohimbine in product 9 
was declared as earlier described, the relatively high maximal dose per day prescribed on the 
label (23.2 mg ± 4.5) could be dangerous especially for patients with blood pressure problems 
or taking other medications.  The yohimbine amount in product 12 was also high and in addition 
the suggested use did not limit the intake (19.0 mg ± 1.0) of a maximal dose per day. Product 14 
had a maximal dose per day prescribed (11.64 mg ± 0.31) which was lower than the last cited 
products  but not declaring the quantity of yohimbine could create dosage problems, even if 
used as directed on label. The use of product 18 could result in a serious health risk because of 
its yohimbine amount (3.15 mg ± 0.34 per tablet) and above all for not having a label with 
ingredients and directions on the bottle. Moreover, the presence in this mixture of two 
ingredients not allowed by the Swiss drug registration authorities drastically increases the health 
risks for the patient. 
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1. Introduction 
1.1. Catuaba: a popular Brazilian aphrodisiac 
For over a century, catuaba has been one of the most famous herbal medicines in Brazil. In 
recent times, it has been the focus of great worldwide public interest because of the use of the 
bark as an aphrodisiac and a remedy for erectile dysfunction. In the mid-nineteenth century, 
catuaba was a popular remedy, and from the early part of the last century it has been sold in 
Brazilian herbal markets. Nowadays, different catuaba “wines” are sold on supermarket shelves 
in many regions of the country and many websites advertise miraculous natural aphrodisiacs 
containing the bark of this plant. People of Northeastern Brazil (Piauí, Bahia, Pernambuco, and 
Paraíba) still utilize catuaba as an aphrodisiac or tonic, and for other purposes (Daly, 1990; De 
Almeida, 1993). Moreover, it has been attributed in traditional medicine with curing some 
rather unusual ailments, including neurasthenia, hypochondria, and nervous insomnia (De 
Almeida, 1993; Teixeira da Fonseca, 1922).  
The meaning of catuaba was first referenced in 1860 by Freire Alemão who indicated that 
this name in the Tupi language was a compound word meaning “homem válido” (“true man”) 
(Pereira, 1978). Other interpretations support that the name catuaba probably comes from 
língua geral, a predominantly Tupi-Guarani language developed by the Jesuits, meaning “good 
leaf” or “good tree” (“árvore boa”) (Pío Corrêa, 1931). This name is a polymorphic descriptive 
term with two components, the first of which, Katu, indubitably means “good”.  The second 
component of the word could be interpreted as “leaf” (-rába), “tree” (-íba), or “person” (-abá). 
Even if neither of these interpretations corresponds perfectly, it is most likely that “good leaf” is 
the true meaning for catuaba (Daly, 1990). Another name given to this plant by Pío Carrêa is 
catuíba corroborating the “good tree” interpretation. 
Despite its popularity, no one seems to be able to identify with certitude the plant 
corresponding to catuaba. Depending on the source, plants of different genera, from the 
Erythroxylaceae, Bignoniaceae, Sapotaceae, Euphorbiaceae, Myrtaceae, Meliaceae, 
Apocynaceae, or Burseraceae, have been referred to as catuaba. The identification problems 
have been complicated by two factors. First, the plant is known as an aphrodisiac and, as other 
“magic potions”, has a certain air of mystery around it, and, as a consequence, the taxonomic 
ambiguity. Second, the movement over the century of Northeastern Brazilians due to several 
catastrophic droughts has resulted in the spread of Northeastern culture and traditional medicine 
through other parts of the country. Originally, the name catuaba corresponded to a single 
species, but the displacement of Northeasterners extended the folk term to other species. As a 
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result, the name catuaba corresponds to different species in different regions, even if the uses 
are the same. 
The identification of the original plant corresponding to catuaba has called the attention of 
many Brazilian botanists over the years. One of the greatest, Adolpho Ducke, dedicated much 
time to this identification problem as reported in his last paper published posthumously (Ducke, 
1966). The confusion about catuaba identity has been maintained and even increased by 
inaccurate publications on economic plants. Sometimes, these publications fail to cite evidence 
or references, and report identifications without citing vouchers. Once mistakes are in the 
literature, it is very difficult to correct them and they can become the origin of other 
misinterpretations. As an example, in the Northeastern region of the country, catuaba has been 
referred to different Erythroxylum species and some authors erroneously stated that all these 
species corresponded to E. catuaba. This nomen nudum§ has been inaccurately reported by 
different authors over the years and its employment still generates some confusion. Additional 
misunderstandings have been created from a doctoral thesis written by A. J. Silva in Salvador in 
1904 (Silva, 1904). According to Ducke (1966), this PhD student was the first to report the 
identification of E. catuaba but unfortunately the description of the plant is a composite of three 
distinct species. Ducke concluded that the described plant in the Silva’s thesis did not even 
belong to the Erythroxylum genus but was probably a Trichilia. 
Ducke spent the last years of his life in the Northeastern Brazil writing about the flora of this 
region. Among other plants, he identified Erythroxylum specimens collected in the Ceará region 
and in particular, in Serra do Araripe. A plant locally known as catuaba was recognized by the 
famous botanist as E. vacciniifolium Mart. Another botanist, Monteiro Silva, also identified in 
this area a plant called catuaba as an Erythroxylum, even though he used the nomen nudum E. 
catuaba (Silva, 1951). He also reported detailed instructions for the preparation of tinctures and 
decoctions of this plant by traditional healers. In the early 1980s, during one of his research 
field trips in Serra do Araripe, the great Erythroxylaceae specialist T. C. Plowman noted that the 
bark of adult individuals of E. vacciniifolium Mart. had been stripped. Later, it was discovered 
that this bark was used by local populations as part of their traditional health care systems and 
particularly as an aphrodisiac. In an ethnobotanical study of an area in the interior of the 
Northeastern state of Piauí, L. Emperaire found that a plant locally called catuaba preta (“black 
catuaba”) was an Erythroxylum and it was used as an aphrodisiac and a hallucinogen 
(Emperaire, 1983). In 1983, during an ethnobotanical study in Goiás state, M. J. Balick 
discovered that the Apinajé Indians were using a plant named catuaba as an aphrodisiac. The 
Indians used the bark of this plant and they drank a decoction or an alcohol infusion. Vouchers 
of this plant were subsequently identified by T. Plowman as E. subracemosum Turcz. 
                                                
§
 Latin term (plural nomina nuda) referring to a name that has been published or mentioned without a 
proper and complete description or lacks a type species. 
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By accessing most of the evidence presented above, it is possible to conclude that the folk 
name catuaba corresponds to different species depending on the region. In Northeastern Brazil, 
catuaba is mainly referred to as a plant of the Erythroxylum genus and two principal species are 
recognized with this folk term: E. vacciniifolium Mart. and E. subracemosum Turcz. (Daly, 
1990). 
1.2. Characteristics of Erythroxylaceae 
1.2.1. Botanical aspects 
Erythroxylaceae can be recognized by their leaves, stipules that are at least in part 
interpetiolar and usually fasciculate inflorescence with rather small flowers; both calyx and 
filaments persist at the base of the fruit. 
 
Family classification. Recent classifications have placed the Erythroxylaceae in the 
Linales, which includes the Hugoniaceae , Humiriaceae, Ixonanthaceae, and Linaceae 
(Cronquist, 1988; Takhtajan, 1997; Thorne, 1992). This family is distinguished from the 
remainder of the order by the petals having a ligular appendage toward the base adaxially, 
usually only one locule of the ovary ovuliferous, disc and nectary glands absent, and the 
presence of alkaloids. 
 
 
Table 0-1 
Taxonomy of Erythroxylaceae according to Cronquist (1988). 
Kingdom: Plantae (Plants) 
Subkingdom: Tracheobionta (Vascular plants) 
Superdivision: Spermatophyta (Seed plants) 
Division: Magnoliophyta (Flowering plants) 
Class: Magnoliopsida (Dicotyledons) 
Subclass: Rosidae 
Order: Linales 
Family: Erythroxylaceae 
 
 
Current efforts at a reorganization of angiosperm phylogeny, incorporating and emphasizing 
molecular data, have placed the Erythroxylaceae in an expanded Malpighiales order that joins 
elements of the Linales with the Euphorbiaceae, Flacourtiaceae, Malpighiaceae, 
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Chrysobalanaceae, Pandaceae, Passifloraceae, Salicaceae, Turneraceae, Violaceae, and others 
(Daly, in press  2003). 
According to the Angiosperm Phylogeny Group classification (APG, 1998), the systematic 
position of the Erythroxylaceae is reported in Figure 0-1. 
 
Angiosperms
Eudicots Monocots
Core-Eudicots
Asterids Rosids
Eurosids I Eurosids II
Malpighiales Oxalidales Fabales Rosales Cucurbitales Fagales
Erythroxylaceae
 
Figure 0-1 
Classification of the Erythroxylaceae according to the Angiosperm Phylogeny Group (APG, 1998). 
 
 
Number of genera and species. The Erythroxylaceae comprise four genera with about 
250 species; three of the genera (Aneulophus, Nectaropetalum, and Pinacopodium), with few 
species (10-20), are restricted to tropical Africa. Erythroxylum is by the far the largest genus and 
occurs in the tropical part of Australia, Asia, Africa, and America. It is represented by 230 
species of which about 180 are found in the Neotropics. The genus Erythroxylum was divided 
by Schulz into 19 sections (Schulz, 1907). In spite of subsequent taxonomic revisions, often 
engendered by the production of regional floras, Evans used these sections as a  scheme for the 
purpose of comparative phytochemical considerations (Evans, 1981). 
 
Distribution and habitat. Although pantropical (Figure 0-2), the Erythroxylaceae are very 
unequally distributed. The majority of species are in tropical America, while very few are found 
in the four tropical continents. Aneulophus, Nectaropetalum, and Pinacopodium are limited to 
Africa, while Erythroxylum occurs mostly in the Neotropics. The centers of diversity for the 
family are found in Venezuela, eastern Brazil and Madagascar. At least 40 species of 
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Erythroxylum have been recorded in Venezuela and in the Guyana region, while in Northeastern 
Brazil the state of Bahia alone contains at least 45 species. This genus occurs also in Ecuador, 
where at least 14 species, including two cultivated or naturalized, were recorded (Plowman, 
1989). 
Erythroxylum rarely attains high densities where the genus occurs, but it is ecologically 
versatile, occurring as an understory tree in low elevation rain forests, a thick-barked shrub or 
tree in savanna woodlands, a microphyllous shrub in arid thorn-scrub, and a membranous-
leaved shrub in montane habitats (Daly, in press  2003). 
 
 
 
Figure 0-2 
Distribution map of Erythroxylaceae. 
 
 
Features of the family. Glabrous shrubs or small trees, evergreen or deciduous, wood 
hard; sometimes spiny at the hardened tips of short shoots (e.g., Erythroxylum spinescens 
Rich.); cataphylls often present, imbricate and persistent. Leaves alternate (opposite in the 
Aneulophus), usually distichous, simple; lamina margins entire; venation pinnate; vernation 
involute sometimes imprinting 2 parallel lines and/or a distinct central panel on the lower 
surface. Foliar stipules persistent on twigs or caduceus. Inflorescences axillary, sometimes 
short-pedunculate, composed of few-many flowered fascicles, or flowers solitary; subtended by 
small scarious bracteoles. Flowers actinomorphic, bisexual or seldom unisexual (plants 
dioecious), 5-merous, usually distylous; calyx persistent, the 5 valvate sepals united below; 
petals free, 5, alternate with sepals, imbricate in bud, caducous, usually appendaged on the 
adaxial surface; androecium with 10 stamens, in 2 whorls of 5, the outer whorl alternate with 
petals, united at the base by filaments and usually forming a short tube; anthers dithecal, 
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longitudinally dehiscent; gynoecium syncarpous, ovary superior, 3-locular or less commonly 2-
locular, usually only one locule ovuliferous; placentation axile, ovules solitary, rarely 2 (in 
Nectaropetalum), pendulous, epitropous; styles 3 or less commonly 2, distinct or connate 
basally; stigmas capitellate, rarely sessile. Fruits small, red or purplish, drupaceous and  one-
seeded, rarely capsular and 2-3-seeded (in Aneulophus). Seeds with straight embryo, endosperm 
copious, rarely absent, starchy (Daly, in press  2003; Plowman, 1989; Schulz, 1907). 
1.2.2. Phytochemical aspects 
The phytochemical aspects of the Erythroxylaceae are represented by the phytochemical 
characters of the largest of four genera of the family, Erythroxylum. This genus, apart from the 
cocaine-producing species, has unexpectedly received relatively little phytochemical attention. 
Many constituents of different species used in traditional medicine remain unknown. Some 
studies, carried out over many years, indicates the occurrence, in various organs of 
Erythroxylum species, of alkaloids (principally ornithine-derived), phenylpropane derivatives, 
flavonoids, tannins, mono-, sesqui-, di- and triterpenoids, fatty acids and wax alcohols 
(Hegnauer, 1966, 1989). Among these groups, the ornithine-derived alkaloids and the 
diterpenoids seem to have the greatest potential as chemotaxonomic characters (Evans, 1981). 
 
Alkaloids. The ornithine-derived moieties of Erythroxylum are mainly ecgonine derivatives 
(Figure 0-3) or hydroxytropanes (Figure 0-4) and their respective nor-derivatives. Tropine and 
pseudotropine alkaloids also occur in other families and are particularly widespread in the 
Solanaceae. Conversely, the ecgonine-type alkaloids (pseudotropine bearing an additional 
carboxylic group at position 2) seem to be restricted to the Erythroxylaceae.  Substitution of the 
tropane moiety at position 2 is not known in the Solanaceae, but it does occur in  the Proteaceae.  
 
 
 
R1
 
R2
 
R3
 
 Trivial name 
CH3 H H Ecgonine 
H H H Norecgonine 
CH3 CH3 C6H5CO (benzoyl) Cocaine 
CH3 CH3 C6H5–CH=CH–CO (cinnamoyl) Cinnamoylcocaine 
CH3 H C6H5CO (benzoyl) Benzoylecgonine 
CH3 H CH3 Methylecgonine 
CH3 CH3 α-truxillic acid Cocamine (α-Truxilline) 
N
R1
OR3
C
H
O
OR2
H
 
CH3 CH3 β-truxillic acid Isococamine (β-Truxilline) 
Figure 0-3 
Ecgonine and its derivatives occurring in the Erythroxylaceae. 
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R1
 
R2
 
R3
 
R4 R5  Trivial name 
CH3 H OH H H 3α-hydroxytropane 
CH3 OH H H H 3β-hydroxytropane 
CH3 H OH H OH 3α,6β-dihydroxytropane 
CH3 H OH OH OH 3α,6β,7β-trihydroxytropane 
H H OH H H 3α-hydroxynortropane 
H OH H H H 3β-hydroxynortropane 
H H OH H OH 3α,6β-dihydroxynortropane 
N
R1
R3
R2
R5
R4
1
2
3
4
56
7
 
H H OH OH OH 3α,6β,7β-trihydroxynortropane 
Figure 0-4 
Hydroxytropanes and respective N-nor-derivatives occurring in the Erythroxylaceae. 
 
 
Sometimes the biosynthetically related bases hygrine, hygroline and cuscohygrine are also 
present (Figure 0-5), and in one instance small amounts of nicotine were observed (Hegnauer, 
1981). 
 
 
N
CH3
O
CH3
N
CH3
CH3
OH
N
CH3
O
N
CH3
hygrine hygroline cuscohygrine
 
Figure 0-5 
Biosynthetically related bases of tropane alkaloids in the Erythroxylaceae. 
 
 
The phytochemical investigations on Erythroxylum species have often been restricted to the 
occurrence of cocaine and cocaine-derived compounds in their leaves. These alkaloids were 
found only in 2 species and 4 varieties: E. coca var. coca Lam. (Bolivian or Huanuco coca) and 
var. ipadu Plowman (Amazonian coca); E. novogranatense var. novogranatense Morris 
(Columbian coca) and var. truxillense Morris (Trujillo coca) (Plowman, 1982). In a review 
article, Rivier reports cocaine and the cis and trans isomers of cinnamoyl cocaine in these two 
species (Rivier, 1981) but the ratios between the various alkaloids served no chemotaxonomic 
purpose as there was great variation within the species. Among the species examined, cocaine is 
produced in quantity only in the cultivated varieties; wild species morphologically close to E. 
coca do not appear to contain the alkaloid (Holmstedt et al., 1977). Apart from these cultivated 
species, traces of cocaine were found only in two plants of Venezuela, E. recurrens Huber and 
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E. steyermarkii Plowman. Cocaine does not seem to be an alkaloid of the Old World species 
while ecgonine derivatives have been reported for E. dekindtii O. E. Schulz (Alyahya et al., 
1979) and for E. monogynum Roxb. (Chopra and Ghosh, 1938).  
The characteristic alkaloids of the Erythroxylum species are the hydroxytropanes, and the 
species presently investigated contains an extensive range of their esters. The tropane moieties 
of alkaloids  within this genus, in themselves,  show little use as intrageneric chemotaxonomic 
characters, while esterifying acids are often distinctive features of certain species (Griffin and 
Lin, 2000). Benzoic, cinnamic, trimethoxybenzoic, trimethoxycinnamic, truxillic (cinnamic 
acids dimers) and phenylacetic acids are common esterifying acids of both New and Old World 
species (Figure 0-6). 
 
 
COOH COOH
COOH COOHCH3O
CH3O
OCH3
CH3O
CH3O
OCH3
C6H5H5C6
COOHHOOC
benzoic acid cinnamic acid
3,4,5-trimethoxybenzoic acid 3,4,5-trimethoxycinnamic acid
β-truxillic acid
COOH
phenylacetic acid
 
Figure 0-6 
Common esterifying acids of tropane alkaloids in Erythroxylaceae. 
 
 
The combination of certain of these acids for any one species is sometimes unique. In E. 
australe Muell a number of tigloyl esters are present, tiglic acid esters not yet having been 
isolated from any other species of the genus. Some acid moieties, such as pyrrole-2-carboxylic 
acids and 2-furoic acid are unique for certain species, E. vacciniifolium Mart. and E. dekindtii O. 
E. Schulz, respectively (Figure 0-7). 
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pyrrole-2-carboxylic acid N-methylpyrrole-2-carboxylic acid
ON COOH
H
COOH N
H3C
COOH
furoic acid
 
Figure 0-7 
Unique esterifying acids of tropane alkaloids for E. vacciniifolium Mart. (pyrrole-2-carboxylic and N-
methylpyrrole-2-carboxylic acids) and E. dekindtii O. E. Schulz (2-furoic acid). 
 
 
Aromatic acids. Aromatic acids are common constituents of the Erythroxylaceae. The 
cinnamic acids are mainly represented by caffeic acid and its derivatives such as chlorogenic 
acids (Hegnauer, 1981). Methyl salicylate is present in different species of Erythroxylum which 
probably contain monotropitoside- or violutoside-like glycosides. In addition, as reported before, 
different aromatic acids (benzoic, cinnamic, trimethoxybenzoic, trimethoxycinnamic, 
phenylacetic and 2-hydroxy-3-phenylpropionic acids) occur esterifying with alkamines in the 
alkaloid mixtures of many species of Erythroxylum (Evans, 1981). 
 
Flavonols and related flavonoids. Flavonoid compounds are largely present in leaves of 
Erythroxylaceae and the few true phytochemical investigations suggest the prevalence of 
flavonols. The main flavonoid compounds are kaempferol- and quercetin-3-glycosides. Rutin, 
quercitrin, isoquercitrin and ombuin-3-rutinoside  were isolated from different New and Old 
World species, and seem to be the primary flavonoids of the Erythroxylaceae. The scarcity of 
available facts, however, does not allow any general conclusion yet about the flavonoid 
chemistry of this family. 
 
Tannins. Little is known about the true nature of tannins of Erythroxylaceae, but it seems 
that these phenolic compounds are more or less abundant in roots, stems and leaves. The 
isolation of specific types of tannins from some species suggests that Erythroxylaceae belong to 
those families of Angiosperms which produce condensed tannins and ellagitannins in variable 
amounts (Hegnauer, 1981). 
 
Isoprenoid compounds. Whereas mixtures of essential oils and resins (i.e., balsams), 
composed of mono-, sesqui- and diterpenoid metabolites, tend to be deposited in wood, 
triterpenoid compounds seem to be in leaf- and fruit-waxes of Erythroxylaceae. Unfortunately, 
only few species have been investigated thoroughly for a definitive conclusion.  
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The wood of E. monogynum Roxb. has proved to be a rich source of diterpenoids, including 
stachene and a number of its derivatives, together with a range of alcohols such as 
erythroxytriol P (Connolly et al., 1966). Five new diterpenoids related to stachene, all of which 
possessed an oxygen substituent at C-1, were isolated from E. australe Muell (Figure 0-8) 
(Connolly and Harding, 1972). 
 
 
stachene erythroxytriol P
ketostachene erythroxydiol X
O
OH
OH
CH2OH
OH
CH2OH
 
Figure 0-8 
Example of diterpenoids of Erythroxylum. 
 
 
1.2.3. Economic uses 
By far the most important species of the family is the coca plant, Erythroxylum coca Lam. 
Archaeological evidence indicates that coca was domesticated by 1500 BC in South America. In 
pre-Columbian times, coca was a major element of the economy (Hastdorf, 1987). Andean 
peasants and miners traditionally have consumed coca by masticating wads of leaves, combined 
with chalk or ash, which helps dissolve the alkaloids into saliva. Coca chewing has been used as 
a tonic and stimulant to allay hunger and altitude sickeness, and for other medicinal and ritual 
purposes. A lowland Amazonian cultivar, E. coca var. ipadu Plowman, has figured prominently 
in some western Amazonian indigenous cultures for similar purposes (Daly, in press  2003).  
With the Spanish conquest, coca became an important commercial crop, grown in the Yungas 
to supply workers in the rich silver mines of Bolivia. In the late 1800’s Europeans and north 
Americans learned about coca and begun importing it for elixirs and patent medicines (Boucher, 
1991). A real commercial success of coca leaves began with the production of “Vin Mariani” 
which was introduced by Angelo Mariani in the 1860s and it was claimed to have stimulant, 
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analgesic, anesthetic, and carminative properties. Scientists like Sigmund Freud described it as a 
“magical drug” and encouraged family, friend, and colleagues to use it (in the book “Über 
Coca” by Freud). An extract of coca leaves, together with extracts of Cola nitida Schott et Endl. 
Sterculiaceae (caffeine), were primary ingredients in an even more famous beverage, Coca-
Cola®. In 1904 fears about the narcotic properties of cocaine led to the deletion of coca leaf 
extract. Cocaine which served as the template compound  for the development of numerous 
invaluable synthetic anesthetics including lidocaine, novocaine, and xylocaine, is still used in 
ophthalmic surgery. Unfortunately, the coca plant is now widely regarded as a nuisance to 
society, because of the distorted use on a massive scale of one of its ingredients, cocaine. In 
1997, an estimated 1.5 million Americans were current cocaine users, according to the 1997 
National Household Survey on Drug Abuse (NHSDA). This number has not changed 
significantly since 1992, although it is a dramatic decrease from the 1985 peak of 5.7 million 
cocaine users (3% of the population). Based upon additional data sources that take into account 
users underrepresented in the NHSDA, the Office of National Drug Control Policy estimates the 
number of chronic users at 3.6 million (NIDA, 1999). 
In the Northeastern Brazil, E. vacciniifolium Mart. and E. subracemosum Turcz. are two of 
the plants most prominently referred to as catuaba, a Tupi name applied to a number of species 
used as tonics and aphrodisiacs (see chapter 1.1). 
E. dekindtii O. E. Schulz, called Olokuto by the natives, is a small West African shrub found 
particularly in the mountainous ravines of Angola. A decoction prepared from the roots and 
leaves of this plant is used as a febrifuge (Alyahya et al., 1979). 
E. moonii Hochr. is a small shrub which is used in Sri Lanka as an effective anthelmintic for 
roundworms and for the suppuration of boils and abscesses (Jayaweera, 1980). Another plant 
endemic to this country is E. zeylanicum O. E. Schulz which is traditionally also used as an 
anthelmintic (Jayaweera, 1980). E. pervillei Baill. is an Erythroxylaceae from Madagascar. It is 
known locally as Tsivano and has several folkloric uses, including as a fish poison and to treat 
abdominal pain and tumors (Silva et al., 2001). E. macrocarpum O. E. Schulz and E. 
sideroxyloides Lam. are members of the E. laurifolium Lam. sensu lato complex and are 
indigenous to Mauritius, Réunion and the Seychelles. In Mauritius, these small trees are known 
as bois de ronde and find use as a popular treatment for kidney disorders as well as furnishing a 
hard timber (Al-Said et al., 1986a). 
The wood of some species of Erythroxylum is hard, strong and durable and is valued locally 
for making telephone poles, supports, and furniture (Daly, in press  2003). 
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1.3. The tropane alkaloids 
Generalities. Tropane alkaloid is a trivial name to designate alkaloids with a tropane 
structure. The variations in this alkaloid group are given by: 
• α- or β-position of the 3-OH-substituent (tropine and pseudotropine, respectively). 
• Presence or absence of carboxyl group at position C-2 (ecgonine derivatives or 
hydroxytropane, respectively). 
• Esterification of tropane moiety with different acids (e.g., benzoic , cinnamic, 
trimethoxybenzoic, trimethoxycinnamic, truxillic, phenylacetic acids, etc.). 
• Additional hydroxyl groups in the tropane ring (e.g., calystegines). 
• Presence or absence of N-methyl group of tropane alkaloids (tropane or 
nortropane moiety). 
The tropane alkaloids, such as hyoscyamine and scopolamine (Figure 0-9), are prominent and 
have been the focus of wide attention over the years. They were constituents of popular magical 
potions containing plants of the Solanaceae family, e.g. henbane (Hyoscyamus niger L.) and 
mandrake (Mandragora officinarum L.), which were used in the Middle Ages as hallucinogens. 
The toxic effects of thorn-apple (Datura stramonium L.), also known as Jamestown weed are 
well-known too. Atropine, the racemic hyoscyamine, has a potent mydriatic action and has been 
widely used in ophthalmics as a pupil dilatory agent. During the Renaissance fashionable ladies 
would drop belladonna fruit juice (Atropa belladonna L.) into their eyes to make themselves 
appear more attractive. The plant E. coca var. coca Lam. was traditionally known for its central 
nervous system stimulating properties and for improving endurance, and cocaine was first 
isolated from the leaves of this plant by Niemann in 1860. These attractive properties led to a 
worldwide spread of the drug which has been also used as anesthetic. 
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Figure 0-9 
Legendary tropane alkaloids. 
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The structural elucidation of the tropane ring system, found in hyoscyamine and cocaine, was 
first secured in 1901 by Willstätter with his extensive synthetic work on this alkaloid group. The 
tropanes were one of the first key alkaloid, represented by coniine, nicotine, quinine, and 
morphine, to succumb to total synthesis. Ladenburg’s synthesis of (+)-coniine was previously 
described in 1886 (Hesse, 2002).   
The number of tropane alkaloids known from natural sources exceeds 200 (Drager, 2002). 
They have been isolated from different families, e.g. Solanaceae, Erythroxylaceae, Proteaceae, 
Euphorbiaceae, Rhizophoraceae, Convolvulaceae and Cruciferae, and some phylogenic trends 
were observed (Griffin and Lin, 2000). These families comprise mono-, di- and triesters, 
carboxylated and benzoylated tropanes. Recently, the location of tropanes has widened with the 
discovery of dimeric and trimeric forms. 
 
Biogenesis of tropane alkaloids. Most studies in biosynthesis of tropane alkaloids have 
been performed on various species of Datura but all the available evidence suggests that similar 
pathways operate in other tropane alkaloid-producing plants. Because the characteristic of these 
alkaloids are esters of hydroxytropanes and various acids (see chapter 1.2.2) there are two 
distinct biogenetic moieties for each alkaloid. Generally, the amino acid ornithine, its 
decarboxylation products putrescine and proline constitute the basic unit of the tropine, 
ecgonine, nicotine (pyrrolidine ring), necine, and stachydrine groups of alkaloids.  
The early discoveries in tropane alkaloid and cocaine biosynthesis must be attributed to Leete. 
He was the first to describe the involvement of ornithine as a precursor to the amino acid 
portion of the tropane ring (Leete et al., 1954). Another amino acid, arginine, can clearly 
contribute to this pathway, as ornithine and arginine have a close metabolic relationship. As a 
result of feeding experiments with radiolabeled [2-14C]ornithine (the label was incorporated into 
hyoscyamine in D. innoxia), Leete proposed a pathway from ornithine to putrescine through a 
decarboxylation (Figure 0-10). The N-methylation of putrescine to give N-methylputrescine 
followed by oxidative transamination would yield the 4-methylaminobutanal, a compound 
which is primed for spontaneous cyclisation to a N-methyl-∆1-pyrrolium cation. Condensation 
with the as yet unknown acetate-derived moiety (acetoacetic acid) would then deliver ecgonine 
or respectively tropinone after a decarboxylation of  hygrinecarboxylic acid. Stereospecific 
hydrogenation of tropinone yields 3α-tropine or 3β-tropine (pseudotropine). These early 
experiments of Leete indicated a regiospecific incorporation of [2-14C]ornithine into C-1 of the 
tropane moiety of hyoscyamine in D. stramonium L. (Leete, 1962, 1964), while later studies on 
this plant and other species of Solanaceae and Erythroxylaceae, have shown equal labeling into 
C-1 and C-5 (Hashimoto et al., 1989; Leete, 1982; Liebisch et al., 1963). These accumulated 
evidences suggest a symmetrical rather than a regiochemical incorporation. 
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Figure 0-10 
Possible biogenetic route for the tropane nucleus (Duran-Patron et al., 2000). (ODC: 
ornithinedecarboxylase; PMT: putrescine-N-methyltransferase; MPO: methylputrescineoxidase; TRI: 
tropinonereductase I; TRII: tropinonereductase II). 
 
Structural elucidation. The general structures of the tropane moieties are based on the 
following spectroscopic criteria. Esters of 3α-hydroxytropane give in their electron impact mass 
spectra a prominent ion, often constituting the base peak, at m/z 124, and correspondingly for 
the nor-derivative, at m/z 110 (Agar and Evans, 1976). Esters of the dioxygenated and 
trioxygenated tropane alkaloids fragment readily by loss of the C(6) –C(7) bridge to give an ion, 
m/z 113 if there is a free hydroxyl group at C-3 (m/z 99 for a nor-alkaloid); esterification of C-3 
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causes the corresponding ion to incorporate the acid moiety. By this means, the substitution 
pattern of the tropane ring can be established. 
1H-NMR spectroscopy gives significant information for the structural elucidation of tropane 
moieties and their esterifying acids. The structures of a di- or trisubstituted tropane core 
skeleton were illustrated by their typical chemical shifts (El-Iman et al., 1987; Graf and Lude, 
1978): a methyl linked to nitrogen (δH around 2.5), three or two –CH2 (δH in the regions of 1.4-
1.8, 2.0-2.3 and 2.7), two –CH (δH ca. 3.2-3.5) and two or three CHO– groups (δH ca. 4.0-5.8). 
The relative configuration of the substituent at C-3 can be established by the interpretation of  
1H-NMR spectrum: α-orientation gives a triplet at δH ca. 5 (J 5 Hz) for an ester and at δH ca. 4.0 
for the free alcohol; β-orientation gives a quintet at similar frequencies with a coupling constant 
of ca. 15 Hz (Al-Said et al., 1986a). The substituents at C-6 and C-7 appear to be exo when the 
corresponding  endo-protons show coupling J ca. 0 Hz with the vicinal bridgehead protons (C-5 
and C-1, respectively); inversely, exo-protons exhibit marked coupling (J 3-4 Hz) in similar 
fused systems. 
1.4. Description of Erythroxylum vacciniifolium Mart. 
Botanical aspects. Densely branched, closely spaced shrubs with rigid, sharp-tipped 
branches, 6 feet high, grey bark, with terete (narrowly cylindric) branches, warty, sub-distichous 
branchelets, the youngest flattened. Leaves short petiolate, rounded at basis and apex, 
mucronulate at apex, mucrone deciduous, 1-3 cm long, 0.5-2 cm broad, upper surface glaucous 
(blue-green) and glossy, lower surface paler, the median nerves prominent on both surfaces. 
Petiole 2 mm long. Foliar stipules triangular section, keeled, apex shortly aristated and bifid 
(two-cleft to about half way). Thin, membranous scales, the half lower part aristate, the tips 
deciduous, similar to stipules. Flowers produced singly, by two or three in axils of the scales. 
Pedicel 4 mm long, sticky on the upper part, pentangular. Sepales 2 mm long, oval-triangular, 
thicker at apex, lightly membraneous edge. Lanceolate, sharp and small prophylla. Doubled 
ligule, 4 mm long, oblong-long, wavy edge petals, with lateral anterior lobes scarcely longer 
than the lobe bifid on the junction, irregularly toothed margine, with the lateral posteriors lobes, 
three time shorter than the anterior lateral lobe, linked to a lobule, not completely squared. The 
staminal urceole shorter than the sepals, with a toothed pointed opening. The filaments, in the 
flowers with short styles, are the same length: twice longer than the staminal ureceole. In the 
flowers with long styles, the filaments are unequal, the shorter almost twice shorter than the 
urceole, and the longer almost the same size as the urceole. Ovary: ovoid, three separeted styles. 
Stigma: bristled, truncate at apex. 
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Figure 0-11 
Erythroxylum vacciniifolium Mart. (Martius, 1965). 
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Figure 0-12 
Specimen of Erythroxylum vacciniifolium Mart. collected in Buraquinho rain forest (João Pessoa, Paraíba, 
Brazil), in August 2000. The voucher specimen was deposited at the HLPQN (Herbarium do Laboratorio 
de Química de Produtos Naturais), Universidade Federal de Paraíba, 58059 João Pessoa, Paraíba, Brazil 
(JPB.-N° 152) and identified by Prof. Zoraide Maria de Medeiros Gouveia of the Department of Science 
of Nature, University of Paraíba, Brazil and Dr. Douglas C. Daly, The New York Botanical Garden. 
 
 
 
Distribution and habitat. E. vacciniifolium Mart. is widespread in Brazil, occurring from 
Ceará south to Santa Catarina in a diversity of habitats (Figure 0-13). In Northeastern Brazil, 
this species inhabits an open vegetation type best described as “closed shrubby Caatinga”. There 
is little agreement on the classification of dry vegetation types in Northeastern Brazil, and 
different authors vary widely in their opinion. In Serra do Araripe, E. vacciniifolium Mart. was 
said to be growing in carrasco, a term which locally is used for closed Caatinga scrub 
vegetation on sandy soil. 
Caatinga covers most of northeast Brazilian with an area of 300,000 square miles, interrupted 
by some areas of humid tropical forest. Climatic irregularity is its main characteristic, 
presenting a long drought period, which is reflected in the landscape. In spite of its arid and 
poor appearance, the Caatinga is seen as a complex ecosystem for the capacity of its various life 
forms to adapt to the aridity of the territory. Besides, it presents relatively fertile soils that, due 
to its high biodiversity, provide the area with abundant genetic resources. The formation 
presents heterogeneity in appearance and composition. In some places, it exhibits a short or 
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open forest, from which originates the name Caatinga, which means white forest in the 
indigenous language; in other places, the soil appears almost “nude”, showing isolated bushes. 
The area has two seasons: hot and dry, in the winter; and hot with rains, in the summer. During 
the period of drought, the vegetation has a dry aspect, without foliage, and the roots pierce the 
stony soil, an adaptation of the plants to the climatic conditions. In this way, the fine leaves that 
fall off the trees cause the plants to reduce transpiration, avoiding the loss of water, and their 
roots, staying on the surface of the soil, absorb the water from the rains more rapidly. In the 
beginning of the year, when it begins to rain, the landscape of the Caatinga changes and the gray 
appearance of the period of the droughts gives place to the flowers. The trees reappear full of 
leaves and the soil is lined with small plants. 
Three other species of Erythroxylum have been found growing alongside E. vacciniifolium in 
the carrasco vegetation on the Chapada do Araripe: E. stipulosum Plowman, E. rosuliferum O. 
E. Schulz, and E. loefgrenii Diogo. These three species are restricted to dry formations in 
Northeastern Brazil and none of the four species occurred in adjacent cerado woodland where E. 
barbatum O. E. Schulz and E. suberosum A. St.-Hil. were found. 
 
 
 
 
 
Figure 0-13 
Known geographical distribution of E. vacciniifolium Mart. in Brazil. 
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Traditional uses. In Northeastern Brazil, E. vacciniifolium Mart. is known as catuaba and has 
been attributed in traditional medicine with aphrodisiac and tonic properties (De Almeida, 1993; 
Teixeira da Fonseca, 1922). The bark can be smoked, burned or drunk as a water infusion. The 
infusion is also used against gastrointestinal problems (Emperaire, 1983). Near human 
settlements, the bark is found stripped from most individuals of this species and sold in 
medicinal markets of Northeastern Brazil (Figure 0-14).  For over a century, catuaba has been 
one of the most popular herbal remedies in Brazil, even though the use of this folk name for 
other species in traditional medicine has generated some confusion (see chapter 1.1). 
 
 
 
 
Figure 0-14 
E. vacciniifolium Mart. sold in a medicinal plant market of João Pessoa, Paraíba, Brazil (photo E. F. 
Queiroz, 2001). 
 
 
 
Previous phytochemical investigations. Despite widespread commercialization of 
catuaba, only a few pharmacological and phytochemical studies have been reported on E. 
vacciniifolium Mart. and E. catuaba Silva. Two describe the isolation and structure elucidation 
of three tropane alkaloids from E. vacciniifolium Mart. (Graf and Lude, 1977, 1978). Another 
shows hot water and alkaline extracts to have an effect on human immunodeficiency virus 
(HIV) and suggests a medical potential of E. catuaba Silva against opportunistic infections in 
HIV patients (Manabe et al., 1992). 
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Graf and Lude reported that the leaves and bark of E. vacciniifolium Mart. contain at least 
eight, probably eleven alkaloids (total alkaloid content 0.032%). The three main bases were 
isolated by percolation, extraction, column and thin-layer chromatography. These three 
alkaloids were previously unknown and were named catuabines A, B and C. The structures of 
these catuabines were determined by EI mass spectrometry, 1H- and 13C-NMR spectroscopy, 
and elemental analysis, comparing the data obtained with those of known tropane-3,6-diesters. 
As shown by 1H-NMR spectroscopy, these alkaloids are esters of tropane-3,6-diol with an α-
configuration at C-3 and a β-configuration at C-6 (Figure 0-15). 3,4,5-Trimethoxybenzoic acid 
(catuabines A and B) and pyrrole-2-carboxylic acid (catuabine C) are bound at C-3. N-
Methylpyrrole-2-carboxylic acid (catuabines A and C) and benzoic acid (catuabine B) are 
bound at C-6. The concentration of catuabines A, B and C in the leaves of E. vacciniifolium 
Mart. was calculated by Graf and Lude as 0.01%, 0.0005% and 0.00064%, respectively. 
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Figure 0-15 
Structures of tropane alkaloids isolated from E. vacciniifolium Mart. (Graf and Lude, 1977, 1978). 
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2. Results and Discussion 
2.1. Quantitative determination of total alkaloids 
The quantitative estimation of total alkaloids in the bark of E. vacciniifolium was carried out 
using gravimetric and colorimetric procedures (see chapter VI.7). Gravimetric analysis is a 
macroscopic method involving relatively large sample amounts compared with 
spectrophotometric analysis. The gravimetric analysis was concerned with the weighing of total 
alkaloids that had been separated from other constituents by acid-base partition. Results of 
quantification by gravimetry are exposed in Table 0-2.  
 
 
Table 0-2 
Results of quantitative estimation of total alkaloids in the bark of  E. vacciniifolium by gravimetry. An 
amount of stem bark powder (840.13 g) was extracted with chloroform to give 15.741 g of alkaloid 
extract. Three portions (a, b and c) of this homogenized extract were then used for the analysis. (b. p.: 
before partition; a. p.: after partition) 
Sample Weight b. p. Weight a. p. Alkaloid 
content Average SD RSD CI 
a 335.6 mg 129.6 mg 0.72%     
b 330.2 mg 122.9 mg 0.70% 0.70% ± 0.03% 4.3% ± 0.07% 
c 335.7 mg 120.1 mg 0.67%     
 
 
Quantitative analysis by UV spectrophotometry is based on the relationship between the 
degree of absorption and the concentration of the absorbing material. This relationship is valid 
only as long as Beer’s law is obeyed. It was determined experimentally, using the same 
conditions that were used for subsequent analytical determinations. This was done using a 
calibration curve obtained by preparing several aliquots of a derived main alkaloid (catuabine D, 
22), each at different known concentrations. Consistent parameters and results of photometric 
quantification are reported in Table 0-3. 
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Table 0-3 
Results of quantitative estimation of total alkaloids in the bark of  E. vacciniifolium by colorimetry. (Abs.: 
absorbance; Conc.: concentration; SD: standard deviation; RSD: relative standard deviation; CI: 
confidence interval) 
Sample Weight Abs. Conc. Alkaloid 
contenta Average SD RSD CI 
a 997.3 mg 0.382 UA 2.33·10-5 M 0.52%     
b 996.7 mg 0.387 UA 2.38·10-5 M 0.53% 0.53% ± 0.02% 2.9% ± 0.04% 
c 982.1 mg 0.392 UA 2.42·10-5 M 0.55%     
Range: 1.15-6.92·10-5 M    
n: 7    
Slope: 11600 ± 110    
Y-intercept: 0.113 ± 0.0049    
Calibration curve 
r2: 0.9995    
a Alkaloid content calculated as catuabine D (22).  
 
 
 
The gravimetric and colorimetric methods showed acceptable precision and gave comparable 
alkaloid content for the bark of E. vacciniifolium (0.70% ± 0.07% and 0.53% ± 0.04%, 
respectively). The main alkaloid catuabine D was used as standard for the calibration curve 
because the ratio of its molecular weight and amount in the extract was near the average of the 
ratio for all constituents. Even though the quantitative results were of the same order of 
magnitude, the two methods gave different alkaloid contents. This difference was probably a 
consequence of an under-estimation of total alkaloid quantification by colorimetry as the 
reaction between the bromocresol green indicator and the different N-oxide alkaloids was 
interfered by the supplementary oxygen atom at the N-CH3 position of the tropane. 
The tropane alkaloid content of E. vacciniifolium bark is relatively high compared to that 
found by Graf and Lude in the leaves (0.032%) (Graf and Lude, 1977). This is not surprising 
since the total alkaloid content of other Erythroxylum species or other plants of different genus 
containing tropane alkaloids may vary considerably depending on the analyzed organ or the 
period of collection. Table 0-4 illustrates some example of total alkaloid content in different 
Erythroxylum and Solanaceae.  
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Table 0-4 
Total alkaloid content in different Erythroxylum and Solanaceae. 
Species Organ Total alkaloid content 
E. coca var. coca Lam. Leaves 0.5-2% 
E. corymbosum Boivin ex Baill. Leaves 0.03-0.06% 
E. discolor Liebm.ex O.E.Schulz Leaves 0.35% 
E. discolor Liebm.ex O.E.Schulz Roots 0.23% 
E. ecarinatum Hochr. Leaves 0.03-0.12% 
E. ecarinatum Hochr. Stem bark 0.03% 
E. gerrardii Baker Twigs 0.1% 
E. pervillei Baill. Roots 0.2% 
Atropa belladonna L. Leaves >0.3% 
Datura stramonium L. Leaves >0.25% 
Hyoscyamus niger L. Leaves >0.05% 
 
 
 
2.2. On-line investigation of the alkaloid extract 
2.2.1. Preliminary LC-UV-DAD and LC-APCI-MSn analyses 
In order to obtain a preliminary idea of the constituents present in E. vacciniifolium, a 
combined LC-UV-DAD and positive ion LC-APCI-MS analysis of the specific alkaloid extract 
was performed.  The preparation of the alkaloid extract is reported in chapter VI.1.2. The 
separation was carried out using a reversed phase C18 column and a gradient of acetonitrile-
water buffered with triethylamine (pH=11). The use of the alkaline buffer was required to 
increase the affinity of alkaloids to the reversed phase and to avoid charged molecules which 
could be responsible for hydrogen bonding and ionic interactions with silanol groups of the 
stationary phase, leading to additional retention and peak tailing. 
In the LC-UV chromatogram (272 nm), a dozen main peaks and several minor peaks were 
recorded (Figure 0-16). Most of the constituents of the alkaloid extract had the same UV 
spectrum with a maximum of absorbance varying between 269 and 272 nm. Only three minor 
peaks presented different UV spectra: two of these peaks (4 and 9) had three maxima recorded 
at ca. 241, 271 and 329 nm; the other one (2) had two maxima recorded at ca. 241 and 294 nm. 
These observations suggested that almost all molecules shared the same chromophore and 
probably a similar core structure. 
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The LC-APCI-MSn spectra were recorded during the same run. The total ion current trace 
(TIC) (Figure 0-17) was comparable to the UV trace at 272 nm. The different constituents 
showed protonated molecules [M+H]+ in the range of 265 to 488 Da including several isomers 
(1 and 3: 297 Da; 5-8: 281 Da; 11-15: 265 Da; 17 and 20: 374 Da; 18 and 21: 388 Da) (Table 
0-5). The presence of alkaloids with different numbers of nitrogen atoms was shown by even 
and odd m/z values. The MS2 and MS3 traces exhibited similar low molecular weight (MW) 
fragments for almost all detected peaks, suggesting a common main moiety for each molecule. 
MS3 was needed in some cases for the recording of the characteristic low MW fragments not 
always observable in the MS2 spectra. 
In order to obtain additional structural information about the detected alkaloids, the 
observation of possible exchangeable protons (e.g., N-H or O-H) was undertaken by LC-APCI-
MSn using D2O-MeCN as eluent (Figure 0-18). In HPLC-MS analysis the exchange of 1H2O 
against 2H2O is commonly used for the determination of the total number of exchangeable 
protons in the molecule (Bringmann et al., 2000b; Sandvoss et al., 2000). Under these 
conditions all exchangeable hydrogens were replaced by deuterium. A shift of 1 Da for all 
constituents was due to the presence of deuterated [MD+D]+ instead of protonated molecules 
[M+H]+. The remaining mass difference was attributable to the number of exchangeable protons 
of the molecules (Table 0-5). This analysis demonstrated that all detected compounds had at 
least one exchangeable proton, except 18, 19, 23 and 24. 
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2.2.2. High-resolution LC-APCI-TOF-MS 
For an on-line molecular formula assignment, the extract was analyzed by LC-APCI-TOF-MS 
under identical conditions to those described  for LC-MSn. Accurate mass measurements were 
performed with the help of a reference compound for the lock mass. The [M+H]+ of codeine at 
300.1594 Da was used as a reference during the first 8 min of the HPLC analysis. Due to the 
instability of this ion with the increase of the MeCN concentration in the LC-gradient, the more 
stable [M+H-18]+ codeine fragment at 282.1489 Da was then employed for the lock mass. 
Accurate masses could be measured for six constituents of the alkaloid extract (1, 2 and 21-24) 
and for their protonated molecules [M+H]+, these ranged from 297.1462 to 430.2015 Da (Table 
0-6). The elemental composition of these six compounds was determined with a difference of 
less than 10 ppm between their measured and calculated masses. 
 
 
 
Table 0-6 
High-resolution LC-APCI-TOF-MS data of the alkaloid extract of E. vacciniifolium. 
Compound [M+H]
+
 
measured 
[M+H]+ 
calculated 
ppm 
difference 
Elemental 
compositionc 
1  297.1462 297.1445b 5.6  C14H21N2O5 
2  308.1518 308.1493b 8.1  C16H22NO5 
21  388.1902 388.1867a 8.9  C20H26N3O5 
22  358.1760 358.1762a -0.5  C19H24N3O4 
23  430.2015 430.1973a 9.7  C22H28N3O6 
24  372.1954 372.1918a 9.6  C20H26N3O4 
a Lock mass of the fragment of protonated codeine recalculated according to elemental composition 
[M+H-18]+: m/z 282.1489. 
b Lock mass of protonated codeine [M+H]+ : m/z 300.1594. 
c Elemental composition corresponding to the [M+H]+ ions; one proton has to be deduced for calculation 
of the molecular formula of the different constituents. 
 
 
 
Preliminary analyses showed homogeneity in the spectral data recorded for all constituents of 
the alkaloid extract, which suggested close structural similarities. One of the detected 
compounds (22) was particularly interesting because of its identical molecular formula and 
fragmentation pattern with those reported for a tropane alkaloid esterified by two pyrrolic acids. 
Among the alkaloids (catuabines A, B and C) previously reported for E. vacciniifolium (Graf 
and Lude, 1978), only catuabine C matched with the on-line data recorded. The putative 
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detection of catuabine C in the extract and the common structural features shown by LC-UV 
and LC-MS, confirmed the possible presence of various related tropane alkaloids. This 
hypothesis was strengthened by chemotaxonomic data from the genus Erythroxylum, which is a 
well-known source of various tropane alkaloids. In order to confirm this deduction, the isolation 
of compound 22 was undertaken in view of its use as a reference molecule for further on-flow 
and stop-flow LC-NMR analyses. 
 
2.2.3. Isolation and structure elucidation of compound 22 
A single MPLC separation step performed on the alkaloid extract gave 13 fractions (A to M) 
(see chapter 2.3). Fraction L yielded pure compound 22 (813 mg). The structure elucidation of 
this compound was established by spectroscopic methods, including EIMS, HREIMS, IR, 1H-, 
13C-, and 2D-NMR experiments (see chapter 2.4.1). Accordingly, alkaloid 22 (catuabine D) was 
identified as 3α-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]-6β-[(1H-pyrrol-2-yl)carbonyloxy] 
tropane (Figure 0-19). Thus, compound 22 was a regioisomer of catuabine C (6β-[(1-methyl-
1H-pyrrol-2-yl)carbonyloxy]-3α-[(1H-pyrrol-2-yl)carbonyloxy]tropane), differing by an 
inversion of the ester substituents. 
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Figure 0-19 
Structure of the isolated compound 22 (catuabine D). 
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2.2.4. On-flow and stop-flow LC-NMR 
For sensitive on-flow LC-1H-NMR detection, the amount of extract injected in the system was 
increased to 3.0 mg. The HPLC conditions were consequently optimized in order to achieve a 
good separation of the extract constituents. The internal diameter of the analytical column, 
packed with analogous C18 stationary phase, was increased to 8 mm. H2O was replaced by D2O, 
Et3N by deuterated ammonia and the flow-rate was set to 1.2 mL/min for a separation over 80 
min. Under these HPLC conditions, 32 scans per increment were sufficient to obtain LC-NMR 
spectra with good resolution. Before each set of spectra, a fast solvent suppression (WET) was 
run for the acquisition of LC-NMR spectra. The pulse shape for solvent suppression was 
calculated on fly and automatically adapted to the changes in gradient composition.  With these 
on-flow LC-NMR conditions, the 1H-NMR spectra of five main alkaloids (14 and 21-24) were 
successfully recorded. The proton signals of these compounds were recognizable on a contour 
plot of the on-flow LC-NMR experiments (Figure 0-20). This two-dimensional (2D) plot 
represents the usual way of processing on-flow LC-NMR data, one dimension corresponding to 
the NMR ppm scale and the other to the time scale. All cross peaks on this plot characterize the 
signal resonances of the different constituents (Wolfender et al., 2001). Two other compounds 
(7 and 13), not sufficiently concentrated to be detected on-flow, were well recorded in the stop-
flow mode. The interruption of the flow during the stop-flow acquisitions did not affect the LC 
resolution. 
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Figure 0-20 
On-flow LC-NMR contour plot of the alkaloid extract of E. vacciniifolium. On this 2D plot all 1H-NMR 
resonances of the analytes appear as dots. 1H-NMR spectra of compounds 7 and 23 are shown as examples of 
resolution for on-flow and stop-flow analyses, respectively. Chromatography conditions: Nucleosil AB 100-5 
C18 column (125 x 8.0 mm i.d., 5 µm; Macherey-Nagel) with a pre-column of the same material (8 x 8.0 mm i.d., 
5 µm); gradient of MeCN (+2 mM ND3) : D2O (+2 mM ND3) (5:95 to 100:0 in 80 min); injection of 3.0 mg; pH 
= 10; flow-rate 1.2 mL/min; detection at 272 nm. NMR conditions (Varian Unity Inova 500 MHz): 1H[13C] pulse 
field gradient indirect detection microflow probe (cell 60 µL; 3 mm i.d.); references of the solvent signal at δ 
2.10 for MeCN; solvent suppression with the WET sequence; NT=32 in on-flow mode; NT=1024 in stop-flow 
mode. 
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2.2.5. Interpretation of on-line data 
Correlation of 1H-NMR and LC-1H-NMR data of compound 22. The 1H-NMR 
resonances of 22 obtained by on-flow LC-1H-NMR differed by less than 0.2 ppm from those of 
the isolated compound (see chapter 2.4.1), measured in CDCl3 at 30°C. This LC-1H-NMR 
spectrum, recorded at a retention time (RT) of 42 min (Figure 0-21), showed characteristic 
chemical shifts associated with catuabine D (22). Thus, the typical resonances for a 
methylpyrrole substructure were exhibited by the signals at δH 3.96 (N-CH3), 6.23 (H-4'), 7.05 
(H-5') and 7.21 (H-3'). A non methylated pyrrole was associated with signals at δH 6.29 (H-4''), 
7.12 (H-5'') and 7.09 (H-3''). The presence of the secondary nitrogen atom in this substructure 
was confirmed by the observation of an exchangeable proton by LC-MSn analysis using D2O as 
eluent (Table 0-5). 
 The structure of the disubstituted tropane core skeleton was illustrated by three saturated 
methylenes at δH 1.79 (Hendo-2), 2.30 (3H, Hexo-2, Hexo-4, Hexo-7) and 2.75 (Hendo-7). The solvent 
suppression around 2.10 ppm affected the signal detection of Hendo-4 protons. Two methine 
groups and one methyl group linked to the nitrogen atom were also recorded at δH 3.38 (H-5), 
3.46 (H-1) and 2.54 (N-CH3), respectively. The last two oxygenated methine moieties showed 
resonances at δH 5.19 (H-3) and 5.75 (H-6). The multiplicity (triplet) of the H-3 signal with the 
coupling constant (J = 4.4 Hz) indicated the α-orientation (i.e., endo) of the substituent at C-3 
(Agar and Evans, 1976; Al-Said et al., 1989b; El-Iman et al., 1987). The arrangement of the 
substituent at C-6 was established by the analysis of the coupling constants of H-6, H-7 and H-5 
protons. The H-6 proton of the disubstituted tropane alkaloid showed two couplings (J = 7.7, 
2.8) with the two H-7 protons and it did not present any coupling with the vicinal H-5 proton. 
This observation implied a β-orientation (i.e., exo) of the substituent and a dihedral angle close 
to 90° between H-5 and H-6α (Al-Said et al., 1986b; Bringmann et al., 2000a). 
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Figure 0-21 
On-line and off-line 1H-NMR spectra of compound 22 (catuabine D). On-line spectrum recorded at a 
RT of 42 min. 
 
Structural elucidation of compounds detected by LC-1H-NMR. The on-flow LC-
NMR contour plot of the extract permitted a direct comparison of the chemical shifts of the 
other detected compounds with those mentioned for 22 (Figure 0-20). The signals exhibited 
great homogeneity, corroborating the hypothesis that the major constituents of the alkaloid 
extract of E. vacciniifolium were tropanic analogues of catuabine D. 
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The LC-1H-NMR spectrum recorded for compound 24 at a retention time of 58 min 
exhibited similar chemical shifts to those of the spectrum of 22 (Table 0-7), supporting the 
presence in the molecule of a tropane moiety dioxygenated at C-3 and C-6. The difference 
between the two compounds was in their ester substituents. In fact, two methyl groups were 
recorded at δH 3.93 (3H, s, N-CH3) and 3.94 (3H, s, N-CH3) in the LC-1H-NMR spectrum of 
24 (Figure 0-22), indicating two methylpyrrole acid moieties. The presence of an additional 
methyl group in the structure of compound 24 was corroborated by the observation of its 
protonated molecule [M+H]+, recorded at 372.1954 by LC-TOF-MS analysis, associated with 
a molecular formula of C20H25N3O4. Moreover, the LC-MS performed when using D2O as the 
cosolvent confirmed the absence of exchangeable protons. On the basis of the above evidence, 
the structure of 24 was elucidated on-line as 3α,6β-di-[(1-methyl-1H-pyrrol-2-
yl)carbonyloxy]tropane. 
 
Table 0-7 
LC-1H-NMR data.a 
proton 7 13 14 21 22 23 24 
1 3.18 br s 3.28 br s 3.41 m 3.45 br s 3.46 br s 3.43 br s 3.46 br s 
2exo 2.25 m 1.98 m 1.75 m 2.32 m 2.30 m 2.35 m 2.35 m 
2endo 
 
1.75 d 
(15.4) 
1.48 d 
(15.4) 
1.41 m 
 
1.88 d 
(16.5) 
1.79 d 
(15.4) 
1.93 d 
(15.3) 
1.82 d 
(15.4) 
3α - - 1.48 m - - - - 
3β 
 
4.08 t 
(4.4) 
4.06 t 
(4.4) 
1.94–2.30 m 
 
5.20 t 
(4.4) 
5.19 t 
(4.4) 
5.26 t 
(4.4) 
5.19 t 
(4.4) 
4exo 2.25 m 1.98 m 4.99 m 2.32 m 2.30 m 2.32 m 2.35 m 
4endo 
 
1.77 d 
(15.4) 
1.72 d 
(15.4) 
b 
 
b 
 
b 
 
b 
 
b 
 
5 3.34 br s 3.21 br s 3.21 d (3.3) 3.25 br s 3.38 br s 3.43 br s 3.38 br s 
6α 
 
5.71 d 
(6.6) 
5.71 dd 
(7.7, 2.8) 
b 
 
5.75 d 
(6.6) 
5.75 dd 
(7.7, 2.8) 
5.90 d 
(6.6) 
5.74 dd 
(7.7, 2.8) 
7α 
 
4.88 d 
(6.6) 
2.71 dd 
(14.8, 7.7) 
1.94–2.30 m 
 
4.85 d 
(6.6) 
2.75 dd 
(14.3, 7.7) 
5.80 d 
(6.6) 
2.74 dd 
(14.3, 7.7) 
7β - 2.03–2.06 m 1.94–2.30 m - 2.30 m - 2.35 m 
N-CH3 2.57 s 2.53 s 2.53 s 2.63 s 2.54 s 2.64 s 2.54 s 
 Mpc Mpc Mpc Mpc Mpc Mpc Mpc 
3' 
 
7.13 dd 
(3.9, 1.1) 
7.10 dd 
(3.9, 2.2) 
7.11 dd 
(3.9, 2.7) 
7.21 dd 
(3.9, 2.2) 
7.21 dd 
(3.9, 2.2) 
7.23 dd 
(3.9, 1.7) 
7.15 dd 
(3.9, 1.7) 
4' 
 
6.24 dd 
(3.9, 1.1) 
6.23 m 
 
6.24 dd 
(3.9, 2.7) 
6.30 dd 
(3.9, 2.7) 
6.23 dd 
(3.9, 2.7) 
6.27 dd 
(3.9, 2.7) 
6.26 dd 
(3.9, 2.7) 
5' 
 
7.06 dd 
(3.9, 1.1) 
7.06 m 
 
7.06 m 
 
7.09 m 
 
7.05 m 
 
7.06 m 
 
7.03 m 
 
N-CH3 3.93 s 3.93 s 3.93 s 3.95 s 3.96 s 3.92 s 3.93 s 
    Mpc Pc Mpc Mpc 
3'' 
 
   
7.12 dd 
(3.9, 2.2) 
7.09 dd 
(3.9, 2.2) 
7.09 m 
 
7.08 dd 
(3.9, 1.7) 
4'' 
 
   
6.23 dd 
(3.9, 2.7) 
6.29 dd 
(3.9, 2.7) 
6.23 dd 
(3.9, 2.7) 
6.21 dd 
(3.9, 1.7) 
5'' 
 
   
7.05 m 
 
7.12 dd 
(3.9, 1.7) 
7.06 m 
 
7.03 m 
 
N-CH3    3.96 s - 3.96 s 3.94 s 
      CH3COO  
      2.24 s  
a
 δ values given in ppm, J values in parentheses given in Hz. 
b
 the solvent suppression of acetonitrile and water respectively affected the signal detection. 
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Figure 0-22 
On-flow LC-1H-NMR spectrum of compound 24 (RT = 58 min). 
 
 
 
Spectral data of 21 (RT = 37 min) showed that its structure was very close to that of 
compound 24, with the presence of a tropanic nucleus and two methylpyrrole ester groups 
(Table 0-7). However, compound 21 had an additional hydroxyl group at C-7, as indicated by 
the extra deshielded signal at δH 4.85 (H-7) and the absence of the resonance around δH 2.75 
associated previously with the saturated methylene moiety at the 7-position for compounds 22 
and 24 (Figure 0-23). The lack of any coupling constant with vicinal protons H-5 and H-1 
suggested an α-orientation of protons at 6- and 7-positions, respectively. The hydroxyl group 
was also confirmed by the presence of one exchangeable proton in the deuterated molecule 
([MD+D]+ 390 Da) when compared to the corresponding protonated molecule ([M+H]+ 388 
Da). The molecular formula C20H25N3O5 obtained by LC-TOF-MS analysis confirmed the 
structure elucidation of 21 as 3α,6β-di-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]-7β-
hydroxytropane. 
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Figure 0-23 
On-flow LC-1H-NMR spectrum of compound 21 (RT = 37 min). 
 
 
 
LC-TOF-MS analysis of compound 23 exhibited a protonated molecule at [M+H]+ 
430.2015 Da indicating a molecular formula of C22H28N3O6 and implying a supplementary 
C2H2O element when compared with 21. Furthermore, the presence of a trioxygenated 
tropanic skeleton and two methylpyrrole ester moieties was deduced by comparison of its LC-
1H-NMR spectrum (RT = 54 min) with those of compound 21. The significant differences 
between the two compounds were an additional resonance for one methyl group at δH 2.24 
and a major variation (∆δH + 0.95) in the chemical shift of the signal associated with Hendo-7 
(Figure 0-24). The downfield shifted signal suggested here the occurrence of an ester 
substitution in the 7-position (Al-Said et al., 1986a; El-Iman et al., 1987; Payo-Hill et al., 
2000). According to the molecular formula and the additional methyl group mentioned above, 
only an acetyl moiety could be located at this position. The presence of this acetyl group was 
also confirmed by the loss of 42 Da in the LC-MS2 spectrum. Compound 23 was thus 
elucidated as 7β-acetoxy-3α-6β-di-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane. 
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Figure 0-24 
On-flow LC-1H-NMR spectrum of compound 23 (RT = 54 min). 
 
 
 
The stop-flow LC-1H-NMR data (RT = 14 min) of compound 7 showed characteristic 
resonances for trisubstituted tropane alkaloids, as in compound 21, but here a single 
methylpyrrole ester was present (Figure 0-25). The absence of the second methylpyrrole 
group was confirmed by the observation of a protonated molecule at 281 Da deduced from 
LC-MSn experiments (Table 0-5). The similar chemical shift to other compounds associated 
with Hendo-6 at δH 5.71 supported the substitution of this single ester at the 6-position. The 
signal at δH 4.08, highfield shifted with respect to esterified compounds such as 21 or 23, 
indicated a hydroxyl group at C-3 (Al-Said et al., 1986a; El-Iman et al., 1987; Payo-Hill et al., 
2000). The observation of two exchangeable protons confirmed the presence of two OH 
groups in the alkaloid. Thus, the structure of compound 7 was elucidated as 3α,7β-dihydroxy-
6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane. 
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Figure 0-25 
Stop-flow LC-1H-NMR spectrum of compound 7 (RT = 14 min). 
 
 
 
The stop-flow LC-1H-NMR spectrum of compound 13 (RT = 20 min) showed similar 
chemical shifts to those of the spectrum of 7 supporting the presence in the molecule of a 
single methylpyrrole ester at C-6. The chromatographic peak at this retention time had a poor 
resolution, consequently, additional signals appeared in the spectrum (Figure 0-26). These 
extra signals probably belonged to compound 14, a main alkaloid of the extract showing a 
large peak with a RT of 22 min. Subtracting the supplementary chemical shifts, the remaining 
signals were attributed to compound 13. The LC-MSn experiment of 13 showed a protonated 
molecule at 265 Da, suggesting the lack of an oxygen atom when compared to 7. For this 
compound only one exchangeable proton was recorded confirming the presence of only one 
hydroxyl group. The NMR data of 13 exhibited a signal at δH 2.71, suggesting a saturated 
methylene moiety at the 7-position as for compounds 22 and 24. Compound 13 was then 
elucidated as a 3,6-disubstituted tropane alkaloid corresponding to the structure 3α-hydroxy-
6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane. 
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Figure 0-26 
Stop-flow LC-1H-NMR spectrum of compound 13 (RT = 20 min). (* are additional signals belonging 
to compound 14) 
 
 
 
From LC-1H-NMR experiments, another main alkaloid (14) was detected (RT = 22 min). 
The on-flow LC-1H-NMR indicated that 14 possessed a single methylpyrrole ester as in 7 and 
13, and the remaining signals supported the presence of a tropanic nucleus (Figure 0-27). Its 
LC-MSn analyses exhibited [M+H]+ and [MD+D]+ at 265 Da and 267 Da, respectively, 
demonstrating isomeric character with compound 13. Despite a careful analysis of the NMR 
data only one deshielded tropanic proton was observed at δH 4.99 suggesting that the water 
suppression around 4.5 ppm affected the signal detection of the second oxygenated methine. 
The recorded values of the oxygenated methines at δH 4.99 and probably around 4.5 for 14 
were different from those measured for the other compounds, which could implicate a 
variation in the oxygenated pattern of the tropanic skeleton. Accordingly, these variations 
impeded the complete structural elucidation of this compound. 
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Figure 0-27 
On-flow LC-1H-NMR spectrum of compound 14 (RT = 22 min). 
 
 
 
Partial identification of the minor alkaloids. The LC-MSn analysis of the other 
constituents of the alkaloid extract showed similar patterns of fragmentation for each 
compound, giving important information for their core structures. The selective MS2 of each 
peak showed that all the different molecules shared a central structural element with fragment 
ions at m/z 140, 138, 122 or 120. Comparing this fragmentation pathway to that of the other 
on-line elucidated compounds and to the literature (Graf and Lude, 1978), these corresponded 
to a monohydroxylated tropane or a tropane moiety. The difference of 2 Da between 
fragments of the same type was related to the nature of their parent ions: disubstituted tropane 
alkaloids gave daughter ions at m/z 140 and 122, while trisubstituted tropane moieties gave 
daughter ions at m/z 138 and 120. Two other fragment ions with low m/z (110 and 108) were 
also found in almost all molecules and they probably corresponded to the ester moieties. 
Based on the assignments made for the previously elucidated alkaloids and on literature data 
(Graf and Lude, 1978),  these fragments were identified as 1-methyl-2-(oxoniomethyl)-1H-
pyrrolium groups (e.g., see fragment structure of 23 in Figure 0-28). As illustrated by the MS3 
experiments of ions at m/z 156 and 140, the fragments at m/z 110 and 108 could also be 
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obtained from the fragmentation of a tri- or dioxygenated tropane center. Due to its higher 
MW, compound 23 was selected as an example to illustrate a hypothetical fragmentation 
pathway for the tropane alkaloids of E. vacciniifolium (Figure 0-28). 
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Figure 0-28 
Proposed fragmentation pattern for protonated compound 23. Due to the higher MW, compound 23 
was selected as an example. The other molecules gave similar low MW fragment ions. MSn conditions: 
capillary temperature: 150°C; vaporizer temperature: 380°C; corona needle current: 6.0 µA; sheath gas 
(nitrogen) pressure: 60 psi; positive mode; collision energy: 35%. 
 
 
 
The superposition of the MS2 and MS3 traces at m/z 140, 138, 122, 120, 110 or 108 with the 
TIC trace of the extract showed that almost all detected molecules had the same daughter ions 
(Figure 0-29). This evaluation suggested that the differences among nearly all tropane 
molecules relied on the number and position of the ester substituents or hydroxyl groups. 
Blossey et al. reported the possibility of differentiating these positions in disubstituted tropane 
alkaloids by EI-MS, demonstrating the influence of functional groups on the fragmentation 
pattern of the tropane nucleus (Blossey et al., 1964). In this study, the fragments obtained by 
collision induced dissociation in the LC-APCI-MSn were not sufficiently homogeneous for a 
definitive determination of substitution positions. 
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Figure 0-29 
(A) LC-UV-APCI-MS analysis of the crude alkaloid extract of E. vacciniifolium. The total ion current 
(TIC) trace was recorded in the positive mode between 150 Da and 2000 Da. (B) Selective MS2 traces 
of characteristic fragment ions. (C) Complementary MS3 traces of low MW fragments. MSn conditions: 
capillary temperature: 150°C; vaporizer temperature: 380°C; corona needle current: 6.0 µA; sheath gas 
(nitrogen) pressure: 60 psi; collision energy: 35%. 
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The combined interpretation of LC-UV-MSn data led to the conclusion that all compounds 
with an absorbance maximum around 270 nm were esterified by one or two pyrrolcarboxylic 
acids or contain one or two pyrrolic chromophores, as for 7, 13 and 21-24 identified on-line. 
Comparison of these data for the minor alkaloids with those previously elucidated gave 
important information for their characterization. Most of these alkaloids could be grouped in 
sets of isomeric structure. In many cases a molecular weight difference of 16 Da between 
these sets were recorded, indicating variation due to additional oxygen. The extra oxygen 
atoms could also appear in their fragment ions (e.g. m/z 263 and 247 for 21 and 24 in Table 
0-5). This molecular ion difference occurred between compounds: 5-8 (each 281 Da) and 1, 3 
(each 297 Da); 9 (445 Da) and 4 (461 Da); 11-15 (each 265 Da) and 5-8 (each 281 Da); 17, 
20 (each 374 Da) and 10 (390 Da); 22 (358 Da) and 17, 20 (each 374 Da); 24 (372 Da) and 18, 
21 (each 388 Da). In order to confirm that these oxygens corresponded to an additional 
hydroxyl group in the molecules, the number of exchangeable protons was calculated as 
mentioned before. Compounds 17 and 20 exhibited the same protonated molecule (16 Da 
more than 22), but they had different numbers of exchangeable protons (1 for 17 and 2 for 20). 
This observation suggested an additional hydroxyl group for 20 and probably the presence of 
an N-oxide in compound 17. A similar deduction could also be made for compounds 18 and 
21. They had the same [M+H]+ (16 Da more than 24) but only 21 showed an additional 
exchangeable proton, suggesting the presence of an extra hydroxyl group. Therefore, 
compound 18 probably included an N-oxide in its structure (Figure 0-30). In the same way, 
five other tropane alkaloids (1, 3, 5, 10 and 16) were deduced to contain an N-oxide in their 
structure in comparison with 7, 8, 13, 20 and 21, respectively. The occurrence of tropane 
alkaloid N-oxides in plants has previously been reported (Aripova, 1996; Katavic et al., 1999; 
Phillipson and Handa, 1978; Silva et al., 2001). The ratio of N-oxides to tertiary bases in 
plants varies for different organs during ontogenesis. This fluctuation is an indication that N-
oxides are not artifacts but that they are involved in the metabolic processes of the plant 
(Phillipson and Handa, 1978). In contrast, Achenbach et al. reported that model experiments 
performed with indole alkaloids showed N-oxidation occurring in presence of air or during 
work-up of  plant extracts (Achenbach et al., 1997). These divergent considerations do not 
allow to conclude whether N-oxides are genuine natural products or artifacts. 
Compound 19 did not present any exchangeable protons and seemed to share a similar core 
structure with 18. In fact, its most abundant fragment obtained by MS2 (m/z 388) 
corresponded to the protonated molecule of 18. After a comparison with the literature on 
tropane alkaloids, this fragment was assigned to the loss (m/z 100) of an isovaleranyl moiety 
(Christen et al., 1993). 
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Compounds 9 and 4 had three absorbance maxima (241, 271 and 329 nm), indicating the 
presence of at least one different substituent. The MS2 analysis of these two compounds gave 
typical fragment ions at m/z 247 and 263, respectively, for a tropane or a hydroxytropane 
esterified by a methylpyrrole, but a new daughter ion at m/z 181 appeared in the fragmentation 
pathway, confirming the presence of a new esterifying group. According to the fragmentation 
pattern of catuabine A, previously isolated from E. vacciniifolium  (Graf and Lude, 1978), this 
fragment ion probably corresponded to a [(4-hydroxy-3,5-
dimethoxyphenyl)methylidyne]oxonium. The presence of this ester was confirmed by the MS3 
experiment of 9 which gave fragment ions at m/z 181, 140 and 122 from a parent ion at m/z 320 
assigned to a tropane moiety esterified by 4-hydroxy-3,5-dimethoxybenzoic acid. The 
trimethoxybenzoic acid ester in tropane alkaloids is relatively common and its occurrence was 
easily detected by MS-MS experiments giving the typical fragment at m/z 195 for its acyl unit 
(Agar and Evans, 1976; Bringmann et al., 2000a; El-Iman et al., 1987; Silva et al., 2001). The 
presence of an additional hydroxyl group in 4 was also confirmed by the observation of one 
more exchangeable proton than in 9. 
The presence in the extract of another tropane alkaloid with an original substituent was 
demonstrated by the occurrence of a different chromophore for compound 2 (two maxima of 
absorbance at ca. 241 and 294 nm). The absence of a maximum around 270 nm suggested the 
lack of a pyrrolic chromophore. The MS2 experiments of 2 gave typical fragment ions for a 
tropane center with a most abundant ion at m/z 156, corresponding to a dihydroxylated moiety. 
The loss of the substituent during the fragmentation was shown by the loss of 152 Da from the 
molecular ion (308 Da) of 2. According to the literature on tropane alkaloids (Silva et al., 2001), 
this esterifying group could be a 3-hydroxyphenylacetic acid, but supplementary analysis is 
needed for unambiguous identification. 
On the basis of the above interpretation of the LC-UV-MSn spectroscopic data and by analogy 
with the on-line elucidated compounds, 1-6, 8-12 and 14-20 were partially identified as di- or 
trisubstituted tropane alkaloids, mono- or diesterified by pyrrolic, methylpyrrolic, 
hydroxydimethoxybenzoic or hydroxyphenylacetic acids (Figure 0-31). The pyrrole substituent 
is uncommon in tropane alkaloids (only three have been isolated previously) and may play an 
important role in the biological activity of the compounds. The proposed structures of these 
compounds suggested them to be new and their targeted isolation was undertaken for complete 
characterization. 
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Compounda R1
 
R2 R3 Other 
7  H Mpc OH - 
13  H Mpc H - 
21  Mpc Mpc OH - 
22  Mpc Pc H - 
23  Mpc Mpc CH3COO - 
24  Mpc Mpc H - 
Compoundb Mpc
 
Pc OH Other 
1  1 - 2 N→O 
2  - - 2 3-OHPhCH2CO 
3  1 - 2 N→O 
4  1 - 1 Hdmb 
5  1 - 1 N→O 
6  1 - 2 - 
8  1 - 2 - 
9  1 - - Hdmb 
10  1 1 1 N→O 
11  1 - 1 - 
12  1 - 1 - 
14  1 - 1 - 
15  1 - 1 - 
16  2 - 1 N→O 
17  1 1 - N→O 
18  2 - - N→O 
19  2 - - N→O; C4H9COO 
20  1 1 1 - 
a
 Fully identified and characterized compounds. 
b
 Partially identified compounds.  
Figure 0-31 
Structures of tropane alkaloids from E. vacciniifolium identified on-line. All compounds had a di- or 
trisubstituted tropane moiety mono- or diesterified by Mpc, Pc, Hdmb, 3-OHPhCH2CO or C4H9COO. 
Several tropane centers had an N-oxide group. The structures differed in the number and position of the 
ester substituents or hydroxyl groups. 
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2.3. Fractionation and purification of the alkaloid extract by MPLC and 
semi-preparative HPLC 
The alkaloid extract (10 g) was fractionated by MPLC with MeCN-H2O-2 mM Et3N (460 x 70 
mm, flow rate: 5.0 mL/min, gradient: MeCN 5% to 100% in 3 days, UV detection at 280 nm) to 
give 13 fractions (A to M). Fraction L yielded directly in one step compound 22 (813 mg). The 
scheme of fractionation and isolation of all compounds is reported in Figure 0-32. 
Fraction F was rechromatographed by MPLC with MeCN-H2O-2 mM Et3N (460 x 36 mm, 
flow rate: 3.4 mL/min, gradient: MeCN 5% to 15% in 24 hs, UV detection at 280 nm) to give 5 
fractions (F1 to F5). Fractions F2 and F5 yielded compounds 2 (180 mg) and 8 (117 mg), 
respectively. 
Fraction G was purified by MPLC MeCN-H2O-2 mM Et3N (460 x 36 mm, flow rate: 6.6 
mL/min, gradient: MeCN 5% to 10% in 8 hs, UV detection at 280 nm) to afford compound 7 
(198 mg). 
Fraction H was separated by MPLC with MeCN-H2O-2 mM Et3N (460 x 36 mm, flow rate: 
3.4 mL/min, gradient: MeCN 5% to 30% in 47 hs, UV detection at 280 nm) to give 10 fractions 
(H1 to H10). Fractions H7 and H10 yielded compounds 11 (17 mg) and 15 (86 mg), 
respectively. 
Fraction I was purified by MPLC MeCN-H2O-2 mM Et3N (460 x 36 mm, flow rate: 5.0 
mL/min, gradient: MeCN 5% to 20% in 20 hs, UV detection at 280 nm) to afford compound 14 
(543 mg). 
Fraction J was purified by MPLC with MeCN-H2O-2 mM Et3N (460 x 36 mm, flow rate: 3.0 
mL/min, gradient: MeCN 5% to 25% in 2.5 days, UV detection at 280 nm) to give 8 fractions 
(J1 to J8). Fractions J1, J3, J6 and J7 yielded respectively compounds 4 (13 mg), 9 (33 mg), 18 
(37 mg) and 20 (8 mg). Fraction J4 was rechromatographed by HPLC with MeCN-H2O-2 mM 
Et3N (Nucleosil 100-5 C18 AB, 125 x 8 mm, 5 µm, flow rate: 2.0 mL/min, isocratic: MeCN 13% 
for 30 min, UV detection at 272 nm) to afford compounds 13 (22 mg) and 12 (7 mg). 
Fraction K was separated by MPLC with MeCN-H2O-2 mM Et3N (460 x 36 mm, flow rate: 
5.0 mL/min, gradient: MeCN 15% to 60% in 4 hs, UV detection at 280 nm) to give 9 fractions 
(K1 to K9). Fraction K3 yielded compound 6 (81 mg), while fractions  K6 and K8 gave 
compound 21 (631 mg) and compound 23 (232 mg), in that order. 
Fraction M was purified by MPLC MeCN-H2O-2 mM Et3N (460 x 36 mm, flow rate: 5.0 
mL/min, gradient: MeCN 15% to 60% in 19 hs, UV detection at 280 nm) to afford compound 
24 (727 mg). 
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2.4. Structure elucidation of catuabines D to I, vaccinines A and B, and 
their derivatives 
2.4.1. Catuabine D 
Catuabine D (22) was isolated as white amorphous powder. High-resolution electrospray 
ion cyclotron resonance mass spectroscopic analysis (HRESMS) of this compound suggested 
a molecular formula of C19H23N3O4, implicating 10 centers of unsaturation and/or ring 
structures. The 13C-NMR spectrum recorded in chloroform-d indicated 10 sp2-hybridized 
carbon atoms (Table 0-11; Figure 0-33), of which six had protons attached and four were non-
protonated. The IR spectrum of 22 exhibited a large absorption band at 1700 cm-1 indicating 
the presence of ester group(s) (Figure 0-34). 
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Figure 0-33 
13C-NMR spectrum of compound 9. The 13C assignments were ascertained by DEPT, gHSQC, and 
gHMBC experiments. (Spectrum recorded in CDCl3 at 125.70 MHz using CDCl3 as internal standard) 
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Figure 0-34 
IR spectrum of compound 22. (KBr pellet; 4 scans; 2.0 cm-1; 500-4000 cm-1) 
 
 
 
According to the number of sp2-hybridized carbons, two ester functions associated with 
chemical shifts at δC 160.9 and 160.3 and four ethylenic groups were required. These six 
centers of unsaturation suggested consequently the presence of four rings in the molecule. A 
gDQF-COSY NMR experiment on 22 indicated four isolated spin systems corresponding to 
the four different rings (Figure 0-35). 
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Figure 0-35 
gDQF-COSY spectrum of compound 22 showing four isolated spin systems (A: methylpyrrole ring; B: 
pyrrole ring; C: piperidine ring; D: pyrrolidine ring) 
 
 
 
The 1H-NMR spectrum of one of these spin systems exhibited typical resonances for a 
methylpyrrole substructure with signals at δH 3.94 (N-CH3), δH 6.15 (H-4'), δH 6.80 (H-5') and 
δH 7.08 (H-3'), respectively (Figure 0-36). The gHMBC spectrum showed characteristic long-
range 1H-13C correlations between the methyl group at δH 3.94 (N-CH3) and two carbons of 
the pyrrole ring at δC 122.5 (C-2') and 129.7 (C-5'). In addition, the gHMBC spectrum 
exhibited a correlation between the pyrrole proton at δH 7.08 (H-3') and the carbonyl carbon at 
δC 160.3 (C-a') indicating then the substitution of the methylpyrrole moiety at the 2'-position 
by an ester group (Figure 0-37).  
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Figure 0-36 
1H-NMR spectrum of compound 22. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
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Figure 0-37 
Characteristic 1H and 13C-NMR data for a methylpyrrole ester (spin system A) and a pyrrole ester (spin 
system B), and their most important long-range 1H- 13C correlations. (δ values given in ppm; J values 
in parentheses given in Hz) 
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Another spin system deduced from the gDQF-COSY experiment was associated with a 
second pyrrole substructure characterized by resonance signals at δH 6.25 (H-4''), δH 6.94 (H-
5''), δH 6.91 (H-3'') and δH 9.98 (H-N), respectively. Deduced from the observation of a long-
range 1H-13C correlation between H-3'' and the carbonyl carbon at δC 160.9 (C-a'') by a 
gHMBC experiment on 22, the 2-position of this second pyrrole substructure was also 
substituted by an ester moiety (Figure 0-37). 
The two other remaining spin systems belonged to the tropane alkaloid skeleton. The 1H-
NMR spectrum of 22 exhibited a singlet signal at δH 2.58 attributed to the protons of a methyl 
group bonded to the nitrogen (Figure 0-36). The gHMBC experiment showed 1H-13C 
correlations between these methyl protons and two methine moieties at δC 65.5 and 59.6 ppm 
corresponding to C-1 and C-5, respectively (Figure 0-38; Figure 0-39). According to the 
gHSQC spectrum, these two methine carbons were linked to protons with resonances at δH 
3.40 (H-1) and δH 3.34 (H-5) (Figure 0-40). The gDQF-COSY experiment showed that the 
two methine protons belonged to a first spin system of five protons arranged in a 2-oxopropyl 
substructure with signals at δH 1.74 (Hendo-2), 1.96 (Hendo-4), 2.22 (Hexo-2), 2.25 (Hexo-4) and 
5.23 (H-3β). In addition, the methine proton H-1 was linked to a second spin system of three 
coupled protons characterized by chemical shifts at δH 5.81 (H-6α), 2.28 (H-7β) and 2.76 (H-
7α) (Figure 0-35). 
The exact substitution of the tropane alkaloid skeleton was then confirmed by examination 
of gHMBC spectra: the resonance at δH 5.81 (H-6α) showed a long-range 1H-13C correlation 
with a methylene group at δC 32.2 (C-4), and the signals at δH 2.28 (H-7β) and δH 2.76 (H-7α) 
correlated with the carbon at δC 33.7 (C-2). To conclude, the long-range 1H-13C correlations 
between the H-3 and H-6 protons and the carbonyl carbons C-a' and C-a'' of the two pyrrole 
substructures, respectively, led to the general structure 3-[(1-methyl-1H-pyrrol-2-
yl)carbonyloxy]-6-[(1H-pyrrol-2-yl)carbonyloxy]tropane. 
Phytochemical investigation of Erythroxylum vacciniifolium 
used in Brazilian traditional medicine as an aphrodisiac 
 
 
IV. 
119 
 
 
F1 (ppm)
30405060708090110130150
F2
(ppm)
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
C
-a
'
C
-a
''
C
-5
'
C
-4
'
C
-3
''
C
-4
''
C
-2
'
C
-6
C
-3
C
-5
C
-1
C
-9
C
-7
C
-6
'
C
-4
C
-2
C
-3
'
C
-2
''
C
-5
''
H-1
H-5
Hβ-3
Hα-6
H-4'
Hα-7
H-4''
H-5'H-3'',H-5''
H-3'
Hexo-2, Hexo-4
Hendo-2
Hendo-4
H-9
H-6'
Hβ-7
 
Figure 0-38 
gHMBC spectrum of compound 22.  
 
 
 
 
 
N
CH3
O
H
O
R1
N
CH3
O
HO
R2 H
HH
H
H
H
a'
1
3
2
45 a''
1
56
7
C D
H
 
Figure 0-39 
Selected long-range 1H- 13C correlations of tropane moiety (spin systems C and D). 
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Figure 0-40 
gHSQC spectrum of compound 22. 
 
 
 
The relative configuration of 22 was established in order to give the stereochemical 
orientation of the two substituents relative to the nitrogen-containing bridge (Figure 0-41). 
The multiplicity (triplet) of the H-3 signal with the coupling constant (J = 4.9 Hz) indicated 
the α-orientation (i.e. endo) of the substituent at C-3 (Agar and Evans, 1976; Al-Said et al., 
1989a; El-Iman et al., 1987). The arrangement of the substituent at C-6 was established by the 
analysis of the coupling constants of H-6, H-7 and H-5 protons. The H-6 proton showed two 
couplings (7.3, 2.9) with the two H-7 protons and it did not present any coupling with the 
vicinal H-5 proton. This observation implied a β-orientation of the substituent and a dihedral 
angle close to 90° between H-5 and H-6α (Al-Said et al., 1986a; Bringmann et al., 2000a). 
The tropane N-CH3 group stereochemistry was established by NOESY NMR experiments. 
The clear NOESY interactions between the N-CH3 group and the Hexo-2 and Hexo-4 indicated 
an axial orientation of the N-CH3 group in the molecule. 
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Figure 0-41 
Relative configuration of compound 22, as deduced from 1H-NMR coupling constants (a and b) as well 
as NOESY interactions (c). 
 
 
 
Thus, the structure of catuabine D (22) is 3α-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]-6β-
[(1H-pyrrol-2-yl)carbonyloxy]tropane. 
2.4.2. 7β-Hydroxycatuabine D 
Compound 20 was purified as white amorphous powder and was assigned a molecular 
formula of C19H23N3O5, as determined by HRESMS. The EI mass spectrum showed a 
molecular ion at m/z 373, 16 amu higher than that of 22, suggesting the occurrence of an 
additional oxygen atom in the structure of alkaloid 20. The NMR data of those two 
compounds were also closely related, indicating the presence in 20 of a central tropane moiety 
esterified by two methylpyrrole (Mpc) or pyrrole (Pc) acids. By the analysis of the gHMBC 
spectrum, the methylpyrrole and pyrrole esters were located, as for catuabine D, at positions 
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C-3 and C-6, respectively. Except for proton H-7, the 1H-NMR spectrum of the tropane 
nucleus of 20 exhibited similar chemical shifts to 22 (Table 0-10; Figure 0-42).  Actually, this 
spectrum showed typical resonances for a tropane alkaloid skeleton trisubstituted at C-3, C-6 
and also C-7 positions with signals at δH 5.27 (H-3β), δH 5.80 (H-6α) and δH 4.88 (H-7α), 
respectively. According to the molecular formula and the values of the chemical shifts 
associated with the 7-position (δH 4.88 and δC 74.6), a hydroxyl moiety was required at this 
location. 
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Figure 0-42 
1H-NMR spectrum of compound 20. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
 
 
 
The α-orientation of the esterifying group in C-3 was resolved from the multiplicity (triplet) 
and the coupling constant (J = 4.9 Hz) of the H-3 proton signal (Agar and Evans, 1976; Al-
Said et al., 1989b; El-Iman et al., 1987). The α-orientation of protons at C-6 and C-7 position 
was deduced by the lack of any coupling constant with vicinal protons H-5 and H-1, 
respectively. 
Hence, the structure of 20 (7β-hydroxycatuabine D) was deduced as 3α-[(1-methyl-1H-
pyrrol-2-yl)carbonyloxy]-6β-[(1H-pyrrol-2-yl)carbonyloxy]-7β-hydroxytropane. 
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2.4.3. Catuabine E 
Alkaloid 24 was purified as white amorphous powder and also exhibited spectroscopic data 
similar to those of 22. The molecular formula was obtained as C20H25N3O4. The EI mass 
spectrum showed a molecular ion 14 amu higher than that of 22 and a similar fragmentation 
pattern, suggesting the presence of an additional methyl group in the structure of compound 
24. The NMR data strongly resembled those of 22, consistent with a general structure 
containing a central tropane moiety dioxygenated at C-3 and C-6, and esterified by two 
methylpyrrole acids. The signal integrations of the 1H-NMR spectrum confirmed the presence 
of two methyl groups, one at δH 3.93 (3H, s, N-CH3) and the other at δH 3.94 (3H, s, N-CH3), 
linked to the nitrogen atoms of the two pyrrole rings (Figure 0-43). Analysis of the gDQF-
COSY spectrum showed two distinct spin systems for the substituents, allowing assignment 
of each proton to the corresponding methylpyrrole ester and positioning of the two Mpc at 
positions C-3 and C-6, according to the gHMBC experiment.  
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Figure 0-43 
1H-NMR spectrum of compound 24. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
 
 
The relative configuration of 24 was identical to that of 22. 
On the basis of the above evidence, the structure of 24 (catuabine E) was elucidated as 
3α,6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane. 
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2.4.4. 7β-Hydroxycatuabine E 
Compound 21 was isolated as a white amorphous powder and gave a molecular formula of 
C20H25N3O5, according to a HRESMS experiment. Analysis of the NMR data of 21 indicated 
strong similarity to 20 and 24. The 1H-NMR spectrum of the tropane moiety exhibited the 
same pattern of substitution as that of 20, with signals at δH 5.24 (H-3β), δH 5.71 (H-6α) and 
δH 4.79 (H-7α) (Figure 0-44). The other part of 1H-NMR spectrum describing the acyl 
moieties was closely comparable to equivalent data of alkaloid 24 and indicated the presence 
of two Mpc groups as substituents. The positions of their attachment were determined by 
analyzing gDQF-COSY and gHMBC spectra as for compound 24. 
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Figure 0-44 
1H-NMR spectrum of compound 21. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
 
 
 
The relative configuration of 21 was the same as that for 20. The triplet for the proton at C-
3 (J = 4.9 Hz) and the doublets for the protons at C-6 and C-7 (each J = 5.9 Hz) indicated α-, 
β- and β-orientations of the substituents, respectively. 
Thus, alkaloid 21 was 3α,6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]-7β-hydroxytropane, 
named 7β-hydroxycatuabine E. 
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2.4.5. 7β-Acetylcatuabine E 
Alkaloid 23 was isolated as a white amorphous powder. The HRESMS analysis implied a 
molecular formula of C22H27N3O6 and the EIMS experiment showed a [M]+ molecular ion at 
m/z 429. Similarity of fragmentation pattern and a molecular mass of 42 amu higher than that 
of 21 suggested a similar core structure to 7β-hydroxycatuabine E with an additional acetyl 
group. Analyses of the NMR data indicated a close resemblance of the structure of 23 to that 
of compound 21. The presence of two Mpc moieties was established after analysis of the 1H-
NMR spectrum, which was superimposable with 21 between δH 6.0 and 7.3 (Figure 0-45). 
The assignment of each proton to the respective spin system was achieved by a gDQF-COSY 
experiment and the linkage of the esters to the tropane moiety was established by analyzing 
the gHMBC spectrum, as for the other compounds. The remainder of the 1H-NMR spectrum 
showed typical chemical shifts for a trisubstituted tropane skeleton with resonances at δH 5.28 
(H-3β), δH 5.88 (H-6α) and δH 5.81 (H-7α). The signal at δH 5.81, typically shifted downfield 
with respect to non-esterified compounds, like 20 or 21, indicating esterification at C-7 (δC 
77.7) rather than a free alcohol (Al-Said et al., 1986a; El-Iman et al., 1987; Payo-Hill et al., 
2000). The substituent at C-7 was shown to be an O-acetyl group by the signals at δH 2.04 
(3H, s, H-b'''), δC 170.2 (C-a''') and δC 20.8 (C-b'''). Its position was confirmed by a gHMBC 
correlation between H-7 and C-a'''. 
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Figure 0-45 
1H-NMR spectrum of compound 23. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
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The relative configuration of 23 was the same as for the other two trioxygenated tropane 
alkaloids 20 and 21. 
Thus, compound 23 was elucidated as 7β-acetoxy-3α,6β-[(1-methyl-1H-pyrrol-2-
yl)carbonyloxy]tropane and subsequently named 7β-acetylcatuabine E. 
 
 
2.4.6. Catuabine E N-oxide 
Compound 18 was purified as an amorphous solid. HRESMS analysis of its 
pseudomolecular ion [M+H]+ indicated the molecular formula as C20H26N3O5. The analysis of 
NMR data demonstrated that compound 18 was a dioxygenated tropane substituted by two 
methyl pyrrole esters. The proton sequences and the carbon atom locations, respectively 
deduced by gDQF-COSY and gHMBC experiments, implicated the 3- and 6-positions for the 
two ester moieties of the tropane alkaloid. When compared to the previously described 
catuabine E (24), compound 18 seemed to have an additional oxygen atom (16 amu excess of 
molecular weight). Several chemical shifts recorded in 1H and 13C-NMR experiments 
appeared to be strongly deshielded, especially the two methine groups  linked to the nitrogen 
atom [δH 4.07 (H-1 and H-5) and δC 72.5 (C-1), 76.6 (C-5)] and the N-CH3 moiety [δH 3.42 
and δC 48.9] (Figure 0-46). According to the literature (Lin et al., 2002; Silva et al., 2001; 
Wenkert et al., 1974), the deshielding effect observed in the NMR experiments could be 
explained by the presence of a N-oxide function. Moreover, no exchangeable protons were 
detected in the molecule by LC-MS analysis using D2O as eluent (see chapter 2.2.1), 
confirming the presence of the N-oxide group. The additional oxygen atom was then located 
on the N-CH3 moiety and 18 was considered as a tropane alkaloid N-oxide. 
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Figure 0-46 
1H-NMR spectrum of compound 18. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
 
 The relative configuration was deduced by the interpretation of the recorded H-3 
multiplicity and H-6 couplings, and it was confirmed by the NOESY experiment. 
From the evidence of the aforementioned spectroscopic data, compound 18 (catuabine E N-
oxide) was identified as 3α,6β-di-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane N-oxide. 
2.4.7. Catuabine F 
Compound 9 was obtained as an amorphous solid. Its molecular formula C23H28N2O7 was 
determined by HRESMS. The EIMS gave a molecular ion at m/z 444 and a fragmentation 
pattern partially similar to that of the other isolated compounds (Figure 0-47). The appearance 
of a new fragment ion (m/z 181) suggested the presence of a novel substituent linked to the 
tropane nucleus. 
Phytochemical investigation of Erythroxylum vacciniifolium 
used in Brazilian traditional medicine as an aphrodisiac 
 
 
IV. 
128
 
 
50 100 150 200 250 300 350 400 450 500
m/z
0
10
20
30
40
50
60
70
80
90
100
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
94.1
95.1
108.0
122.1 247.1
138.181.1 181.0 444.2
[M]+
[C6H8N]
+
[Mpc]+
+
HN
+
HN
HO
[C5H7N]
+
N
O
O
+
HN
 
Figure 0-47 
EI-MS spectrum of  compound 9. (70 eV; vaporization temperature: 50-300°C in 1 min; source 
temperature: 150°C; quadrupoles temperature: 70°C) 
 
 
An extensive NMR analysis indicated that compound 9 was closely related to 24 since the 
NMR data associated to the tropane moiety and the methylpyrrole ester observed for the two 
compounds were superimposable (Figure 0-48; Figure 0-49). The other elements of their 
NMR data exhibited differences only in the nature of their substituents at the 3-position of the 
tropane nucleus. 
gHSQC and gHMBC experiments gave evidence for a trioxygenated benzoyl moiety in the 
alkaloid 9. Indeed, the remaining aromatic signal at δH 7.39 (2H, s, H-2' and H-6'), which 
integrated for two protons, presented long-range 1H-13C couplings with only three aromatic 
carbons at δC 120.7, 139.7 and 147.0 (Figure 0-50). These elements, corroborated by the 
molecular formula, suggested symmetry in this aromatic ring. The exact positions of the two 
methoxyl groups at δH 3.99 (6H, s, 3'-OMe and 5'-OMe) and the undetectable hydroxyl 
phenolic group were deduced by observation of a long-range 1H
¯
13C coupling between the 
signal at δH 7.39 and an ester carbonyl at δC 165.6 (C-a'), showing the protons to be at  2'- and 
6'-positions of the aromatic ring. Thus, this substructure was a 4-hydroxy-3,5-
dimethoxybenzoyloxy moiety and its substitution at the 3-position of the tropane nucleus was 
confirmed by the long-range 1H-13C coupling between H-3 and C-a'. 
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Figure 0-48 
1H-NMR spectrum of compound 9. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard; 1 drop of CD3OD was previously added to facilitate solution of the sample) 
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Figure 0-49 
13C-NMR spectrum of compound 9. The 13C assignments were ascertained by DEPT, gHSQC, and 
gHMBC experiments. (Spectrum recorded in CDCl3 at 125.70 MHz using CDCl3 as internal standard; 
1 drop of CD3OD was previously added to facilitate solution of the sample) 
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Figure 0-50 
Long-range 1H-13C correlations of compound 9, chemical shifts of the hydroxydimethoxybenzoic ester 
(δ values given in ppm) and selected gHMBC interactions. 
 
 
The relative configuration of compound 6 was the same as the other isolated alkaloids. 
Actually, the coupling constants for H-3 (t, J = 4.9 Hz) and absence of coupling between H-6 
and H-5 designated β- and α-orientations, respectively for these protons. On the basis of the 
above evidence, compound 9, or catuabine F, was identified as 3α-(4-hydroxy-3,5-
dimethoxybenzoyloxy)-6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane. 
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2.4.8. 7β-Hydroxycatuabine F 
Compound 4 was purified as an amorphous solid. HRESMS analysis of its pseudomolecular 
ion [M+H]+ indicated the molecular formula as C23H29N2O8. The EIMS exhibited a molecular 
ion at m/z 460, 16 amu higher than that of 9. The fragmentation pattern was akin to that of 4, 
suggesting a similar core structure with the addition of a hydroxyl group. The analysis of 
NMR data demonstrated that compounds 4 and 9 were two alkaloids with the same 
substituents but with a different tropane core skeleton. The 1H- and 13C-NMR spectra of the 
ester substructures of these two alkaloids were superimposable, while the spectral region of 
their tropane centers showed diverse substitution patterns. The 1H-NMR spectrum of 4 
showed typical resonances for a trioxygenated tropane with signals at δH 5.36 (H-3β), δH 5.91 
(H-6α) and δH 4.90 (H-7α) (Figure 0-51). The position of the substituents was determined by 
analysis of the long-range 1H
¯
13C correlations as for compound 9. 
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Figure 0-51 
1H-NMR spectrum of compound 4. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard; 1 drop of CD3OD was previously added to facilitate solution of the sample) 
 
The relative configuration of 4 was established by the observation of the multiplicity and 
the couplings of the protons at C-3, C-6 and C-7 positions, giving identical results to that of 
the other compounds isolated. From the evidence of the aforementioned spectroscopic data, 
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compound 4 (7β-hydroxycatuabine F) was identified as 3α-(4-hydroxy-3,5-
dimethoxybenzoyloxy)-6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]-7β-hydroxytropane. 
2.4.9. Catuabine G 
The molecular formula of 2 was established as C16H22NO5 by HRESMS. The NMR data of 
2 differed from those of the other tropanes. In fact, only thirteen signals were observed in its 
13C-NMR spectrum, indicating a certain symmetry in the molecule (Figure 0-52). In addition, 
1H-NMR data of 2 exhibited typical resonances for a 3-hydroxyphenylacetoxy substructure 
(Al-Said et al., 1986a; Silva et al., 2001) (Figure 0-53). 
Long-range 1H
¯
13C couplings deduced from the gHMBC spectrum of 2 revealed links 
between the phenol moiety, the methylene group and the carbonyl of an ester function (δC 
170.4) (Figure 0-54; Figure 0-55). 
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Figure 0-52 
13C-NMR spectrum of compound 2. The 13C assignments were ascertained by DEPT, gHSQC, and 
gHMBC experiments. (Spectrum recorded in CDCl3 at 125.70 MHz using CDCl3 as internal standard; 
1 drop of CD3OD was previously added to facilitate solution of the sample) 
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Figure 0-53 
1H-NMR spectrum of compound 2. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard; 1 drop of CD3OD was previously added to facilitate solution of the sample) 
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Figure 0-54 
gHMBC spectrum of compound 2. 
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Figure 0-55 
Selected long-range 1H- 13C correlations of compound 2. 
 
The presence of a 3-hydroxyphenylacetoxy substructure was further inferred from the ions 
observed in the EIMS at m/z 156 [M – 3-OHPhCH2CO]+ and 107 [3-OHPhCH2]+ (Figure 
0-56). 
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Figure 0-56 
EI-MS spectrum of  compound 2. (70 eV; vaporization temperature: 50-300°C in 1 min; source 
temperature: 150°C; quadrupole temperature: 70°C) 
 
 
Then, deduced from the reduced number of the remaining signals observed in the 1H and 
13C-NMR spectra of 2, the tropane substructure was characterized by the presence of a plane 
of symmetry. This fact was also corroborated by the integration values in the 1H spectrum 
calculated for the tropanic signals at δH 1.52 (Hendo-2 and Hendo-4), 2.17 (Hexo-2 and Hexo-4), 
2.51 (N-CH3), 3.02 (H-1 and H-5), 4.18 (H-6α and H-7α) and 4.97 (H-3β). Of note was the 
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equivalence of the two positions C-6 and C-7, both substituted by an hydroxyl function. No 
coupling constant was observed between H-6 (or H-7) and the vicinal proton H-5 (or H-1), 
implying an β-orientation of the two hydroxyl moieties. The long-range 1H-13C coupling 
between H-3 and the ester carbonyl at δC 170.4 (C-a') showed attachment of the 3-
hydroxyphenylacetoxy moiety to the 3-position of the tropane nucleus (Figure 0-55). Thus, 
the structure of alkaloid 2 was elucidated as 3α-(3-hydroxyphenylacetoxy)-6β,7β-
dihydroxytropane, a new compound (catuabine G). 
2.4.10. Catuabine H 
Compound 13 was isolated as a white amorphous powder. High-resolution electrospray ion 
cyclotron resonance mass spectroscopic analysis (HRESMS) of this compound suggested a 
molecular formula of C14H20N2O3, implicating six centers of unsaturation and/or ring 
structures in the molecule. The 1H-NMR spectrum of 13 exhibited typical resonances for a 
methylpyrrole substructure with signals at δH 3.93 (N-CH3), δH 6.09 (H-4'), δH 6.77 (H-5') and 
δH 6.90 (H-3') (Figure 0-57). 
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Figure 0-57 
1H-NMR spectrum of compound 13. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
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Long-range 1H-13C couplings deduced from the gHMBC spectrum of 13 revealed that the 
pyrrolic proton at δH 6.90 (H-3') correlated with a carbonyl carbon at δC 161.2 (C-a') 
indicating the substitution of the methylpyrrole moiety at the 2'-position by an ester group. 
The UV spectrum of 13 showed a maximum of absorbance at 267.0 nm supporting the 
presence in the molecule of the 2-(carbonyloxy)methylpyrrole chromophore. According to the 
molecular formula of 13, the remaining moiety was characterized by the presence of one 
nitrogen atom and two ring structures. Two methine groups and one methyl group linked to 
the nitrogen atom were recorded at δH 3.26 (H-5), 3.35 (H-1), 2.55 (N-CH3) and δC 66.6 (C-5), 
60.4 (C-1), 40.6 (N-CH3), suggesting their inclusion in a tropane skeleton. The observation in 
the 1H-NMR data of three saturated methylene moieties at δH 1.66, 2.12 (H-2), 1.91, 2.16 (H-
4), 2.24, 2.75 (H-7) and two deshielded methine groups at δH 4.08 (H-3) and 5.79 (H-6) 
completed the characterization of the tropane core skeleton. The substitution pattern of the 
alkaloid substructure was deduced by extensive NMR analysis with gDQF-COSY, gHMBC 
and NOESY experiments. A long-range 1H-13C coupling associating the deshielded methine 
at δH 5.79 (H-6) and the carbon of the carbonyl function at δC 161.2 (C-a') implicated the 
location of the ester moiety at the 6-position of the tropane nucleus. The remaining oxygen 
atom was associated with the 3-position of the alkaloid because of its characteristic chemical 
shifts at δH 4.08 (H-3) and δC 64.1 (C-3). The presence of one exchangeable proton in the 
molecule was confirmed by its LC-MS analysis using D2O as eluent (see chapter 2.2.1). An 
increase of 2 Da, due to the exchangeable hydroxyl function and the ionizing deuteron, was in 
fact observed in the deuterated molecule ([MD+D]+ 267 Da) when compared to the 
corresponding protonated molecule ([MH+H]+ 265 Da).  
The stereochemical orientation of the substituents relative to the nitrogen-containing bridge, 
was deduced according to the multiplicity and coupling of the corresponding signals. The H-3 
signal showed a triplet and coupling constant J of 4.9 Hz indicating the α-orientation (i.e., 
endo) of the substituent at C-3.(Agar and Evans, 1976; Al-Said et al., 1989b; El-Iman et al., 
1987) The arrangement of the substituent at C-6 was established by the analysis of the 
coupling constants of H-6, H-7 and H-5 protons. The H-6 proton of the disubstituted tropane 
alkaloid showed two couplings (J = 7.3, 3.4) with the two H-7 protons and it did not present 
any coupling with the vicinal H-5 proton. This observation implied a β-orientation (i.e., exo) 
of the substituent and a dihedral angle close to 90° between H-5 and H-6α. The relative 
stereochemistry of the tropane substructure was also corroborated by analysis of its NOESY 
spectrum. 
Thus, the structure of catuabine H (13) is 3α-hydroxy-6β-[(1-methyl-1H-pyrrol-2-
yl)carbonyloxy]tropane. 
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2.4.11. Isocatuabine H 
Compound 11 was purified as a white amorphous powder and was assigned the same 
molecular formula as 13, C14H20N2O3. The spectroscopic data of 11, close to these reported 
for 13 (Figure 0-58), were consistent with a general structure containing a central tropane 
moiety dioxygenated at C-3 and C-6, and esterified by one methylpyrrole acid in the 6-
position. 
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Figure 0-58 
1H-NMR spectrum of compound 11. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
 
 
The main difference between the NMR data of compounds 13 and 11 concerned the 
multiplicity (triplet and doubled triplet, respectively) and the coupling constants (J = 4.9 Hz 
and J = 10.8 and 5.9 Hz, respectively) recorded for their H-3 proton signals. The modification 
of the multiplicity of the H-3 proton signal according to its relative configuration is well-
known in the literature of the tropane alkaloid series (Agar and Evans, 1976; Al-Said et al., 
1986a; Alyahya et al., 1979). As reported for 13, the α-orientation of the hydroxyl group in 
C-3 was associated with a triplet multiplicity, while the doubled-triplet multiplicity of H-3 for 
compound 11 was related to the β-orientation of the substituent (Figure 0-59). The presence 
of NOE interactions between the protons H-6 and H-3 confirmed that these groups were 
located on the same side of the molecule (α-position). 
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Figure 0-59 
Relative configuration of compound 11, as deduced from 1H-NMR coupling constants (a and b) as well 
as NOESY interactions (c). 
 
Hence, the structure of 11 (isocatuabine H) was deduced as 3β-hydroxy-6β-[(1-methyl-1H-
pyrrol-2-yl)carbonyloxy]tropane. 
2.4.12. 7β-Hydroxycatuabine H 
Alkaloid 7 was purified as a white amorphous powder and also exhibited spectroscopic data 
similar to those of catuabine H (13). The HRES mass spectrum of this compound showed a 
protonated molecular ion at m/z 281.1492, 15.9946 amu higher than that of 13, suggesting the 
occurrence of an additional oxygen atom in the molecule (C14H20N2O4). The NMR data of 
these two compounds were also closely related, indicating the presence in 7 of a central 
tropane moiety esterified by one methylpyrrole subunit. Except for proton H-7, the 1H-NMR 
spectrum of the tropane nucleus of 7 exhibited similar chemical shifts to 13 (Figure 0-60). 
Actually, this spectrum showed typical resonances for a tropane alkaloid skeleton 
trisubstituted at C-3, C-6 and also C-7 positions with signals at δH 4.11 (H-3β), δH 5.75 (H-
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6α) and δH 4.84 (H-7α), respectively. According to the molecular formula and the values of 
the chemical shifts associated with the 7-position (δH 4.84 and δC 75.8), a hydroxyl 
substituent was required at this location. 
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Figure 0-60 
1H-NMR spectrum of compound 7. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
 
 
The α-orientation of the hydroxyl group in C-3 was resolved from the multiplicity (triplet) 
and the coupling constant (J = 4.9 Hz) of the H-3 proton signal. The α-stereochemistry of 
protons at C-6 and C-7 position was deduced by the lack of any coupling constant with 
vicinal protons H-5 and H-1, respectively, and confirmed by analysis of the NOESY spectrum. 
Hence, the structure of 7 (7β-hydroxycatuabine H) was deduced as 3α,7β-dihydroxy-6β-
[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane. 
2.4.13. 7α-Hydroxycatuabine H 
Compound 8, purified as a white amorphous solid, had the same molecular formula as 7 
(C14H20N2O4) as deduced from HRESMS analysis. The NMR data strongly resembled to 
those of 7, consistent with a general structure containing a central tropane moiety 
trioxygenated at C-3, C-6 and C-7, and esterified by a methylpyrrolic acid in the 6-position 
(Figure 0-61). 
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Figure 0-61 
1H-NMR spectrum of compound 8. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
 
 
 
NMR analysis of the two compounds revealed only slight differences, essentially 
concerning the multiplicity and the couplings of some proton signals of the tropane core 
skeleton. The absence of any coupling constant between H-6 and H-7 in compound 8 
suggested a vicinal angular relationship around 90° for the two protons. In addition, unlike the 
previous compounds, a coupling constant was observed between H-7 and H-1 (J = 6.4 Hz) 
indicating a dihedral angle close to 0° between the two protons (Figure 0-62).  The presence 
of NOE interactions between the protons N-CH3 and H-7 confirmed the β-orientation of this 
latter. In addition, this NOE contact suggested that compound 8 distinguished itself from the 
other elucidated compounds by the orientation of the tropanic methyl group. 
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Figure 0-62 
Relative configuration of compound 8, as deduced from 1H-NMR coupling constants (a and b) as well 
as NOESY interactions (a). 
 
 
 
On the basis of the above evidence, compound 8, or 7α-hydroxycatuabine H, was identified 
as 3α,7α-dihydroxy-6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane. 
 
2.4.14. Catuabine I 
Compound 12 was isolated as a white amorphous powder. According to a HRESMS 
experiment, it gave a molecular formula of C14H20N2O3 (∆ -0.1 mamu), corresponding to that 
observed for compounds 13 and 11. The NMR spectroscopic data of 12 were consistent with 
a C-3 and C-6 dioxygenated tropane alkaloid substituted by a methylpyrrole ester. 
Nevertheless, in this molecule, the signal at δH 5.15, typically shifted downfield with respect 
to nonesterified compounds, like 13 and 11, indicated esterification at C-3 (δC 65.3) rather 
than a free alcohol (Al-Said et al., 1986b; El-Iman et al., 1987; Payo-Hill et al., 2000) (Figure 
0-63). Conversely, the proton at 6-position exhibited a resonance at δH 4.72, indicating a 
hydroxyl group at C-6 (δC 74.8).  A long-range 1H-13C correlation between the oxygenated 
methine at δH 5.15 (H-3) and the carbonyl signal at δC 160.2 (C-a') confirmed that the pyrrole 
unit substituted the tropane moiety in the C-3 position. 
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Figure 0-63 
1H-NMR spectrum of compound 12. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
 
 
By analysis of its NOESY spectrum, the stereochemistry of 12 was assigned as in 13. The 
relative configuration was corroborated according to the multiplicity of H-3 and coupling 
between H-6 and H-5. 
Thus, the structure of catuabine I (12) is 6β-hydroxy-3α-[(1-methyl-1H-pyrrol-2-
yl)carbonyloxy]tropane. 
 
2.4.15. 7β-Hydroxycatuabine I 
The molecular formula of compound 6 was established as C14H20N2O4 by HRESMS 
suggesting the occurrence of an additional oxygen atom in the alkaloid with respect to 
compound 12. The observation of only eleven signals in 13C-NMR spectrum of 6 indicated a 
symmetrical part in the molecule (Figure 0-64). This suggested the equivalence of the C-6 and 
C-7 positions and, according to the NMR data, the additional oxygen was located at the 7-
position (Figure 0-65). Thus, the tropane moiety was substituted by two hydroxyl functions in 
positions C-6 and C-7. 
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Figure 0-64 
13C-NMR spectrum of compound 6. The 13C assignments were ascertained by DEPT, gHSQC, and 
gHMBC experiments. (Spectrum recorded in CDCl3 at 125.70 MHz using CDCl3 as internal standard; 
1 drop of CD3OD was previously added to facilitate solution of the sample) 
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Figure 0-65 
1H-NMR spectrum of compound 6. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard; 1 drop of CD3OD was previously added to facilitate solution of the sample) 
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No coupling constant was observed between H-6 (or H-7) and the vicinal proton H-5 (or H-
1), implicating a β-orientation of the two hydroxyl groups. As observed for compound 12, the 
gHMBC data of 6 were consistent with the substitution of the tropane moiety at the C-3 
position by a methylpyrrole ester. 
The structure of alkaloid 6 was elucidated as 6β,7β-dihydroxy-3α-[(1-methyl-1H-pyrrol-2-
yl)carbonyloxy]tropane, a new compound named 7β-hydroxycatuabine I. 
 
2.4.16. Vaccinine A 
HRESMS experiments of alkaloid 15 gave C14H20N2O3 as molecular formula. This 
compound exhibited spectroscopic data similar to those of the other isolated tropane alkaloids 
(Figure 0-66; Figure 0-67). 
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Figure 0-66 
1H-NMR spectrum of compound 15. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
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Figure 0-67 
13C-NMR spectrum of compound 15. The 13C assignments were ascertained by DEPT, gHSQC, and 
gHMBC experiments. (Spectrum recorded in CDCl3 at 125.70 MHz using CDCl3 as internal standard) 
 
 
 
As previously reported for compound 13, analysis of the gHMBC spectrum of 15 led to the 
identification of the two methine groups at δH 3.26 (H-1) and 3.37 (H-5). Their linkage to the 
nitrogen atom were confirmed by the observation of long-range 1H-13C correlations between 
the protons at δH 2.54 (N-CH3) and the C-1 (δC 60.5) and C-5 (63.1). Nevertheless, in contrast 
to the other elucidated alkaloids, the gDQF-COSY spectrum of 15 showed a partial spin 
system implicating two oxygenated methine moieties, at δH 4.98 and 3.87, and one saturated 
methylene group at δH 1.86 and 1.96 (Figure 0-68). This observation suggested that these 
three latter structural elements were located on the 6-center ring of the tropane skeleton. 
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Figure 0-68 
gDQF-COSY spectrum of compound 15 showing a single spin system. 
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Analysis of the remaining NMR data corroborated the presence of two saturated methylene 
groups at 6- and 7-positions of the tropane core skeleton. A long-range 1H-13C correlation 
between the oxygenated methine at δH 4.98 (H-4) and the carbonyl signal at δC 161.3 (C-a') 
indicated that the methylpyrrolic moiety substituted the C-4 position of the tropane. The 
signal at δH 4.98, typically shifted downfield, indicated an esterification at C-4 (δC 77.3) 
rather than a hydroxyl group. 
The relative configuration of 15 was deduced by a NOESY experiment and the recorded 
coupling constants (Figure 0-69). Concerning the protons H-3 and H-4, their coupling 
constant was measured as 8.8 Hz, supporting a dihedral angle close to 0° or 180° between the 
two methine groups. The observation of a spatial contact between H-3 and H-4 removed the 
180° dihedral angle possibility. In 1971, Johns and co-workers reported the isolation of a new 
nortropane alkaloid substitued at C-2 and C-3 from the leaves of Peripentadenia mearsii 
(Euphorbiaceae) (Johns et al., 1971). They considered the 9.0 Hz coupling between H-2 and 
H-3 as a trans diaxial arrangement of the two protons and elucidated the structure as 2α-
benzoyloxy-3β-hydroxynortropane. 
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Figure 0-69 
Relative configuration of compound 15, as deduced from 1H-NMR coupling constants and NOESY 
interactions. 
 
 
 
On the basis of the above evidence, the structure of 15 (vaccinine A) was elucidated as 3α-
hydroxy-4α-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane. 
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2.4.17. Vaccinine B 
Compound 14 had the same molecular formula as 11, 12, 13 and 15 (C14H20N2O3) as 
deduced from HRESMS analysis. Its spectroscopic data were consistent with a dioxygenated 
tropanic structure substituted by a methylpyrrole ester (Figure 0-70). 
 
 
ppm2.02.53.03.54.04.55.05.56.06.5
H
-1
H
-5
H
β-
3
H
e
x
o
-2
H
-4
'
H
α
-7
H
-5
'
H
-3
'
H
-9
H
-6
'
H
β-
7
H
e
x
o
-4
H
α
-6 H
e
n
d
o
-2
H
α
-3
N
CH3
1
3
2
45
6
7
O
O
N
CH3
H
2'
5'
a'HO
H
 
Figure 0-70 
1H-NMR spectrum of compound 14. (Spectrum recorded in CDCl3 at 499.87 MHz using TMS as 
internal standard) 
 
 
 
The gDQF-COSY spectrum of 14 suggested that the substituents were located on the same 
side as the N-methine group at δH 3.18 (H-5) implicating oxygenation of the 4 and 6 positions 
of the tropane skeleton (Figure 0-71). The methylpyrrole ester position was deduced by the 
long-range 1H-13C correlation between H-4 (δH 5.12) and C-a' (δC 160.4), and the downfield 
shift of the H-4 signal. The presence of NOE interactions between the N-CH3 protons and H-4 
indicated that these groups were located on the same side of the molecule (β-orientation of H-
4). 
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Figure 0-71 
gDQF-COSY spectrum of compound 14 showing a single spin system. 
 
The relative configuration of H-6 was elucidated according to the absence of coupling 
constants with H-5 and to the NOESY experiment. 
Hence, the structure of 14 (vaccinine B) was deduced as 6α-hydroxy-4α-[(1-methyl-1H-
pyrrol-2-yl)carbonyloxy]tropane. 
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2.5. Biological and biochemical activities 
2.5.1. TLC bioautographic assays 
The different crude extracts of the bark of E.vacciniifolium were submitted to four TLC 
bioautographic assays to evaluate their potential bioactivities. These assays are reported in the 
experimental part (VI.6) and they give an evaluation of the following activities: antifungal 
activities against Cladosporium cucumerinum and Candida albicans; antibacterial activity 
against Bacillus subtilis; acetylcholinesterase (AChE) inhibitory activity. The results of the 
bioassays are reported in Table 0-8. 
 
 
 
Table 0-8 
Antifungal, antibacterial and AChE inhibitory activities of extracts from the bark of E. vacciniifolium. 
 extracts Cladosporium 
cucumerinumd 
Candida 
 albicansd 
Bacillus 
 subtilisd AChE
d
 
 Alk. CHCl3 - - - (+) 
 DCM - - - - 
 MeOH - - - (+) 
 Watera - - - (+) 
 Waterb - - - (+) 
 MeOHc - - - - 
 Watera, c - - - - 
 Waterb, c - - - - 
a
 maceration performed during 24 hs at room temperature. 
b
 infusion performed during 1 hr at 100°C. 
c
 Tannin-free extracts. 
d Tested amount 100 µg of crude extract. (-, inactive; (+), weak activity; +, medium 
activity; ++, strong activity) 
 
 
 
 
At a concentration of 100 µg on a silica gel TLC plate, no extracts showed either antifungal 
or antibacterial activity.  
The enriched alkaloid extract exhibited weak AChE inhibitory activity. This marginal 
bioactivity appeared as white spots on a purple background (TLC). Spots with  higher Rf 
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(0.45-0.75) seemed to be more active than the other spots with lower Rf (0.1-0.40), since the 
responses were more intense. This variation between apolar and polar compounds could be 
associated with their intrinsic activity or with their different concentrations in the extract. 
The dichloromethane extract showed no AChE inhibitory activity, while the methanol 
extract and the two aqueous extracts demonstrated a moderate inhibition of the enzyme. This 
activity was only exhibited by very polar substances (Rf : 0.05-0.25), suggesting the potential 
presence of polyphenolic compounds which could primarily react with the proteins of the 
enzyme. The reactivity of  polyphenolic compounds such as tannins toward proteins is well 
known and several papers have reported the interference of these molecules with bioassays 
(Wall et al., 1996).  The presence of tannins in the methanolic and aqueous extracts was 
detected on TLC by using various reagents. Under UV-light, galloyl esters and gallotannins 
appeared as violet fluorescent spots that are enhanced on fumigation with ammonia vapour. 
Ellagic acid produced a violet spot that darkens on exposure to ammonia vapour. The 
FeCl3/K3Fe(CN)6-spray reagent was also used to detect tannins. This reagent is not a specific 
reagent and gives positive results for other phenolic compounds as blue spots. Another 
polyvalent reagent (Godin’s reagent) gave red/pink spots with flavan-3-ols and condensed 
tannins. After the tannin detection, their removal was undertaken before retesting the extracts 
with AChE. Polyamide column chromatography, Sephadex LH-20, polyvinylpyrrolidone 
(PVP), or collagen have been used by various workers to remove tannins from plant extracts 
(Wall et al., 1996). In the present study, the collagen (hide powder) method was employed 
(see chapter VI.5.3). After effective tannin removal, the AChE inhibitory activity of the 
methanolic and aqueous extracts disappeared. Thus, the activity of these extracts was 
primarily due to the reactivity of these polyphenolic compounds with the proteins of the 
enzyme. 
Isolated compounds 2, 4, 6-9, 11-15, 18, 20-24 were tested as inhibitors of AChE, since the 
alkaloid extract showed a certain activity against the enzyme. The inhibitions were evaluated 
by observing the activity of geometrical dilutions of the pure compounds . 
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Table 0-9 
Semi-quantitative estimation of the AChE inhibitory activity of the isolated compounds from E. 
vacciniifolium. 
Compound 10 µga 1 µga 0.1 µga 0.01 µga 
2  - - - - 
4  - - - - 
6  - - - - 
7  - - - - 
8  - - - - 
9  - - - - 
11  - - - - 
12  - - - - 
13  - - - - 
14  (+) - - - 
15  - - - - 
18  - - - - 
20  (+) - - - 
21  (+) - - - 
22  (+) - - - 
23  (+) - - - 
24  + (+) - - 
Galanthamineb ++ ++ ++ ++ 
a Amounts spotted in µg of pure compounds. (-, inactive; (+), weak 
activity; +, medium activity; ++, strong activity) 
b
 Positive control. 
 
 
 
Compounds 14 and 20-23 were equally active against AChE down to 10 µg but weaker than 
the reference compound 24. The activity of this latter was clearly noticeable down to 1 µg, 
even though this value was much lower than the positive standard galanthamine (active down 
to 0.01 µg). To our knowledge, this inhibition property has not been reported previously for 
any tropane alkaloids. 
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2.5.2. Inhibitory activity against Phosphodiesterase (PDE) 
With the aim of finding out new compounds for the treatment of erectile dysfunction, the 
crude extracts of E. vacciniifolium were evaluated for their specific inhibitory activity against 
PDE2 and PDE5. The assays procedures are reported in the experimental part (chapter 6.2) 
and the experimental results of these primary tests are illustrated in Table 0-10. 
 
 
Table 0-10 
Experimental results of primary biochemical assays on the inhibition of activity of phosphodiesterases. 
extracts PDE2a PDE5a 
Alk. CHCl3 28% 11% 
DCM 18% 19% 
MeOH 12% 6% 
MeOHb 28% 28% 
a
 % of enzyme inhibition at a sample concentration of 100 µM. 
(Significant criteria: ≥50% of maximal inhibition) 
b
 Tannin-free extract. 
 
 
 
All extracts showed a weak inhibitory activity against PDE2 and PDE5 but none of the 
results met significance criteria at concentrations used. Alkaloid and methanolic extracts 
seemed to be more active against PDE2 than PDE5 but these inhibition differences were not 
sufficient to provide a  selectivity between the two isoenzymes. Semi-quantitative data (e.g., 
estimated IC50, Ki and nH) were not applicable (concentration range of 4 log units) and 
secondary functional assays were not carried out because inhibitory activity in primary assays 
was <50% at 1 log unit below initial test concentration (100 µM). Since the results of these 
primary biochemical assays were negative and the cost of testing was high, the tests on 
isolated compounds were not carried out in this study. 
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2.5.3. Nitric oxide (NO) induction 
The potential regulation of nitric oxide synthase (NOS) expression by different extracts and 
isolated compounds of E. vacciniifolium was evaluated. This expression was calculated as the 
improvement of the activity of a NOS III gene promoter fragment transiently and stably 
transfected into EA.hy 926 cells. The detailed test methodologies are described in chapter 
VI.6.3. 
Transfected cells were incubated with or without extracts and pure compounds for 12 hs, 
and cytoplasmatic cell extracts were prepared. The relative luciferase activity (corrected with 
renilla-luciferase activity) was taken as a measure of NOS III promoter activity. Figure 0-72 
shows the relative luciferase activity after transient transfection experiments (incubation with 
100 µg/mL of test substances). Trials with stably transfected cells were carried out with three 
concentrations of test substances (100 µg/mL, 30 µg/mL, 10 µg/mL) and the results are 
reported in Figure 0-73. 
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Figure 0-72 
Potential regulation of NOS expression by different extracts and isolated compounds of E. 
vacciniifolium. The transient transfected EA.hy 926 cells were either kept untreated (Control) or 
exposed to test substances (100 µg/mL) for 12 hs. Then, the cells were lysed, and luciferase activity 
was determined. The relative luciferase activity (corrected with renilla-luciferase activity) was taken as 
a measure of NOS III promoter activity. Bars represent mean ± S.E. of three independent experiments. 
(a Tannin-free extract) 
 
Phytochemical investigation of Erythroxylum vacciniifolium 
used in Brazilian traditional medicine as an aphrodisiac 
 
 
IV. 
155 
 
Co
n
tro
l 2 7 8 9 13 14 15 21 22 23 24
Al
k.
 C
HC
l 3
DC
M
M
eO
H
W
at
er
a
W
at
er
0
50
100
150
200
C
o
rr
e
c
te
d 
lu
c
ife
ra
s
e
 
a
c
tiv
ity
(%
 
o
f c
o
n
tr
o
l)
A
Co
n
tro
l 2 7 8 9 13 14 15 21 22 23 24
Al
k.
 C
HC
l 3
DC
M
M
eO
H
W
at
er
a
W
at
er
0
50
100
150
200
C
o
rr
e
c
te
d 
lu
c
ife
ra
s
e
 
a
c
tiv
ity
(%
 
o
f c
o
n
tr
o
l)
B
Co
n
tro
l 2 7 8 9 13 14 15 21 22 23 24
Al
k.
 C
HC
l 3
DC
M
M
eO
H
W
at
er
a
W
at
er
0
50
100
150
200
250
C
o
rr
e
c
te
d 
lu
c
ife
ra
s
e
 a
c
tiv
ity
(%
 
o
f c
o
n
tr
o
l)
C
 
Figure 0-73 
Potential regulation of NOS expression by different extracts and isolated compounds of E. 
vacciniifolium. The stable transfected EA.hy 926 cells were either kept untreated (Control) or exposed 
to test substances (A: 100 µg/mL; B: 30 µg/mL; C: 10 µg/mL ) for 18 hs. Then, the cells were lysed, 
and light units determined. The relative luciferase activity (corrected with renilla-luciferase activity) 
was taken as a measure of NOS III promoter activity. Columns represent means ± S.E. of three 
independent experiments. (a Tannin-free extract) 
 
Phytochemical investigation of Erythroxylum vacciniifolium 
used in Brazilian traditional medicine as an aphrodisiac 
 
 
IV. 
156
In both experiments, the extracts and pure compounds showed low activity. The pGL3-NOS 
III-Hu-1600 and the pNOS III-Hu-3500-Luc-neo (containing a 1.6-kb NOS III promoter 
fragment and a 3.5-kb human eNOS promoter fragment driving the luciferase genes, 
respectively) showed significant basal activity compared with the pGL3-Basic (containing a 
promoterless luciferase gene) (data not shown). 
In the transient transferase experiments, incubations with the test substances for 12 hs did 
not appreciably augment the activity of the human NOS III promoter and some compounds 
(e.g., 9) even inhibited it (Figure 0-72). 
The stable transferase experiments showed similar results to the transient transferase ones. 
Incubations with different concentrations of test substances for 18 hs did not  significantly 
increase the eNOS promoter. Compound 24 seemed to have an inhibition activity against this 
promoter as the corrected luciferase activity decreased with the increase of the compound 
concentration (Figure 0-73). 
The current study did not allow to identify interesting compounds as efficacious stimulators 
of expression of the enzyme NOS III, implicated in vasoprotection, antiatherosclerosis and 
erection. 
 
2.5.4. Cytotoxicity tests 
The isolated tropane alkaloids from E. vacciniifolium were evaluated against a panel of 
human tumor cell lines according to established protocols (see chapter VI.6.7). In addition to 
the six cell lines used for primary cytotoxicity screening (human lung, colon, oral epidermoid 
and hormone-dependant prostate cancer cell lines; human telomerase reverse transcriptase-
retinal pigment epithelial and human umbilical vein endothelial cells), the compounds were 
tested with a drug-resistant oral epidermoid cancer cell line (with and without vinblastine). 
For pure compounds, activity is taken as ≤5 µg/mL. The results of these bioassays are 
reported in Table 0-11. 
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Table 0-11 
In vitro cytotoxicity of alkaloids 2, 4, 7-9, 11-15 and 20-24 in a human tumor panel.a 
 
ED50 (µg/mL)b 
Compd Lu1 Col2 KB LNCaP hTERT-RPE1 HUVEC KB-V1 (-) KB-V1 (+) 
2 >20 >20 >20 >20 >20 >20 >20 >20 
4 9.4 >20 >20 >20 >20 >20 >20 5.6 
7 >20 >20 >20 >20 >20 >20 >20 >20 
8 >20 >20 >20 >20 >20 >20 >20 >20 
9 15.1 >20 >20 >20 >20 >20 17.8 4.7 
11 >20 >20 >20 >20 >20 >20 >20 >20 
12 >20 >20 >20 >20 >20 >20 >20 >20 
13 >20 >20 >20 >20 >20 >20 >20 >20 
14 >20 >20 >20 >20 >20 >20 >20 >20 
15 >20 >20 >20 >20 >20 >20 >20 >20 
20 >20 >20 >20 >20 >20 >20 >20 16.8 
21 4.5 16.0 6.2 9.8 >20 >20 5.7 2.6 
22 >20 >20 >20 >20 >20 >20 >20 4.1 
23 >20 >20 >20 >20 >20 >20 13.6 6.0 
24 4.4 12.8 6.9 5.7 >20 >20 5.9 1.9 
a
 Key to human cancer cell lines used: Lu1, lung cancer; Col2, colon cancer; KB, oral epidermoid 
carcinoma; LNCaP, hormone-dependant prostate cancer; hTERT-RPE1, human telomerase reverse 
transcriptase-retinal pigment epithelial cells; HUVEC, human umbilical vein endothelial cells; KB-V 
(-), drug-resistant KB assessed in the absence of vinblastine (VLB); KB-V (+), drug-resistant KB 
assessed in the presence of VLB (1 µg/mL). 
b
 The concentration of pure compound required to produce a response in 50% of the subjects to whom 
the compound was given. Also known as median effective dose.  
 
 
 
As deduced from Table 0-11, none of the isolated compounds demonstrated appreciable 
activity against Lu1, Col2, KB and LNCaP cells in culture (>5 µg/mL). None of the tropane 
alkaloids seemed to have a non-specific toxicity against hTERT-RPE1 and HUVEC cells. 
Compounds 21 and 24 exhibited both a certain activity and selectivity for the multidrug-
resistant KB-V1 cell line in the presence of  vinblastine (ED50, 2.6 and 1.9 µg/mL, 
respectively), but they did not approach the potency (<1 µg/mL) or selectivity of tropane 
alkaloids from E. pervillei Baill. (Silva et al., 2001). Moreover, these two compounds showed 
a modest cytotoxicity with Lu1 (4.5 and 4.4 µg/mL, respectively) and KB (6.2 and 6.9 µg/mL, 
respectively) cells. Compounds 4, 9 and 22 displayed low potency against KB-V1 cells 
assessed in presence of VLB, but were more selective than 21 and 24 (Table 0-12). In the 
absence of VLB, 4 and 22 did not show any activity against KB-V1 cells (>20 µg/mL). 
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However, when VLB was added to the media in the presence of these two compounds, 
chemosensitivity was partially restored (5.6 and 4.1 µg/mL, respectively). 
 
 
Table 0-12 
MDR-reversing activity of compounds 4, 9, 21-24 and pervilleines A and B. 
Compound KBa KB-V1 (-)a,b KB-V1 (+)a,b ED50[KB-V1 (-)]/ED50[KB-V1 (+)] 
4 >20 >20 5.6 >3.6 
9 >20 17.8 4.7 3.8 
21 6.2 5.7 2.6 2.2 
22 >20 >20 4.1 >4.9 
23 >20 13.6 6.0 2.3 
24 6.9 5.9 1.9 3.1 
Pervilleine A >20 >20 0.3 >66.7 
Pervilleine B >20 8.8 0.1 88 
a
 Results are expressed as ED50 values (concentration of pure compound required to produce a 
response in 50% of the subjects to whom the compound was given) in µg/mL. 
b
 Incubations were performed in the presence (+) (1 µg/mL) or absence of VLB. 
 
 
 
A multidrug-resistance inhibition by several isolated alkaloids was demonstrated in these 
cytotoxicity tests, even though the potency was approximately one order of magnitude lower 
than those of pervilleines A and B. 
Some observations concerning the structural requirements for activity within these tropane 
alkaloids may be made from the cytotoxicity panel data of the isolated compounds shown in 
Table 0-11. When these alkaloids are considered specifically, two ester substituents at C-3 
and C-6 were seen to be essential to obtain an activity against KB-V1 cells in the presence of 
VLB. The tropane moiety can be substituted at both positions by a 1-methyl-1H-pyrrole-2-
carboxylic or a 1H-pyrrole-2-carboxylic acid, and at C-3 by a 4-hydroxy-3,4-
dimethoxybenzoic acid. The absence or presence of a hydroxyl group at C-7 led to 
approximately the same cytotoxic activity for KB-V1 cells in the presence of VLB, but 
sometimes reduced or increased selectivity. 
Although the results of these preliminary cytotoxicity tests were  not significant, some of 
the data provide encouragement for further work. It would be reasonable to isolate similar 
new compounds and make some derivatives of the most active ones in order to evaluate their 
cytotoxicity and selectivity. 
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1. Qualitative and quantitative determination of yohimbine in 
authentic yohimbe bark and commercial aphrodisiacs 
The first part of the present work, consisting of the evaluation of the potential risks of 
commercialized aphrodisiacs on consumer health, has given interesting and, in some ways, 
surprising results. The amount of yohimbine measured and expressed as the minimal dose per 
day appearing on the product labels has a relative large range, from a minimum of 1.32 to a 
maximum of 23.16 mg. Even though the therapeutic index of yohimbine is not excessively 
narrow, this difference in the amount of active principle in the aphrodisiac products is 
alarming. 
In view of the qualitative and quantitative results obtained, we must consider natural 
aphrodisiac products as a potential cause of toxicity. This toxicity may be due to the product 
itself, to an interaction with other products or to contamination of the product. In addition, the 
increase in the last decade of herbal medication assumed to be safe by patients could amplify 
the potential health hazards to the community. The high costs of modern medicine have 
driven some patients to seek self-medication to reduce the costs, with all the consequences. 
Many of these products are commercialized as dietary supplements, evading any quality 
assessment and omitting specific indications. Rigid quality control standards are not required 
for nutraceuticals, leading to substantial variability in the purity and the potency of these 
substances (LaFrance et al., 2000). Absence of real directives about these herbal aphrodisiacs 
has proved to be very dangerous, as substitution of components, adulteration with 
pharmaceuticals, incorrect preparation of crude plant material, and even plant confusion have 
yielded cases of toxicity in herbal medicine (Ioset et al., 2003). 
In the context of a more restricted regulation of the herbal medication market, the LC-UV-
APCI-MSn technique has proved to be a selective, sensitive, robust and relatively rapid 
method to detect and quantify yohimbine in a very broad survey of aphrodisiac products. In 
the absence of certain isomers such as corynanthine, both LC-APCI-MS and LC-ESI-MS 
have proved to be very selective and robust methods with sensitivities 20 times higher than 
the LC-DAD-UV method. The advantage of the LC-DAD-UV technique compared to the LC-
API-MS is its larger linearity range and the possibility to quantify yohimbine in products 
containing its isomers in small quantities (less than 1% of the total yohimbine amount). On 
the other hand, LC-API-MS techniques could be helpful for the detection of yohimbine 
epimers in authentic yohimbe bark or complex mixtures, because of their stereochemical 
ionization discrimination. The linearity range has also proved to be important for the 
standardization of the sample preparation of a large variety of aphrodisiac products with 
different dosage forms. The relatively high standard deviations obtained for certain products 
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analyzed were the result of the non-homogeneity of these products and the presence of other 
substances and excipients that normally are not present in plant material. In order to avoid this 
problem we could have used a specific extraction method adapted for each product, but this 
would counter the aim of our study, namely the development of a standard method for the 
detection and quantification of yohimbine in aphrodisiac products.  
To conclude, although many products sold over the counter or on internet are labeled as 
“natural”, this does not ensure the product’s safety or efficacy. The research undertaken here 
is aimed to be of benefit to patients who employ this kind of self-medication. 
2. Phytochemical investigation of Erythroxylum 
vacciniifolium Mart. 
The second part of this work consisted in the phytochemical and pharmacological 
investigation of Erythroxylum vacciniifolium Mart. (Erythroxylaceae), a plant used in 
Brazilian traditional medicine as an aphrodisiac. The preliminary information on the 
structures of the compounds present in the alkaloid extract were obtained on-line using 
different coupled techniques: high performance liquid chromatography (HPLC) coupled to 
diode array UV detection (LC-UV-DAD), to mass spectrometry (LC-MS) and to nuclear 
magnetic resonance spectroscopy (LC-NMR). All the data obtained by these LC-hyphenated 
techniques were processed separately or in partial combination to achieve structural 
identification of the compounds in the extract. A complete hyphenation of all these techniques 
together could be problematic because of the differences in the sensitivities of the detectors 
(Louden et al., 2001). The dereplication of crude plant extracts with LC-hyphenated 
techniques represents a strategic element to avoid finding known constituents and to target the 
isolation of new bioactive products, rendering the investigation of new bioactive natural 
products more rapid and efficient. 
Preliminary analyses showed homogeneity in the spectral data recorded for all constituents 
of the alkaloid extract, suggesting close structural similarities. The on-line methods presented 
in the present work allowed complete or partial identification of 24 tropane alkaloids of E. 
vacciniifolium Mart.. The interpretation of the data permitted the structural elucidation of 6 
new tropane alkaloids (7, 13 and 21-24). The structures of the other 18 detected compounds 
were partially characterized as di- or trisubstitued tropane alkaloids, mono- or diesterified by 
pyrrolic, methylpyrrolic, hydroxydimethoxybenzoic or hydroxyphenylacetic acids, and they 
were found to be potentially new natural products. Some of these compounds (1, 3, 5, 10 and 
16-19) were detected as tropane alkaloid N-oxides. In order to completely elucidate their 
structures and to perform a screening of their biological activities, a targeted isolation of the 
constituents of the alkaloid extract was undertaken. 
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The main components of the enriched alkaloid extract were purified by medium pressure 
liquid chromatography (MPLC) and semi-preparative high performance liquid 
chromatography (SP-HPLC) to yield 17 new tropane alkaloids (catuabines E-I, their 
derivatives and vaccinines A and B). 
All catuabines isolated during this and previous studies are tropane alkaloids di- or 
trioxygenated at 3-, 6- or 7-positions, mono- or diesterified with 1H-pyrrole-2-carboxylic, 1-
methyl-1H-pyrrole-2-carboxylic, 4-hydroxy-3,5-dimethoxybenzoic, 3-hydroxyphenylacetic or 
acetic acids. One of the isolated compounds (18) was identified as a tropane alkaloid N-oxide 
(catuabine E N-oxide). The occurrence of tropane alkaloid N-oxides in plants has previously 
been reported (Aripova, 1996; Katavic et al., 1999; Phillipson and Handa, 1978; Silva et al., 
2001). But, according to a study by Achenbach and co-workers which reported the N-
oxidation of indole alkaloids occurring in the presence of air or during work-up of  plant 
extracts (Achenbach et al., 1997), it is not possible to conclude whether the N-oxides detected 
in E. vacciniifolium Mart. are genuine natural products or artifacts. 
The isolated tropane alkaloids are interesting for their ester moieties, which are unique to 
the species of the studied genus, E. vacciniifolium. The tropane moieties of alkaloids do not 
show intrageneric chemotaxonomic characteristics, but esterifying acids are often 
distinguishing features of certain species (El-Iman et al., 1987; Evans, 1981; Griffin and Lin, 
2000). Pyrrole-2-carboxylic and 1-methyl-pyrrole-2-carboxylic acid have been found only in 
this species (section Archerythroxylum) (Graf and Lude, 1977, 1978), while the 3-
hydroxyphenylacetyl moiety found in alkaloid 2 (catuabine G) has been reported in two 
different species, E. hypericifolium Lam. and E. pervillei Baill., both belonging to the section 
Venelia (Al-Said et al., 1986a; Silva et al., 2001). Although the 3,4,5-trimethoxybenzoic acid 
substituent is very common in the Erythroxylum genus, the 4-hydroxy-3,5-dimethoxybenzoyl 
unit found in compounds 4 (7β-hydroxycatuabine F) and 9 (catuabine F) has to be considered 
unique for the time being. 
Vaccinines A and B introduce a new series of tropane alkaloids as they are dioxygenated at 
3-, 4- or 6-positions. The esterifying unit of vaccinines, the same as for catuabines, is placed 
at C-4, while the hydroxyl group can be at C-3 or C-6 positions. Tropanes with esters at C-2 
or C-4 positions are rare in nature, whereas carboxyl groups (e.g. ecgonine derivatives) and 
hydroxyl groups (e.g. calystegines) at the same locations are common. In conclusion, this 
study illustrates that E. vacciniifolium Mart. is a source of original tropane alkaloids, unique 
for their esterifying acids and ester location, representing a useful contribution to the 
chemotaxonomy of the genus. 
In order to evaluate their potential therapeutic interest, the crude extracts of the bark of E. 
vacciniifolium Mart. were examined in different bioassays. They were submitted to four TLC 
bioautographic assays to evaluate their potential bioactivities, including antifungal activities 
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against Cladosporium cucumerinum and Candida albicans, antibacterial activity against 
Bacillus subtilis, and acetylcholinesterase inhibitory activity. The enriched alkaloid extract 
exhibited a weak AChE inhibitory activity, while none of the extracts showed either 
antifungal or antibacterial activity. Based on this positive result, the isolated compounds were 
individually tested for this inhibitory activity. Only compound 24 (catuabine E) showed a 
certain activity which was clearly noticeable down to 1 µg, even though this value was much 
lower than the positive standard, galanthamine (active down to 0.01 µg). 
With the aim of discovering new compounds for the treatment of erectile dysfunction, the 
crude extracts of E. vacciniifolium Mart. were evaluated for their specific inhibitory activity 
against PDE2 and PDE5. The extracts showed only weak inhibitory activities against the two 
isoenzymes and none of the results met significance criteria at the concentrations used. Thus, 
from these primary assays, the aphrodisiac character of E. vacciniifolium cannot be assigned 
to the phosphodiesterase inhibitory activity, but it has probably a different pharmacological 
origin. 
Since nitric oxide (NO) is one of the most important neurohumoral factors involved in 
erection (Archer, 2002), the potential regulation of nitric oxide synthase expression by 
different extracts and isolated compounds of E. vacciniifolium Mart. was evaluated. 
Unfortunately, these bioassays did not allow the identification of lead compounds as 
efficacious stimulators of expression of the enzyme NOS III, implicated in vasoprotection, 
antiatherosclerosis and erection. 
In our ongoing search for new bioactive compounds from higher plants, the alkaloid extract 
and new tropane alkaloids isolated during this work were also evaluated against a panel of 
human tumor cell lines, as recent reports indicated that some new tropane alkaloids from 
different species of Erythroxylum  resulted in extremely potent inhibitors of multidrug-
resistant tumor cells (Mi et al., 2001; Mi et al., 2002b).  
Several isolated alkaloids demonstrated a certain bioactivity in these cytotoxicity tests, even 
though their potency or selectivity did not approach those of pervilleines A and B, two 
tropane alkaloids purified from E. pervillei Baill. (Silva et al., 2001). Although the results of 
these preliminary cytotoxicity tests were  not significant, some of the data provide 
encouragement for further work. 
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3. Perspectives 
As an extension of this work, the development of new methods for the detection and 
quantification of other dangerous or toxic active principles, e.g. cantharidin, in 
commercialized aphrodisiacs could be considered. Many of these herbal products are still sold 
as nutritional supplements with no state or other approval and without making “official” 
therapeutic claims. Consumers should also be made aware that such preparations may not 
have the composition that is declared on the label. 
Although the alkaloid extract of E. vacciniifolium Mart. was intensively investigated, there 
are still several minor compounds to isolate from it. After the LC-APCI-MS analysis of the 
polar fractions of the first MPLC separation, which showed the presence of new tropane 
alkaloids, purification of these fractions has been undertaken. Preliminary investigations have 
allowed a partial elucidation of these compounds as tropane or nortropane alkaloids di- or 
trioxygenated at 3-, 6- or 7-positions, monoesterified by 1-methyl-1H-pyrrole-2-carboxylic 
acid. Certain of these molecules seem to be alkaloid N-oxides. The complete determination 
structure with relative and absolute configurations of this new series of tropane alkaloids is 
underway. In order to discover a therapeutic potential for these compounds, they will also be 
submitted to all bioassays described in this work. 
In view of the results obtained during the phytochemical investigation of E. vacciniifolium 
Mart., new biological tests on the isolated compounds are needed to find a basis for the 
traditional use of this plant as an aphrodisiac. 
A valuable experimental tool for investigating local erectile responses to different 
pharmacological agents could be a simplified in vitro preparation of the rat corpus 
cavernosum, the anatomy of which is very close to that of man (Italiano et al., 1994). This test, 
compared with the in vitro enzymatic assays, has the advantage of measuring simultaneously 
the activity of the compounds on different biological targets involved in erection function, e.g. 
α-adrenergic receptors (De Tejada et al., 1999). 
Since sexual function is also bound to different neuro-biological areas in the central nervous 
system, an investigation of the activity of the new compounds on animal models could give 
significant results. A standard test to measure the effects of drugs on sexual activity is the 
evaluation of copulatory behavior in male rats. Components of sexual behavior in male rats 
can be categorized as motivational (libido; sexual arousal) or consummatory (potency; 
erectile and ejaculatory ability) (Bitran and Hull, 1987). In general, the mating test consists in 
recording and comparing the occurrence of each mount, intromission, and ejaculation in 
vehicle control group and in compound treated group. Sexually receptive females of the same 
strain serve as sexual partners and the frequency of pregnancy could also be an indicator of 
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the compound activity. In addition to mount and intromission latencies serving as indices of 
the level of sexual arousal, the mating test can be assessed by recording the frequency at 
which the male mounts the female in the absence of sensory feedback from genitalia (as after 
penile desensitization). The measurement of sexual activity by using the mating tests could 
aid the discovery of the sites of action of E. vacciniifolium Mart. components. 
As reported beforehand, some of the results obtained with cytotoxicity tests open  several 
new perspectives. The isolation of a series of compounds having the same basic skeleton 
could be helpful for the investigation of the structure-activity relationships (SAR) of these 
molecules. Drug design is an iterative process which begins with a compound that displays an 
interesting biological profile and ends by optimizing both the activity profile for the molecule 
and its chemical synthesis. Without a detailed understanding of the biochemical process(es) 
responsible for activity, the hypothesis generally is refined by examining structural 
similarities and differences for active and inactive molecules. Compounds are selected for 
synthesis which maximize the presence of functional groups or features believed to be 
responsible for activity. In this work, the most hydrophobic catuabines exhibited a certain 
cytotoxicity against specific tumor cell lines; it would be then reasonable to synthesize some 
derivatives in order to increase this activity and render it more specific. The alternative to this 
approach to compound optimization could be to develop a theory that quantitatively relates 
variations in biological activity to changes in molecular descriptors which can easily be 
obtained for each compound. A quantitative structure activity relationship (QSAR) can then 
be utilized to help guide chemical synthesis. 
In recent work, the hypothesis was put forward that there is a certain similarity between the 
multidrug resistance phenotype of mammalian tumor cells and quinoline resistance in 
Plasmodium falciparum, the causative agent of the most deadly form of human malaria (Bray 
and Ward, 1998). Chloroquine has been one of the most successful drugs ever developed 
against this parasite, but recent evolution and spread of resistance to this substance and other 
quinoline-containing drugs means that these compounds are now virtually useless in many 
endemic areas. Since it was demonstrated that chloroquine resistance could be circumvented 
in vitro by a number of structurally and functionally unrelated compounds such as verapamil 
and desipramide, the future prospects for the use of quinoline compounds are considerably 
improved. The phenomenon of resistance reversal by these compounds is also a key feature of 
vinblastine resistance in mammalian tumor cells. In view of the cytotoxicity results obtained 
by testing the compounds isolated from E. vacciniifolium Mart., new assays to evaluate the 
capability of these compounds to reverse the resistance to quinoline-containing drugs in P. 
falciparum could be undertaken. 
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1. Materials and extraction 
1.1. Analysis of commercial aphrodisiacs containing yohimbine 
Materials. Authentic yohimbe bark powder was obtained from Dixa AG (St. Gallen, 
Switzerland). Aphrodisiac products were purchased from different sources found on the Internet 
(Table 0-1). Yohimbine HCl was purchased from Carl Roth GmbH (Karlsruhe, Germany). 
Rauwolscine hydrochloride, corynanthine hydrochloride, codeine and yohimbinic acid 
monohydrate were purchased from Sigma-Aldrich Chemie GmbH (Steinheim, Germany). 
HPLC grade acetonitrile was obtained from Romil LTD (Cambridge, UK). De-ionized water 
was prepared using a Reinstwasser-System Clear cartridge system (SG GmbH, Hamburg, 
Germany) and passed through a 0.45 µm filter (Millipore, Bedford, MA, USA). Analysis grade 
triethylamine (Et3N) was purchased from Fluka Chemie GmbH (Buchs, Switzerland). Synthesis 
grade chloroform (SDS SA, Peypin, France) and reagent grade ammonia solution 32% (Merck 
KgaA, Darmstadt, Germany) were used in the extractions. Deuterated methanol (isotopic purity 
of 99.50 %), purchased from Dr. Glaser AG (Basel, Switzerland), was used in the preparation of 
deuterium-labeled yohimbine. 
 
Extractions. For the extraction of yohimbe, 500 mg of authentic bark powder were moistened 
with 1 mL of concentrated NH4OH and extracted four times with 100 mL CHCl3 during 1 hour. 
The chloroform layers were united, and solvent was removed by rotary evaporation (Büchi 
Rotavapor) at 35°C. Aphrodisiac products included solid (tablets, gelatin capsules and bulk 
powder) and liquid dosage forms. For the liquid preparations, a volume of 15.0 mL was 
evaporated to dryness at 35°C before being treated as described before. For tablets, bulk powder 
and content of gelatin capsules, 5000 mg were considered. They were grounded and 
homogenized in a mortar and pestle. The fine powders were moistened with 5 mL of 
concentrated NH4OH and extracted four times with 150 mL CHCl3 during 1 hour. The 
chloroform layers were combined and treated as described before. The quantities for the liquid 
and solid dosage forms corresponded to 1 to 4 times of the maximal daily doses suggested by 
the manufacturers. Each sample, including authentic bark powder, aphrodisiac products and 
spiked sample for recovery measures, were extracted in triplicate. In order to validate a 
quantitative extraction procedure, a fifth extraction was performed and analyzed by HPLC 
separately in order to determine the amount of residual alkaloids. 
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Table 0-1 
Name, form and origin of aphrodisiac products containing yohimbine. 
Sample Name Form Origin 
1  Vuka vuka Herbal Tea Powder Zim4U Trading, Canada 
2  Vuka vuka Capsules Zim4U Trading, Canada 
3  Vuka vuka Tablets Kejo Limited Company, Clearwater, FL, USA 
4  Vuka vuka Liquid Kejo Limited Company, Clearwater, FL, USA 
5  Extra-Plus (Vuka vuka) Capsules James Mobb Imm. Enhanc., Harare, Zimbabwe 
6  Vuka Nkuzi Capsules Ageless Co., Sunnyside, RSA 
7  Vuka vuka Powder Mbara market, Harare, Zimbabwe 
8  Erectol Capsules Fantasy Man, Tampa, FL, USA 
9  Milagro Tablets International Vascular Clinic, Largo, FL, USA 
10  Stamina Chi Liquid Advanced Living Foundation, Paia, HI, USA 
11  Virile 1 Tablets Biotech Corporation , Glastonbury, CT, USA 
12  Virile-max (Male formula) Capsules Capital Health products, Boca Raton, FL, USA 
13  Super Herbal V Capsules M.D. Healthline, Phoenix, AZ, USA 
14  Male-Repro Masse Ayurvedic Rasayanas Intl., Eugene, OR, USA 
15  Endow Plus (for men) Capsules Tiger-one.com, Dewey, AZ, USA 
16  Herbal V Tablets Smart Health USA, Inc., Bevverly Hills, CA, USA 
17  Virility-V (Herbs for Life) Tablets Herbs for Life, Salt Lake City, UT, USA 
18  UVP - Male formula Tablets NuBio Research, Inc., Cincinnati, OH, USA 
19  Bois bandé des caraïbes Liquid Harmonie SA, Couvet, Switzerland 
20  Kama Sutra Tablets P.M.C., GmbH, Monschau, Germany 
 
 
1.2. “Catuaba” 
The stem bark of Erythroxylum vacciniifolium was collected in Buraquinho rain forest (João 
Pessoa, Paraíba, Brazil), in August 2000. A voucher specimen was deposited at the HLPQN 
(Herbarium do Laboratorio de Química de Produtos Naturais), Universidade Federal de Paraíba, 
58059 João Pessoa, Paraíba, Brazil (JPB.-N° 152) and identified by Prof. Zoraide Maria de 
Medeiros Gouveia of the Department of Science of Nature, University of Paraíba, Brazil and Dr. 
Douglas C. Daly, The New York Botanical Garden. 
The collected plant material was air dried and ground in liquid nitrogen to prevent heating that 
could alter its components. The pulverized stem bark (840 g) was moistened with 20 mL of 
concentrated NH4OH and exhaustively extracted with 3L of CHCl3 three times during 24 hours 
at room temperature and under constant agitation. After filtration of the extracts, CHCl3 was 
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removed by rotary evaporation (Rotavapor Büchi) under vacuum at a maximum temperature of 
35°C. The filtrate was neutralized with concentrated HCl and was successively extracted with 
about 3L dichloromethane and then 3L methanol. Maceration was performed 3 times for each 
solvent during 24 hours at room temperature and under continuous agitation. Solvents were 
evaporated to dryness as described before. A water extract was carried out in a similar way, 
with a second sample of ground material (16.5 g) exhaustively extracted with 0.5L of water 
three times during 24 hours. Another water extract was performed with the same amount of 
pulverized stem bark (16.5 g) infused in 0.5L boiling water during 1 hour. The water extracts 
were respectively combined and lyophilized. Table 0-2 presents the different extraction 
conditions and the weights of extracts obtained for E. vacciniifolium. 
 
 
Table 0-2 
Extraction conditions and corresponding amount of extract obtained for E. vacciniifolium Mart. 
Extracts Plant material Solvent Time Temperature Extract 
Alk. CHCl3 840 g  3 x 3L  CHCl3 3 x 24 hs R.T. 15.74 g 
DCM 840 g  3 x 3L  DCM 3 x 24 hs R.T. 5.92 g 
MeOH 840 g  3 x 3L  MeOH 3 x 24 hs R.T. 81.83 g 
Water  16.5 g  3 x 0.5L  H2O 3 x 24 hs R.T. 2.93 g 
Water  16.5 g  0.5L  H2O 1 hs 100°C 4.58 g 
 
 
2. Analytical chromatographic methods 
2.1. Thin layer chromatography (TLC) 
Thin layer chromatography (TLC) has so far been applied more than any other 
chromatographic technique and has become widely adopted for rapid and positive analysis of 
drugs and drug preparations. The popularity of this method is due to three main reasons: the 
time required for the identification of most characteristic constituents of a drug by TLC is very 
short, TLC gives semi-quantitative information on the main constituents of the drug or drug 
preparation and the chromatographic drug fingerprint provided by TLC is suitable for 
monitoring the identity and purity of drugs, and for detecting adulterations and substitutions 
(Wagner and Bladt, 1996). 
 TLC is the method of choice for routine phytochemical analyses of crude extracts, fractions 
and pure compounds. This technique is also used as a support for chemical and biological 
screening of extracts and pure compounds.  
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Commercially available TLC plates were used: Silicagel 60 F254 pre-coated TLC aluminium 
sheets (Merck, Darmstadt). Some biological tests (Candida albicans and Bacillus subtilis) were 
performed on Silicagel 60 F254 pre-coated TLC glass plates (Merck, Darmstadt). The TLC plates 
were developed in twin trough Camag chromatographic tanks saturated with the appropriate 
eluent. The solvent systems, often consisting of a binary or tertiary mixture, were adapted to the 
specific needs of an analysis. They were chosen for their minimal temperature sensitivity and all 
TLC separations were performed between 18 and 24°C. In order to obtain sharply resolved 
zones, the quantity of material applied to the chromatogram was usually 50-100 µg of extracts 
and 5-10 µg of pure compounds. After migration, the detection of the main, characteristic 
compounds of a drug, was carried out by the observation of the extinguishing of fluorescence in 
UV-254 nm, the appearance of fluorescence in UV-366 nm and the coming out of striking 
colors after revelation with appropriate chemical reagents. General TLC conditions for extracts 
and fractions were resumed in Table 0-3. 
 
 
Table 0-3 
Standard TLC conditions employed systematically for extracts and fractions separation (Silicagel 60 F254 
pre-coated TLC aluminium sheets from Merck, Darmstadt). 
Extracts or fractions Solvent system Detection 
Alkaline CHCl3 extract toluene-ethyl acetate-diethylamine (70:20:10) Dragendorff reagent 
DCM extract hexane-ethyl acetate (1:1) Godin’s reagent 
MeOH extract chloroform-methanol-water (65:35:5) Godin’s reagent 
Water extract chloroform-methanol-water (4:5:2) Godin’s reagent 
Polar fractions chloroform-methanol-water (65:35:5) Godin’s reagent 
Hydrophobe fractions hexane-ethyl acetate (1:1) Godin’s reagent 
Alkaline fractions toluene-ethyl acetate-diethylamine (70:20:10) Dragendorff reagent 
 
 
2.2. High performance liquid chromatography coupled to ultraviolet 
detection (HPLC-DAD-UV) 
High performance liquid chromatography (HPLC) is one of the most appreciated techniques 
in modern phytochemical analysis. The separation of complex mixtures is based on the selective 
distribution of analytes between a liquid phase and a stationary phase, as for TLC method. The 
advantage of HPLC in relation to TLC is the separation resolution, the sensible decrease of the 
detection limit and the possibility of automation of the procedure.  A conventional HPLC 
system is based on the injection of the sample by means of an injection port into the mobile 
phase stream delivered by the high-pressure pump and transported through the column, the heart 
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of the system where the separation takes place. The separation is monitored with a flow-through 
detector and visualized by an interface (integrator or computer) (Niessen, 1999). Currently, one 
of the most utilized detectors coupled to HPLC is the diode array detector (DAD). The 
development of DAD in early 1980s made a significant change in relation to classical UV 
detectors. In fact, the DAD adds a third dimension (the wavelength) to the time and absorption, 
giving a wealth of information, for example, on peak purity and identity (Huber and George, 
1993). 
In this study, analytical HPLC was used to: analyze qualitatively and quantitatively the 
extracts of commercial aphrodisiacs, analyze raw extracts and fractions of “catuaba”, guide the 
separation and isolation processes, optimize the conditions for MPLC and semi-preparative 
HPLC, and check the purity of the isolated compounds. 
Two HPLC systems were used for the different analyses: a HP-1100 system  (Hewlett 
Packard, Palo Alto, CA, USA) equipped with a binary pump, with a DAD and an autosampler; a 
HP-1090 series II system (Hewlett Packard, Palo Alto, CA, USA) including a quaternary pump, 
DAD and an autosampler. The various components of these two HPLC systems were controlled 
by Agilent ChemStation 8.01 software. This software was also employed for the data processing. 
The HPLC conditions routinely used for the analysis of commercial aphrodisiacs and “catuaba” 
were reported in Table 0-4. In some cases, these conditions were adapted to the specific 
requirements of the analyses. 
 
 
Table 0-4 
General HPLC conditions for the analysis of commercial aphrodisiacs and “catuaba”. 
 Commercial aphrodisiac analysis “Catuaba” analysis 
Column Nucleosil 100-5 C18 AB (Macherey-Nagel, Düren, Germany) 
Nucleodur 100-5 C18 
(Macherey-Nagel, Düren, Germany) 
Column size 125 x 2.0 mm i.d., 5 µm  125 x 4.6 mm i.d., 5 µm  
Pre-column 
size 8 x 3.0 mm i.d., 5 µm  8 x 4.0 mm i.d., 5 µm  
Solvent system MeCN (+2 mM Et3N) : water (+2 mM Et3N) MeCN (+2 mM Et3N) : water (+2 mM Et3N) 
Gradient 20:80 to 100:0 in 20 min (4 elution steps) 5:95 to 100:0 in 34 min (5 isocratic elution 
steps) 
pH 11 11 
Pressure 40-100 bar 45-110 bar 
Temperature 20-21°C 19-24°C 
Flow rate 0.3 mL/min 1.0 mL/min 
Detection 
(DAD) 280 nm 272 nm (UV scan: 200-500 nm) 
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2.3. High performance liquid chromatography coupled with mass 
spectrometry (LC-MS) 
The combination of high performance liquid chromatography - the abbreviation LC is used 
throughout this text - and mass spectrometry (MS) offers the possibility of taking advantage of 
both LC as a powerful separation technique and MS as a powerful and sensitive detection and 
identification technique (Niessen, 1999). In general, MS detection is used in combination with 
DAD detection resulting in an extremely powerful analytical tool, which can be considered as a 
hyphenated technique. 
LC-UV-MS was employed for the qualitative and quantitative analysis of yohimbine in 
commercial aphrodisiacs, for a preliminary study of “catuaba” crude extracts, for the 
dereplication of the “catuaba” alkaloid extract and to on-line obtain spectroscopic information. 
Current LC-UV-MS analyses were made on the following apparatus and the ionization 
conditions are reported in Table 0-5: 
 
• HPLC HP-1100 (see Ch. 2.2); 
• Atmospheric pressure chemical ionization (APCI) or electrospray ionization (ESI) 
interface; 
• Finnigan MAT (San José, CA, USA) LCQ ion trap or TSQ triple quadrupole mass 
spectrometer, or Micromass (Manchester, UK) LCT time-of-flight mass 
spectrometer. 
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Table 0-5 
MS conditions for the different instruments and analyses. 
 Commercial aphrodisiac analysis “Catuaba” analysis 
 
LCQ TSQ 700 LCQ LCT 
APCI source     
Capillary temperature 150°C 150°C 150°C - 
Source temperature - - - 120°C 
Vaporizer temperature 360°C 360°C 380°C 500°C 
Ionization mode positive positive positive positive 
Corona needle current 6.0 µA 6.0 µA 6.0 µA 5.0 µA 
Sheath gas pressure 90 psi (N2) 90 psi (N2) 60 psi (N2) 60 psi (N2) 
In-source CID - -15 eV - -30 eV 
Collision energy 30%a - 35%a - 
ESI source     
Capillary temperature 270°C 270°C   
Source voltage 4.5 kV 4.5 kV   
Ionization mode positive positive   
Sheath gas pressure 90 psi (N2) 90 psi (N2)   
Auxiliary gas pressure 25 psi (N2) 25 psi (N2)   
In-source CID - -15 eV   
Collision energy 30%a -   
a
 Energy levels on Finnigan IT-MS are given in % and not in eV since the voltages applied vary 
according to the m/z value of the precursor ions. 
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2.4. High performance liquid chromatography coupled with nuclear 
magnetic resonance (LC-NMR) 
The coupling of high performance liquid chromatography with nuclear magnetic resonance 
spectroscopy (LC-NMR) is one of the most powerful methods for the separation and structural 
elucidation of unknown compounds in mixtures (Wolfender et al., 2001). LC-NMR represents a 
potentially interesting complementary technique to LC-UV-MS in phytochemical analysis for 
the detailed on-line structural analysis of natural products (Wolfender et al., 1998b; Wolfender 
et al., 1998a).  
The analyses were performed with following equipment: 
 
• a Varian (Palo Alto, CA, USA) modular HPLC system, including a Varian 9012 
pump, a Valco injection valve and a Varian 9050 UV detector, controlled by 
Varian LC Star software; 
• a Varian Unity Inova 500 MHz NMR instrument equipped with a 1H[13C] pulse 
field gradient indirect detection microflow LC-NMR probe (flow cell 60 µL; 3 
mm i.d.); 
• a Valco (Houston, TX, USA) stop-flow valve E60-220. 
 
The separations were performed by using a Nucleosil 100-5 C18 AB prepacked column (125 x 
8.0 mm i.d., 5 µm; Macherey-Nagel, Düren, Germany) with MeCN (+ 2 mM ND3OD) : D2O (+ 
2 mM ND3OD) (5:95 to 100:0; 80 min). The resulting pH of the eluent was 10. In order to 
achieve satisfactory on-flow LC-NMR detection the amount of extract injected was increased to 
3.0 mg on-column. The flow rate was increased to 1.2 mL/min and the on-flow run consisted of 
107 increments of 32 transients each. The total analysis time for this experiment was 80 min. 
During LC-NMR the UV traces were measured at 272 nm for monitoring the chromatographic 
separation. For the stop-flow experiments, the UV detector was used to trigger the stop-flow 
valve and trap precisely the LC-peak of interest in the LC-NMR flow cell. In the stop-flow 
mode, 1024 transients were accumulated for each spectrum. References of the solvent signals 
were set at δ 2.10 for acetonitrile. For each increment, solvent suppression was performed with 
the WET sequence (Smallcombe et al., 1995). During gradient elution the shapes of the 
selective pulses were automatically calculated on the fly based on a scout scan recorded before 
each increment. 
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3. Preparative chromatographic methods 
3.1. Medium pressure liquid chromatography (MPLC) 
The principle of this method is similar to HPLC, but it allows the separation of larger sample 
loads with good resolution. The equipment used consisted of a Büchi B-681 pump, a Büchi B-
687 gradient device, a Knauer K 2001 UV detector, a Pharmacia LKB Rec 1 recorder and an 
automatic Büchi B-684 fraction collector. A Lichroprep® C18 stationary phase (15-25 µm, 
Merck) was used for all separations and it was packed in a pressure-resistant column of variable 
size, depending on the sample amount. The choice of the solvent system was performed by 
analytical LC-UV and transposed directly to MPLC. For the isolation of alkaloids, a gradient 
mixture of MeCN-water-Et3N (2 mM) as mobile phase was employed. The maximal pressure 
was set to 20 bars and the sample was placed in an introduction cartridge after having been 
mixed with 2-3 times its weight of stationary phase. 
3.2. Semi-preparative high performance liquid chromatography (SP-
HPLC) 
The term “semi-preparative” is conventionally applied to columns with an i.d. of 8-10 mm, 
often packed with 5-10 µm particles , and  useful for the separation of 1 mg to 100 mg mixtures 
(Hostettmann et al., 1998).  
SP-HPLC was used in order to purify the compounds previously isolated by MPLC. A 
Nucleosil 100-5 C18 AB prepacked column (125 x 8.0 mm i.d., 5 µm; Macherey-Nagel, Düren, 
Germany) was employed for the separations. 
Depending on the needs, this column was connected to two different systems. For the 
purification of small amounts, a Shimadzu LC-10AD pump (Kyoto, Japan) equipped with a 
Pharmacia LKB UV detector and a Pharmacia LKB Rec 1 recorder was used.  The flow-rate 
was set between 1 and 2 mL/min and the injected amounts ranged from 0.3 to 1.0 mg. 
For the isolation of larger quantity, a Gilson pump (model 321; Middleton, WI, USA) 
equipped with a Gilson UV/VIS detector (model 151) and a Gilson fraction collector (model 
206) were used. All these components were controlled by Gilson Unipoint 3.2 software. The 
flow-rate was generally augmented to 2 mL/min and the injected amounts to 3.0 mg. 
Optimization of separation conditions were determined by analytical HPLC using a Nucleosil 
100-5 C18 AB column (125 x 4.6 mm i.d., 5 µm; Macherey-Nagel, Düren, Germany) before 
transposition to a semi-preparative scale. 
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4. Physico-chemical methods 
4.1. Optical rotation ([α]D) 
The optical rotation of the pure compounds was measured on a Perkin-Elmer 241 polarimeter 
(Wellesley, MA, USA) with the sodium D line (589.3 nm) as the source of light. The 
measurements were made at 20°C in a 10 cm long cell. The results were calculated with the 
following formula and the concentrations were expressed in g/100 mL, according to 
conventions: 
[ ]20 CD 1000l c
α
α
° ⋅
=
⋅
 
α = observed rotation 
l = cell length in dm 
c = concentration in g/L 
4.2. Circular dichroism (CD) spectroscopy  
Circular dichroism (CD) spectroscopy is a form of light absorption spectroscopy that 
measures the difference in absorbance of right- and left-circularly polarized light by a substance. 
CD spectra were recorded on a JASCO J-810 spectropolarimeter (Easton, MD, USA) in the 
195-350 nm range with compound concentrations of 0.325-1.432 mM in MeOH and/ or MeCN 
solution. All CD spectra are reported as the difference in molar absorptivity (∆ε = εl- εr). 
Experiments were performed at room temperature (near 22°C) in the Department of Organic 
Chemistry of Prof. Sándor Antus in the University of Debrecen (Debrecen , Hungary) by Dr. 
Timbor Kurtán. 
4.3. Infrared spectrophotometry (IR) 
The IR spectra of the pure compounds were obtained on a Perkin-Elmer 1600 FTIR 
instrument (Wellesley, MA, USA). The technique used for the preparation of the solid sample 
was the formation of KBr pellets. Generally 1 mg of the isolated compound was mixed with 200 
mg of dry KBr. This mixture was finely ground using a ball mill, and pressed to a transparent 
pellet using an evacuable die. The spectra of the pellets were recorded versus the empty 
reference beam (4 scans, 2.0 cm-1, 500-4000 cm-1). 
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4.4. Ultraviolet spectrophotometry (UV) 
The UV spectra of the isolated compounds were recorded in ethanol on a Perkin-Elmer 
Lambda 20 spectrophotometer (Wellesley, MA, USA). Quartz cells were used for samples and 
blanks. The results were reported in  EtOHmaxλ  nm (log ε), where EtOHmaxλ  nm represented the wave-
length of the maxima and ε the extinction coefficient at this wave-length according to the 
Lambert-Beer law: 
A = ε ⋅  c ⋅  b 
A = absorbance (au) 
c = molar concentration (mol/L) 
b = thickness of the cell (cm) 
4.5. Mass spectrometry (MS) 
Mass spectra of the isolated compounds were run in the electron ionization (EI) and 
desorption chemical ionization (D/CI) modes. In EI, the analyte vapour is subjected to a 
bombardment of energetic electrons from a direct electrically-heated tungsten or rhenium 
filament. A radical cation M+• is produced  and it is called the molecular ion, since its m/z ratio 
corresponds to the molecular mass Mr of the analyte. In D/CI the ionization is based on a 
chemical reaction between a reagent gas ion (i.e., NH4+) and the analyte molecule. The reagent 
gas ions are generated by EI and subsequent ion-molecule reactions. The protonated molecules 
reacts with an analyte molecule transferring the proton and generating a protonated analyte 
molecule, generally with low internal energy and consequently less prone to fragmentation than 
the molecular ion generated by EI ionization. In D/CI the combination of rapid heating and the 
direct interaction of vaporized molecules with reagent gas ions enables the mass analysis of 
many relatively non-volatile analytes (Kellner et al., 1998). 
EI and D/CI mass spectra of pure compounds were measured on a Finnigan-MAT/TSQ-700 
triple stage quadrupole instrument with the following parameters: 
 
• EI-MS: 70 eV applied on the filament; vaporization of the analytes by a linear 
increase of the temperature of the probe (50-300°C in 1 min); temperatures of the 
source and quadrupoles maintained at 150°C and 70°C, respectively. 
• D/CI-MS: ammonia as reagent gas for measurements in the positive mode; linear 
increase of desorption filament temperature (50-1000°C in 1 min). 
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• In order to confirm the molecular formulae of the isolated compounds, high 
resolution mass spectra were recorded. The measurements were carried out on a 
Bruker FTMS 4.7T mass spectrometer (Billerica, MA, USA) in the Laboratoire de 
Chimie Organique of Prof. Titus Jenny in the University of Fribourg, Switzerland.  
4.6. Nuclear magnetic resonance spectrometry (NMR) 
The nuclear magnetic resonance spectrometry (NMR) was chosen as main analytical method 
for the structural elucidation of the isolated compounds. The NMR is a phenomenon which 
occurs when the nuclei of certain atoms are immersed in a static magnetic field and exposed to a 
second oscillating magnetic field. Under appropriate conditions, the analyte can absorb 
electromagnetic radiation in the radio frequency region at frequencies depending on the 
characteristic of the analyte. 
The nuclei of greatest interest were mainly protons (1H) and carbon-13 (13C) as their 
resonances are the most important for the identification of natural organic molecules. The 1H 
and 13C-NMR spectra were recorded on a Varian Inova 500 MHz spectrometer (Palo Alto, CA, 
USA) at 499.87 and 125.70 MHz, respectively. The instrument was controlled by Varian 
VNMR software installed on a Sun workstation (Santa Clara, CA, USA). All NMR 
measurements were performed at 30°C in deuterated chloroform (Dr Glaser AG, Basel, 
Switzerland). In the case of polar compounds, a drop of deuterated methanol was previously 
added in order to facilitate the sample dissolution. The shifts are indicated in ppm, with 
trimethylsilane (TMS) as an internal standard for 1H spectra, and the chloroform-d shift (77.0 
ppm) as reference for 13C spectra. 
In order to observe homo- and heteronuclear correlations between proton and carbon atoms of 
the analyte, complementary two dimentional (2D) experiments were performed. For advanced 
and 2D spectra including gDQF-COSY, gHSQC, gHMBC and NOESY, standard pulse 
sequences provided in the original VNMR software were employed. DEPT spectra consisted of 
90° pulse spectrum (CH signals positive) and 135° pulse spectrum (CH and CH3 signal positive 
and CH2 signals negative). 
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5. Chemical methods 
5.1. Reagents for TLC detection 
After development and mobile-phase solvent evaporation, zones were detected by various 
means. Colored substances may be viewed in daylight without any treatment. Colorless 
substances were first detected if they showed self-absorption in the short-wave UV region (254 
nm) or if they could be excited to produce fluorescence by UV radiation (366 nm). Otherwise, 
detection was achieved by means of chemical reagents (chromogenic or fluorogenic reagents) 
producing colored or fluorescent zones. Two main chemical reagents were used to detect 
compounds of “catuaba” on TLC plates: 
 
• Godin’s reagent (Godin, 1954): general reagent. First, the plate was sprayed with a 
solution of equivalent volumes of 1% vanillin in ethanol and 3% perchloric acid in 
water. Then, the dried layer was covered with an ethanolic solution of 10% 
sulfuric acid and heated to about 100°C during 5 min. Colored zones were 
produced on a pale background. 
• Dragendorff reagent (Munier, 1953): specific reagent (alkaloids). (a) 0.85 g of 
bismuth subnitrate and 10 g of tartaric acid were dissolved in 40 mL of water. (b) 
16 g KI were dissolved in 40 mL of water. Color reagent: 5 mL of (a), 5 mL of (b), 
20 g of tartaric acid and 100 mL of water were mixed extemporary and then 
sprayed on the plate to give orange zones on a yellow  background. 
5.2. Preparation of yohimbine-d3 
In order to improve the precision of yohimbine quantitative analysis, an internal standard was 
needed and isotopically labeled yohimbine was selected for the LC-MS experiments. 
Deuterium-labeled yohimbine ([methyl-2H]-labeled yohimbine) was obtained by esterification 
of yohimbinic acid with [2H]-methanol under acidic conditions (pH = 2). The reaction was 
reversible, but an excess of [2H]-methanol favored a quantitative esterification. Yohimbinic acid 
monohydrate (2 g; Sigma Chemical Co., St. Louis, MO, USA) was dissolved in 50 mL of 
perdeuterated methanol (Dr Glaser AG, Basel, Switzerland) containing 0.1 M H2SO4 and 
refluxed for 5 h. The reaction was followed by a determination of the ratio of the original and 
the esterified acid in the reaction mixture by LC-MS. Once the reaction was quantitative, the 
solution was cooled to 20°C, neutralized with Na2CO3 and the solvent evaporated to dryness 
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under reduced pressure. The residue was poured into 50 mL of water, basified (pH = 9) and 
extracted 3 times with 50 mL of CHCl3. The combined extracts were evaporated by rotary 
evaporation at 35°C and the residue was analyzed by MS-MS. The synthesized compound 
presented a protonated ion [M+H]+ at m/z 358.4 and fragment ions at m/z 215.2, 144.3 and 
226.2 corresponding to deuterium-labeled yohimbine. The yield was 1.8 g (90%). 
5.3. Removal of tannins from plant extracts 
Tannins are secondary metabolites widely distributed in the plant Kingdom. The reactivity of 
such polyphenolic compounds to proteins is established and several instances reported the 
interference of tannins in certain assays due primarly to their reaction with proteins of enzymes 
(Wall et al., 1996). 
The bark of E. vacciniifolium demonstrated to have polyphenolic compounds such as tannins 
and their elimination from methanolic and aqueous extracts had to be undertaken in order to 
avoid some interference during the bioassays. 
The different extracts (1 g) were dissolved into 25% ethanolic solution (100 mL) containing 1 
g of hide powder(for determination of tannic acid slightly chromated; Merck, Darmstadt, 
Germany), stirred at room temperature for 60 min and centrifuged. The supernatant was 
withdrawn and the procedure repeated . The supernatants were combined , dried and submitted 
to the bioassays. 
 
6. Bioassays 
6.1. Acetylcholinesterase (AChE) inhibitory activity 
The enzyme acetylcholinesterase (AChE; EC 3.3.3.7) has the function of terminating the 
action of  acetylcholine (ACh)  at the junctions of the various cholinergic nerve endings with 
their effector organs or postsynaptic sites. Inhibitors of this enzyme cause ACh to accumulate at 
cholinergic receptor sites producing an increase of their stimulation. Anticholinesterase agents 
have therapeutic utility in the treatment of glaucoma, the facilitation of gastrointestinal and 
bladder motility, influencing activity at the neuromuscular junction of skeletal muscle, as 
desired in myasthenia gravis, and in the symptomatic treatment of Alzheimer’s disease (Taylor, 
1996). 
All crude extracts and isolated compounds were submitted to a test developed to detect 
anticholinesterase agents directly on TLC plates (Marston et al., 2002): 
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AChE from electric eel (1000U) purchased from Sigma Chemical Co. (St. Louis, MO, USA) 
was dissolved in 150 mL of 0.05 M Tris-hydrochloric acid buffer at pH 7.8. Bovine serum 
albumin (150 mg) (Merck, Darmstadt, Germany) was mixed with this solution in order to 
stabilize the enzyme during the bioassay. The developed and well-dried TLC plates were 
sprayed with the solution and incubated in humid atmosphere at 37°C for 20 min after being 
dried again. A freshly prepared mixture of 1 part of 1-napthyl acetate (250 mg/mL in MeOH) 
and 4 parts of “Fast Blue salt B” (Fluka, Buchs, Switzerland; 200 mg/ 80 mL water) was then 
sprayed on the incubated plates. A purple coloration appeared on the whole surface after 1-2 
min. Active compounds (inhibitors of the AChE) were localized by colorless spots. In general, 
50 µg of crude extract and  5 µg of pure compounds were spotted on the layer. Galanthamine 
obtained from Sigma Chemical Co. was used as positive control. 
6.2. Inhibitory activity against Phosphodiesterase (PDE) 
Cyclic nucleotide phosphodiesterases (PDE; EC 3.1.4.17) play a key role in the metabolism of 
cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). These 
are high-capacity enzymes that rapidly degrade and thereby inactivate cAMP (to 5’ AMP) and 
cGMP (to 5’ GMP), respectively. Nine families of PDEs (PDE1 to PDE9) are known and they 
differ with respect to tissue distribution, substrate specificity, regulation by kinases, cGMP, or 
calcium, etc. The selective inhibitors of these isoenzymes are interesting pharmacological 
targets because of their diversity, the distinct tissue distribution pattern and the possibility of 
high throughput screening systems with heterologously expressed PDEs (Glossmann et al., 
1999). 
In order to discover new compounds in the treatment of erectile dysfunction, we tested 
“catuaba” crude extracts for their inhibitory activity against phosphodiesterase.  As Sildenafil 
(Viagra®), the most famous and studied compound for the treatment of erection dysfunction, is 
known to be a potent, competitive inhibitor of human PDE5, the biochemical assays were 
performed on the same isoenzyme. Since Sildenafil is a highly selective PDE5 inhibitor relative 
to its activity against PDE1 to PDE4 (Ballard et al., 1998), the tests were also carried out on 
PDE2. 
All these biochemical assays were undertaken at the Pharmacology Laboratories of the MDS 
Pharma Services – Taiwan Ltd. (Taipei, Taiwan) via study directors Fong-Chi Cheng and 
Ching-Chui Lin. The methods employed in this study have been adapted from the scientific 
literature to maximize reliability and reproducibility (Hidaka and Asano, 1976; Nicholson et al., 
1991). Reference standards were run as an integral part of each assay to ensure the validity of 
the results obtained. Assays on alkaloids, MeOH (treated or not for the removal of tannins and 
sugars) and DCM extracts were performed under conditions described in Table 0-6. 
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Table 0-6 
Conditions for the test of inhibition activity against phosphodiesterase isoenzymes. 
 PDE2 (cat. # 148000) PDE5 (cat. # 156000) 
Source Human platelets (hypotonic buffer, polytron homogenization) 
Human platelets (hypotonic buffer, 
polytron homogenization) 
Substrate 25.1 µM [3H]cAMP + cAMP 1.01 µM [3H]cGMP + cGMP 
Vehicle 1% DMSO 1% DMSO 
Pre-Incubation  None None 
Incubation  20 min at 25°C 20 min at 25°C 
Incubation Buffer 50 mM Tris-HCl, 5 mM MgCl2, pH 7.5 50 mM Tris-HCl, 5 mM MgCl2, pH 7.5 
Sample M. W.  300 g/mol (Assumed Weight) 300 g/mol (Assumed Weight) 
Sample concentration 100 µM 100 µM 
Reference Compound 
(IC50) 
3-isobutyl-1-methyl-xantine (IBMX) 
(Historical: 30 µM; Concur. MIC: 58.9 µM ) 
3-isobutyl-1-methyl-xantine (IBMX) 
(Historical: 63 µM; Concur. MIC: 38.5 µM ) 
Quantitation Method Quantitation of [3H]adenosine Quantitation of [3H]guanosine 
Significant Criteria ≥ 50% of max stimulation or inhibition ≥ 50% of max stimulation or inhibition 
 
6.3. Nitric oxide (NO) induction 
Although there are many neurohumoral factors involved in erection, nitric oxide (NO) is one 
of the most important (Archer, 2002). NO is a small inter- and intracellular signaling molecule 
generated by a family of enzymes termed NO synthases (NOS) through the conversion of L-
arginine into citrulline (Knowles and Moncada, 1994). There are three well-characterized 
isoforms of NOS that are named after the tissues from which they were originally isolated: 
endothelial (eNOS), neural (nNOS), and inducible (iNOS). In the penis, nNOS is localized to 
nonadrenergic-noncholinergic nerves, whereas eNOS is found in the smooth muscle cells and 
endothelium. Only nNOS has been conclusively identified histochemically in the penis (at nerve 
terminals) (Burnett et al., 1993), although the eNOS is expressed in the penile cytosol (Penson 
et al., 1997). Despite the importance of nNOS, erectile function is preserved in mice in which 
nNos has been eliminated by targeted gene disruption. This is due to the compensatory up-
regulation of eNOS (Archer, 2002). The essential role of NO in erection has been proved. The 
inhibition of NOS substantially reduces erection and is reversed by the NOS substrate, L-
arginine. Evidence from genetic models, as well as experiments with pharmacological inhibitors, 
has shown that low amounts of NO generated by eNOS are important for normal vascular 
function, regulating vascular tone, and inhibiting platelet aggregation and leukocyte adhesion to 
vessel walls. Decreased endothelial NO production has been seen in pathophysiological 
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conditions such as atherosclerosis, diabetes, and hypertension. In view of the protective effects 
of NO, compounds that increase the NOS activity, expression, or both are of significant 
therapeutic interest. 
In order to discover new compounds in the treatment of erectile dysfunction, vasoprotective 
and probably antiatherosclerotic properties, the different extracts and the isolated compounds of 
E. vacciniifolium were tested for their potential regulation of NOS expression. The bioassays 
were carried out at the Department of Pharmacology, Johannes Gutenberg University, Mainz, 
Germany under the direction of Dr. Huige Li and Prof. Dr. Ulrich Förstermann using the 
following two methods: transient transfection and stable tranfection. 
 
Transient transfection and reporter gene assay. In the transient transfection 
experiments, human endothelial EA.hy 926 cells were transfected with a construct containing a 
1.6-kb human eNOS promoter fragment driving the luciferase** gene (as reporter gene). The 
cells were then treated with plants extracts or pure compounds and luciferase activity were 
determined as a measure of the eNOS promoter activity. 
EA.hy 926 cells were placed in six-well plates 24 hs before transfection. Transient 
transfection was performed with 3 µL/well SuperFect reagent (Qiagen, Hilden, Germany) 
according to the manufacturer’s instructions. Each well received 1 µg of plasmid DNA, i.e., 0.9 
µg pGl3-Basic (Promega, Madison, WI, USA) or 0.9 µg of pGl3-NOS III-Hu-1600 and 0.1 µg 
pRL-simian virus 40 (Promega). pGl3-NOS III-Hu-1600 contains a 1.6-kb NOS III promoter 
fragment (-1600 to +23) cloned before the luciferase gene of  pGl3-Basic. Plasmid pRL-SV40 
contains the renilla-luciferase gene driven by an SV40 promoter and was cotransfected for 
normalization. On the next day, the cells transfected with pGl3-NOS III-Hu-1600 were left 
untreated or incubated with 100 µg/mL  of pure compounds or extracts for 12 hs. Then the cells 
were lysed with passive lysis buffer (Promega) and luciferase/renilla-luciferase activities were 
measured with the Dual-Luciferase System (Promega). The luciferase activity was normalized 
by renilla-luciferase activity after subtraction of background. 
 
Stable transfection and reporter gene assay. The principle of stable transfection is 
similar. EA.hy 926 cells were transfected with a construct containing a 3.5-kb human eNOS 
promoter fragment driving the luciferase gene.  The construct contains additionally a neomycin 
resistance gene so that a selection is possible.  The stable cells were treated with extracts and 
                                                
**
 An enzyme from firefly tails that catalyses the production of light in the reaction between luciferin and 
ATP. Used by the male firefly for producing light to attract females and used in the laboratory in a 
chemiluminescence bioassay for ATP. 
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pure compounds, and the luciferase activity was analyzed for the eNOS promoter 
activity.  Protein concentration in the cell lysates were measured for normalization. 
EA.hy 926 cells were placed onto 30-mm cell culture dishes 24 hs before transfection. The 
cells ( at ≈80% confluence) were transfected with DOTAP (N-[1-(2,3-dioleoyloxy)propyl]-
N,N,N-trimethylammonium methylsulfate) according to the manufacturer’s recommendations 
(Boehringer-Mannheim, Mannheim, Germany); 10 µg pGL3-Basic eNOS III-Hu-3500-Luc-neo 
was used. The cells were washed with culture medium 6 hs after transfection and incubated with 
medium for 18 hs. Then, the cells were separated to dilute them and incubated with medium 
containing 1 mg/mL G418 (blocks polypeptide synthesis and inhibits elongation. For use in the 
selection and maintenance of eucaryotic cells stably transfected with neomycin resistance 
genes).  Single clones were selected from the pNOS III-Hu-3500-Luc-neo-transfected cells and 
propagated in medium containing 1 mg/mL G418. For analysis of enhancement of NOS III 
promoter activity, the stably transfected cells were incubated with pure compounds and extracts 
(100 µg/mL, 30 µg/mL, 10 µg/mL) for 18 hs. Extracts (200 µL) were prepared using the 
reporter lysis buffer (Promega), and luciferase activities were determined as described.  
6.4. Antifungal test against Cladosporium cucumerinum 
Cladosporium cucumerinum is a microscopic phytopathogenic fungus, attacking particularly 
members of the Cucurbitaceae family. Occurrence of Cladosporium species in the environment 
seems to be related to respiratory allergies in humans (Cruz et al., 1997). In addition, other 
species could be responsible for cutaneous (Elgart, 1996) or central nervous system (Salaki et 
al., 1984) infections. 
Testing for antifungal activity was performed by direct bioautography on TLC (Homans and 
Fuchs, 1970): 
After elution, the chromatograms were dried and sprayed with a conidial suspension of C. 
cucumerinum (prepared by Syngenta, Basel, Switzerland) in Sabouraud medium (Sabouraud 
Maltose Broth, Biokar Diagnostics, Beauvais, France). The plates were then incubated during 3 
days at room temperature in a humid atmosphere. The fungal growth was accompanied by the 
production of a greenish grey pigment: active compounds appeared very clearly as white 
inhibition spots. The spotted amounts were 100 µg for extracts or fractions and 10 µg for pure 
compounds. Amphotericin B or miconazole were used as positive controls (10 µg), while 
chloramphenicol was spotted on the TLC plate as negative control (10 µg). 
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6.5. Antifungal test against Candida albicans 
Candida albicans (Robin) Berkhout is a yeast present in the gastrointestinal, buccal and 
vaginal human commensal flora, but it can become pathogenic in immunodepressed patients. In 
last decades, increasing incidence of systemic candidiasis associated with AIDS and also that 
arising after treatment by immunosuppressive drugs, and the apparition of numerous resistances 
to the drugs available has given fresh impetus to the search for new agents against this pathogen. 
Since direct bioautography is not possible with yeasts such C. albicans, a simple and rapid agar 
overlay assay has been developed (Rahalison et al., 1991). This contact bioautography 
technique relies on the transfer by a diffusion process of active compounds from the stationary 
phase into the agar layer containing the micro-organism. After incubation, the plate is sprayed 
with (4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT). The fungus 
converts the MTT into an MTT formazan dye. Inhibition zones are observed as clear spots 
against a purple background. 
The agar overlay method used is as follows: 
A C. albicans  strain was obtained from the Centre Hospitalier Universitaire Vaudois (CHUV, 
Lausanne , Switzerland).  A colony of this micro-organism was put in 50 mL of  Sabouraud 
medium (Sabouraud Dextrose Agar, Biokar Diagnostics, Beauvais, France) and kept for one 
night at room temperature with constant shaking. 1 mL of this solution was diluted with 50 mL 
of  the same Sabouraud medium and shaken at room temperature during 6 hours to achieve 
micro-organism exponential growth. 5 mL of this solution was introduced in 50 mL fractions of 
malt agar (Biokar Diagnostics), prepared and maintained at 45°C. These inoculums contained 
then approximately 105 cells/mL and 20 mL were sufficient for a 10 × 20 cm plate. The extracts 
(100 µg) or the pure compounds (10 µg) were applied on a glass-backed silica gel TLC plate 
and developed as described in Ch. 2.1. Miconazole (10 µg) was used as positive control and 
chloramphenicol (10 µg) as negative control. After elution, the TLCs were dried. The liquid 
agar medium was spread on the plate in a layer of about 1-2 mm and it hardened while cooling. 
The different plates were incubated overnight at 30°C in a humid atmosphere, and then 
homogenously sprayed with the MTT solution (2.5 mg/mL). The micro-organism metabolized 
the MTT into purple formazan, and after 4 hours incubation, the inhibition zones were 
visualized as white spots on the purple background. Ethanol 94% was then sprayed on the plates 
to stop yeast growth. 
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6.6. Antibacterial test against Bacillus subtilis 
Bacillus subtilis is a gram-positive, rod-shaped and endospore-forming aerobic bacterium. It 
is found in soil and rotting plant material and is non-pathogenic. It is one of the most studied 
gram-positive bacteria and only the gram-negative Escherichia coli and its relatives are 
substantially better understood. Several strains related to B. subtilis are used in the commercial 
production of extra-cellular enzymes, such as B. amyloliquefaciens alpha-amylase. Other strains 
produce insect toxins, peptide antibiotics and antifungals, some of which have been used in 
agricultural crop protection. Some bacteria in the genus cause disease, for example B. anthracis 
is the cause of anthrax. This micro-organism, often cited as biological weapon,  is a zoonotic 
agent  to which most mammals, especially grazing herbivores, are considered susceptible. 
Human infections result from contact with contaminated animals or animal products, and there 
are no known cases of human-to-human transmission (Dixon et al., 1999).  
The agar overlay method used in our laboratories was adapted from the literature (Hamburger 
and Cordell, 1987) and described as follows: 
A B. subtilis strain (ATCC 6633) was purchased from Sigma Chemical Co. (St. Louis, MO, 
USA). A colony of the germ was grown in a 50 mL liquid Luria-Bertani Broth (LBB): 10 g/L 
tryptone (Biokar Diagnostics, Beauvais, France) + 5 g/L autolytic yeast extract (Biokar 
Diagnostics) + 10 g/L NaCl. After one night of shaking at room temperature, 0.5 mL of this 
solution were employed to inoculate 50 ml of a second Luria-Bertani culture medium. This 
solution was agitated during 8 hours at room temperature to exponentially increase the micro-
organism growth. Afterwards, 0.5 mL were introduced in fractions of 50 mL of Luria-Bertani 
Agar (LBA), prepared and kept at 45°C: LBB + 15 g/L bacteriological agar type A (Biokar 
Diagnostics). These inoculums contained then approximately 108 cells/mL and 20 mL were 
sufficient for a 10 × 20 cm plate. The extracts (100 µg) or the pure compounds (10 µg) were 
applied on a glass-backed silica gel TLC plate and developed as described in Ch. 2.1. 
Chloramphenicol (10 µg) was used as negative control. After TLC drying, the liquid agar 
medium was laid on the plate in a 1-2 mm layer. As for C. albicans (see Ch. 6.5), the plates 
were incubated and then sprayed with MTT. Active compounds could be detected as white 
zones on the purple formazan background. Ethanol 94% was sprayed on the plates to stop 
bacterial growth after the test. 
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6.7. Cytotoxicity tests 
The development of multidrug-resistant tumor cells during the course of cancer chemotherapy 
is one of the most serious problems associated with the treatment. An important mechanism of 
acquiring the multidrug-resistance (MDR) phenotype in mammalian cells is the improved 
expression of a membrane glycoprotein (P-glycoprotein) (Gottesman and Pastan, 1993). Several 
active principles are known to surmount or circumvent MDR. Recently, some new tropane 
alkaloids isolated from two species of Erythroxylum  were shown to be extremely potent 
inhibitors of MDR (Mi et al., 2001; Mi et al., 2002a). Similarly, the alkaloid extract and the 
isolated compounds (tropane alkaloid aromatic esters) of E. vacciniifolium were tested for their 
potential to reverse MDR. The activity was calculated as the amount of pure compound required 
to produce a response in 50% of the subjects to whom the compound was given (ED50). 
All these bioassay were carried out at the Department of Medicinal Chemistry and 
Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago (IL), USA 
under the direction of Prof. A. Douglas Kinghorn and Prof. John M. Pezzuto. 
 
Cell Lines. Preliminary screening for the cytotoxicity activity of the tropane alkaloids was 
performed on human lung (Lu1), colon (Col2), oral epidermoid (KB) and hormone-dependant 
prostate (LNCaP) cancer cell lines. Also employed for preliminary testing were human 
telomerase reverse transcriptase-retinal pigment epithelial cells (hTERT-RPE1) and human 
umbilical vein endothelial cells (HUVEC). The hTERT-RPE1 was adopted as a substitute for a 
primary cell line for determining toxicity to normal human cells. The HUVEC line test system 
allowed identification of samples with potential antiangiogenic activity (Seo et al., 2001).  
Assays involving carcinoma cell lines utilized established protocols (Likhitwitayawuid et al., 
1993), while HUVEC and hTERT-RPE1 cells were grown in more specialized media. HUVEC 
were purchased and grown in media and components supplied in the EGM-2 BulletKit 
(Clonetics Corporation, Walkersville, MD, USA) with 2% fetal bovine serum (FBS), while the 
hTERT-RPE1 line (Clotech Laboratories, Palo Alto , CA, USA) was maintained in DMEM/F-
12 (Invitrotrogen Corporation, Carlsbad, CA, USA) containing 10% FBS. Both these cell lines 
were tested at an initial cell seed concentration of 5 × 104 cells/mL using standard assay 
procedures (Likhitwitayawuid et al., 1993). 
Multidrug-resistant human oral epidermoid carcinoma (KB-V1) cell lines were used for 
testing the inhibition of MDR in presence or absence of vinblastine (VLB; Sigma Chemical Co., 
St. Louis, MO, USA). KB-V1 cells were supplied by Dr I.B. Roninson (Department of 
Molecular Genetics, University of Illinois at Chicago, Chicago, IL, USA) and were grown in the 
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same medium as KB cells, which was further supplemented with VLB (1 µg/mL). Cell culture 
media and supplements were purchased from Life Technologies, Inc. (Grand Island, NY, USA). 
 
Cytotoxic potential. The cytotoxic potential of test compounds with the various cell lines 
was determined as described in literature (Likhitwitayawuid et al., 1993). In summary, different 
concentrations of test substances (dissolved in 10 µL of 10% DMSO) were transferred to 96-
well plates, and 190 µL aliquots of cell suspensions (5 × 104 cells/mL) were added to each well. 
The plates were then incubated for 72 hours at 37°C (100% humidity with a 5% CO2 
atmosphere in air), and 100 µL of cold 20% aqueous trichloroacetic acid were added to the 
growth medium to fix the cells. The cultures were incubated for 30 min at 4°C, washed, air-
dried, stained with sulforhodamine B solution, and washed with 1% acetic acid. After having 
added 200 µL of 10 mM Tris base to each well, the optical densities were measured at 515 nm 
using an enzyme-linked immunosorbent assay plate reader. A zero-day control was performed 
by adding an equivalent number of cells to several wells and incubating for 30 min at 37°C, and 
processing as described above. Optical density values obtained with zero-day control were 
subtracted, and cell survival, relative to control (solvent-treated) cultures, was calculated. 
7. Quantitative determination of total alkaloids 
The quantitative estimation of total alkaloids in the bark of E. vacciniifolium was calculated 
by two distinct methods, gravimetry and colorimetry using a UV-Vis spectrophotometer. 
7.1. Gravimetric method 
Stem bark powder (840.13 g) of authentic E. vacciniifolium was moistened with 20 mL of 
concentrated NH4OH and exhaustively extracted with 3L of CHCl3 three times during 24 hours 
at room temperature and under constant agitation. After filtration of the extracts, CHCl3 
fractions were combined and the solvent removed by rotary evaporation (Rotavapor Büchi) 
under vacuum at a maximum temperature of 35°C. Three accurately weighed parts of the 
lyophilized and homogenized extract (a: 335.6 mg; b: 330.2 mg; c: 335.7 mg) were transferred 
to separators with the aid of CHCl3 (250 mL each) and extracted with successive portions (4 x 
250 mL each) of a sulfuric acid solution (approximately 0.5 N). The layers were allowed to 
separate and the chloroform layers were discarded at the end of the extraction. The acid phases 
were combined and then made alkaline (pH 11) with some drops of concentrated ammonia. The 
precipitated bases were extracted four times with CHCl3 (250 mL). The organic phases were 
filtered through 50 g of anhydrous sodium sulfate, previously washed with CHCl3 and supported 
in a funnel with a small pledget of glass wool, into a weighed flask. The sodium sulfate was 
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washed and the combined organic phases evaporated under reduced pressure at a temperature 
below 35°C. The three extracts were lyophilized and precisely weighed. 
7.2. Colorimetric method 
The choice of a colorimetric procedure for the determination of total alkaloid content depends 
on the consideration that this method often gives more accurate results at low concentrations 
than the corresponding titrimetric or gravimetric procedures. Even though all constituents of the 
alkaloid extract seemed to have the same chromophore (a 1-methyl-1H-pyrrole-2-carboxylic 
acid esterifying the tropane nucleus) with a maximum of absorbance around 268 nm, the 
presence of other substances with absorption at this wavelength could interfere with the analysis. 
The eventual action of interfering substances was suppressed by the derivation of the tropane 
alkaloids and consequent shift of their maximum of absorbance at definite wavelength. In view 
of the selective character of the colorimetric reaction, it is important to control the operational 
procedure so that the color is specific for the components being determined. Alkaloids form 
with acidic indicators (e.g., bromocresol green) a non-dissociable salt, which can be extracted 
with an organic solvent while the excess indicator anions remain in the water phase. The 
photometric intensity of the organic phase is then an indirect measure of the alkaloid 
concentration. Many reactions take place within well-defined limits of pH, so the specificity 
may be improved by adjusting the pH. The bromocresol green indicator used for this experiment 
has a transition interval from pH 4.0 to 5.4 with color changes from yellow to blue. After the 
reaction, the chloroform solution had a maximum absorbance at ca. 590 nm with pH 5.5. 
In absorption spectrophotometry, the absorptivity of a substance is a constant independent of 
the intensity of the incident radiation, the internal cell length, and the concentration, with the 
result that concentration may be determined photometrically. A calibration curve was then 
constructed with different concentrations of a derived main alkaloid (catuabine D) and the 
quantitative determination of the constituents was carried out under the same experimental 
conditions. 
 
Assay preparation. An accurately weighted quantity of E. vacciniifolium bark powder (a: 
0.9973 g; b: 0.9967 g; c: 0.9996 g) was mixed with 2.0 g of Kieselguhr (Fluka Chemie, Buchs, 
Switzerland) and moistened with 1.0 mL of a sodium carbonate solution (57% w/v). This 
mixture was placed in a percolator (15 cm x 1.5 cm i.d.) with approximately 30 mL of CHCl3 
and macerated overnight. The following day, the mixture was percolated slowly until the 
residue from a 10 mL portion of percolate, when dissolved in 0.5 mL of a DCM and MeOH 
mixture (3:1) and spotted on a TLC plate, was negative to Dragendorff reagent. The extraction 
was carried out during 6 hs and required 450 mL of CHCl3. The organic solvent was evaporated 
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under vacuum to 200 mL, transferred to a 250-mL volumetric flask, and diluted to the required 
volume with CHCl3. A portion of the organic solution (200.0 mL) was evaporated to dryness 
under reduced pressure and the residue was made up to 10.0 mL with pH 5.5 citrate buffer 
( 9.054 g of citric acid and 40.796 g of sodium hydrogenphosphate were made up to 1000.0 mL 
with distilled water; the pH was  adjusted with concentrated HCl). This solution was filtered 
though a paper filter and 5.0 mL of the filtrate were pipetted into a 60-mL separator. To the 
separator were added 5.0 mL of citrate buffer, 2.0 mL of a bromocresol solution (0.10 g of 
bromocresol green were dissolved in 2.4 mL of a 0.1 N sodium hydroxide solution and diluted 
to 100 mL with water), and finally 10 mL of CHCl3. The mixture was shaken vigorously, the 
layers were allowed to separate, and the organic phase was taken. The extraction was repeated 
three more times with CHCl3 (10 mL each) and finally the aqueous layer was discarded. The 
chloroform layers were combined and transferred to a 250.0-mL volumetric flask. Piperidine 
(3.0 mL) was added and the solution diluted to 250.0 mL with CHCl3. The absorption of this 
solution were measured at 593 nm (maximal absorbance) after 15 minutes. 
 
Standard curve. Standard solutions were prepared as follows: The pure compound 
catuabine D (10.3 mg) was dissolved with pH 5.5 citrate buffer into a 25-mL volumetric flask 
(Solution A). As directed under assay preparation, 5.0 mL of Solution A were transferred to a 
60-mL separator, 5.0 mL of citrate buffer and 2.0 mL of bromocresol green were added, and the 
derived compound extracted four times with 10 mL of CHCl3. The chloroform layers were 
combined and transferred to a 50.0-mL volumetric flask. Piperidine (3.0 mL) was added and the 
volumetric flask filled to the mark with CHCl3 (Solution B). Seven dilutions were prepared from 
Solution B to establish a calibration curve in the range of 1.15-6.92·10-5 M. 
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8. Physical constants and spectral data for the isolated 
compounds 
 
Compound 2 
Structure 
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Chemical name 3α-(3-hydroxyphenylacetoxy)-6β,7β-dihydroxytropane 
Trivial name catuabine G 
Formula C16H21NO5 
Exact Mass 307.1420 Da 
Molecular Weight 307.3417 Da 
Aspect amorphous white solid 
[ ]20Dα  +0.0 (c 0.57, EtOH) 
UV λmax (log ε) 217.7 (4.35), 276.3 nm (3.85, EtOH) 
IR νmax (KBr) 3455 (–OH), 2930 (C–H), 1735 (C=O), 690 
1H-NMR data see Table 0-8 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
307 (10) [M]+, 247 (15) [M – OHCH=CHOH]+, 156 (10) [M – 3-
OHPhCH2CO]+, 107 (20) [3-OHPhCH2]+, 95 (55) [C6H9N]+, 94 (100) 
[C6H8N]+ 
D/CI-MS m/z 308 [M+H]+ 
HRESMS m/z 308.1493 [M+H]+ (calculated for C16H22NO5, 308.1492) 
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Chemical name 3α-(4-hydroxy-3,5-dimethoxybenzoyloxy)-6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]-7β-hydroxytropane 
Trivial name 7β-hydroxycatuabine F 
Formula C23H28N2O8 
Exact Mass 460.1846 Da 
Molecular Weight 460.4771 Da 
Aspect amorphous white solid 
[ ]20Dα  -2.6 (c 0.44, EtOH) 
UV λmax (log ε) 220.7 (4.16), 269.3 (4.13), 293.4 nm (3.71, EtOH) 
IR νmax (KBr) 3445 (–OH), 2945 (C–H), 1700 (C=O), 1415, 1330, 1220, 1110, 745 
1H-NMR data see Table 0-8 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
460 (10) [M]+, 335 (10) [M – MpcOH]+, 263 (10) [M – HdmbO]+, 181 (12) 
[Hdmb]+, 138 (60) [M – HdmbO – MpcOH]+, 122 (10) [M – HdmbO – MpcO 
– OH]+, 108 (40) [Mpc]+, 94 (100) [C6H8N]+, 81 (15) [C5H7N]+ 
D/CI-MS m/z 461 [M+H]+ 
HRESMS m/z 461.1916 [M+H]+ (calculated for C23H29N2O8, 461.1918) 
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Chemical name 6β,7β-dihydroxy-3α-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane 
Trivial name 7β-hydroxycatuabine I 
Formula C14H20N2O4 
Exact Mass 280.1423 Da 
Molecular Weight 280.3197 Da 
Aspect amorphous white solid 
[ ]20Dα  -0.0 (c 0.60, EtOH) 
UV λmax (log ε) 267.4 nm (4.13, EtOH) 
IR νmax (KBr) 3500 (–OH), 2930 (C–H), 1705 (C=O), 1415, 1320, 1250, 1100, 745 
1H-NMR data see Table 0-8 
13C-NMR data see Table 0-9 
EIMS m/z (rel. int.) NA 
D/CI-MS m/z 281 [M+H]+ 
HRESMS m/z 281.1493 [M+H]+ (calculated for C14H21N2O4, 281.1496) 
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Chemical name 3α,7β-dihydroxy-6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane 
Trivial name 7β-hydroxycatuabine H 
Formula C14H20N2O4 
Exact Mass 280.1423 Da 
Molecular Weight 280.3197 Da 
Aspect amorphous white solid 
[ ]20Dα  -1.5 (c 0.53, EtOH) 
UV λmax (log ε) 266.9 nm (4.04, EtOH) 
IR νmax (KBr) 3460 (–OH), 2930 (C–H), 1705 (C=O),1415, 1330, 1240, 1110, 750 
1H-NMR data see Table 0-8 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
280 (10) [M]+, 156 (25) [M – MpcO]+, 155 (60) [M – MpcOH]+,  138 (10) [M – 
MpcOH – OH]+, 127 (35) [M – Mpc – C2H5O]+, 113 (100) [M – MpcO – 
C2H3O]+, 108 (80) [Mpc]+, 96 (45) [C6H10N]+, 94 (25) [C6H8N]+, 82 (20) 
[C5H8N]+ 
D/CI-MS m/z 281 [M+H]+ 
HRESMS m/z 281.1492 [M+H]+ (calculated for C14H21N2O4, 281.1496) 
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Chemical name 3α,7α-dihydroxy-6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane 
Trivial name 7α-hydroxycatuabine H 
Formula C14H20N2O4 
Exact Mass 280.1423 Da 
Molecular Weight 280.3197 Da 
Aspect amorphous white solid 
[ ]20Dα  -40.7 (c 0.57, EtOH) 
UV λmax (log ε) 268.1 nm (4.11, EtOH) 
IR νmax (KBr) 3390 (–OH), 2935 (C–H), 1700 (C=O),1415, 1320, 1250, 1110, 745 
1H-NMR data see Table 0-8 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
280 (10) [M]+, 156 (25) [M – MpcO]+, 155 (45) [M – MpcOH]+,  138 (10) [M – 
MpcOH – OH]+, 127 (35) [M – Mpc – C2H5O]+, 113 (100) [M – MpcO – 
C2H3O]+, 108 (80) [Mpc]+, 96 (55) [C6H10N]+, 94 (30) [C6H8N]+, 82 (20) 
[C5H8N]+ 
D/CI-MS m/z 281 [M+H]+ 
HRESMS m/z 281.1501 [M+H]+ (calculated for C14H21N2O4, 281.1496) 
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Chemical name 3α-(4-hydroxy-3,5-dimethoxybenzoyloxy)-6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane 
Trivial name catuabine F 
Formula C23H28N2O7 
Exact Mass 444.1897 Da 
Molecular Weight 444.4777 Da 
Aspect amorphous white solid 
[ ]20Dα  -32.8 (c 0.46, EtOH) 
UV λmax (log ε) 220.7 (4.27), 270.0 (4.30), 293.4 nm (3.85, EtOH) 
IR νmax (KBr) 3420, 2945 (C–H), 1700 (C=O), 1415, 1330, 1215, 1110, 745 
1H-NMR data see Table 0-8 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
444 (10) [M]+, 247 (22) [M – HdmbO]+, 181 (10) [Hdmb]+, 138 (15) [M – 
Hdmb – MpcOH]+, 122 (24) [M – HdmbO – MpcOH]+, 108 (28) [Mpc]+, 94 
(100) [C6H8N]+, 81 (15) [C5H7N]+ 
D/CI-MS m/z 445 [M+H]+ 
HRESMS m/z 445.1968 [M+H]+ (calculated for C23H29N2O7, 445.1969) 
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Chemical name 3β-hydroxy-6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane 
Trivial name isocatuabine H 
Formula C14H20N2O3 
Exact Mass 264.1474 Da 
Molecular Weight 264.3203 Da 
Aspect amorphous white solid 
[ ]20Dα  -8.0 (c 0.41, EtOH) 
UV λmax (log ε) 266.6 nm (3.96, EtOH) 
IR νmax (KBr)  
1H-NMR data see Table 0-9 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
264 (20) [M]+, 156 (20) [M – Mpc]+, 139 (10) [M – MpcOH]+, 122 (10) [M – 
MpcOH – OH]+, 113 (100) [M – Mpc – C2H3O]+, 108 (40) [Mpc]+, 96 (40) 
[C6H10N]+, 94 (35) [C6H8N]+, 82 (10) [C5H8N]+ 
D/CI-MS m/z 265 [M+H]+ 
HRESMS m/z 265.1552 [M+H]+ (calculated for C14H21N2O3, 265.1547) 
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Chemical name 6β-hydroxy-3α-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane 
Trivial name catuabine I 
Formula C14H20N2O3 
Exact Mass 264.1474 Da 
Molecular Weight 264.3203 Da 
Aspect amorphous white solid 
[ ]20Dα  -1.1 (c 0.39, EtOH) 
UV λmax (log ε) 267.1 nm (4.02, EtOH) 
IR νmax (KBr)  
1H-NMR data see Table 0-9 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
264 (10) [M]+, 140 (25) [M – MpcO]+, 139 (15) [M – MpcOH]+, 108 (15) 
[Mpc]+, 96 (15) [C6H10N]+, 95 (60) [C6H9N]+, 94 (100) [C6H8N]+, 82 (10) 
[C5H8N]+ 
D/CI-MS m/z 265 [M+H]+ 
HRESMS m/z 265.1546 [M+H]+ (calculated for C14H21N2O3, 265.1547) 
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Chemical name 3α-hydroxy-6β-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane 
Trivial name catuabine H 
Formula C14H20N2O3 
Exact Mass 264.1474 Da 
Molecular Weight 264.3203 Da 
Aspect amorphous white solid 
[ ]20Dα  -9.6 (c 0.46, EtOH) 
UV λmax (log ε) 267.0 nm (4.10, EtOH) 
IR νmax (KBr)  
1H-NMR data see Table 0-9 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 264 (25) [M]
+
, 113 (100) [M – Mpc – C2H3O]+, 108 (30) [Mpc]+, 96 (40) 
[C6H10N]+, 94 (35) [C6H8N]+, 82 (10) [C5H8N]+ 
D/CI-MS m/z 265 [M+H]+ 
HRESMS m/z 265.1546 [M+H]+ (calculated for C14H21N2O3, 265.1547) 
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Chemical name 6α-hydroxy-4α-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane 
Trivial name vaccinine B 
Formula C14H20N2O3 
Exact Mass 264.1474 Da 
Molecular Weight 264.3203 Da 
Aspect amorphous white solid 
[ ]20Dα  -2.0 (c 0.47, EtOH) 
UV λmax (log ε) 266.9 nm (4.10, EtOH) 
IR νmax (KBr) 3140 (–OH), 2950 (C–H), 1690 (C=O), 1415, 1330, 1245, 1120, 745 
1H-NMR data see Table 0-9 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
264 (55) [M]+, 156 (50) [M – Mpc]+, 140 (20) [M – MpcO]+, 139 (10) [M – 
MpcOH]+, 108 (80) [Mpc]+, 96 (30) [C6H10N]+, 94 (10) [C6H8N]+, 82 (100) 
[C5H8N]+ 
D/CI-MS m/z 265 [M+H]+ 
HRESMS m/z 265.1549 [M+H]+ (calculated for C14H21N2O3, 265.1547) 
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Chemical name 3α-hydroxy-4α-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane 
Trivial name vaccinine A 
Formula C14H20N2O3 
Exact Mass 264.1474 Da 
Molecular Weight 264.3203 Da 
Aspect amorphous white solid 
[ ]20Dα  +37.1 (c 0.51, EtOH) 
UV λmax (log ε) 268.1 nm (4.19, EtOH) 
IR νmax (KBr) 3390 (–OH), 2940 (C–H), 1695 (C=O), 1415, 1320, 1245, 1110, 740 
1H-NMR data see Table 0-9 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
264 (25) [M]+, 156 (20) [M – Mpc]+, 140 (30) [M – MpcO]+, 139 (20) [M – 
MpcOH]+, 108 (70) [Mpc]+, 96 (40) [C6H10N]+, 94 (20) [C6H8N]+, 82 (100) 
[C5H8N]+ 
D/CI-MS m/z 265 [M+H]+ 
HRESMS m/z 265.1547 [M+H]+ (calculated for C14H21N2O3, 265.1547) 
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Chemical name 3α,6β-di-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane N-oxide 
Trivial name catuabine E N-oxide 
Formula C20H25N3O5 
Exact Mass 387.1794 Da 
Molecular Weight 387.4297 Da 
Aspect amorphous white solid 
[ ]20Dα  -7.3 (c 0.33, EtOH) 
UV λmax (log ε) 268.2 nm (4.43, EtOH) 
IR νmax (KBr)  
1H-NMR data see Table 0-9 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
 
D/CI-MS m/z [M+H]+ 
HRESMS m/z [M+H]+ (calculated for C20H26N2O5,) 
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Chemical name 3α-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]-6β-[(1H-pyrrol-2-yl)carbonyloxy]-7β-hydroxytropane 
Trivial name 7β-hydroxycatuabine D 
Formula C19H23N3O5 
Exact Mass 373.1638 Da 
Molecular Weight 373.4031 Da 
Aspect amorphous white solid 
[ ]20Dα  -2.8 (c 0.40, EtOH) 
UV λmax (log ε) 267.2 nm (3.92, EtOH) 
IR νmax (KBr)  
1H-NMR data see Table 0-10 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
373 (10) [M]+, 263 (7) [M – PcO]+, 248 (10) [M – MpcOH]+, 122 (10) [M – 
PcO – MpcO – OH]+, 108 (45) [Mpc]+, 95 (50) [C6H9N]+, 94 (100) [C6H8N]+, 
81 (15) [C5H7N]+ 
D/CI-MS m/z 374 [M+H]+ 
HRESMS m/z 374.1709 [M+H]+ (calculated for C19H24N3O5, 374.1710) 
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Chemical name 3α,6β-di-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]-7β-hydroxytropane 
Trivial name 7β-hydroxycatuabine E 
Formula C20H25N3O5 
Exact Mass 387.1794 Da 
Molecular Weight 387.4297 Da 
Aspect amorphous white solid 
[ ]20Dα  +0.8 (c 0.57, EtOH) 
UV λmax (log ε) 267.5 nm (4.41, EtOH) 
IR νmax (KBr) 3500 (–OH), 2945 (C–H), 1695 (C=O), 1410, 1320, 1250, 1115, 740 
1H-NMR data see Table 0-10 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
387 (10) [M]+, 262 (60) [M – MpcOH]+, 154 (16) [M – Mpc – MpcOH]+, 138 
(80) [M – MpcO – MpcOH]+, 137 (100) [M – MpcOH – MpcOH]+, 122 (10) [M 
– MpcO – MpcO – OH]+, 108 (100) [Mpc]+, 94 (100) [C6H8N]+, 81 (15) 
[C5H7N]+ 
D/CI-MS m/z 388 [M+H]+ 
HRESMS m/z 388.1869 [M+H]+ (calculated for C20H26N3O5, 388.1867) 
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Chemical name 3α-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]-6β-[(1H-pyrrol-2-yl)carbonyloxy]tropane 
Trivial name catuabine D 
Formula C19H23N3O4 
Exact Mass 357.1689 Da 
Molecular Weight 357.4037 Da 
Aspect amorphous white solid 
[ ]20Dα  -32.0 (c 0.58, EtOH) 
UV λmax (log ε) 266.8 nm (4.38, EtOH) 
IR νmax (KBr) 2935 (C–H), 1700 (C=O),1410, 1320, 1245, 1110, 740 
1H-NMR data see Table 0-10 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
357 (55) [M]+, 264 (18) [M + H – Pc]+, 249 (15) [M – Mpc]+, 233 (80) [M – 
MpcO]+, 232 (75) [M + H – MpcO]+, 140 (40) [M + H – Pc – MpcO]+, 138 
(32) [M + H – Pc – MpcO]+, 122 (100) [M – PcO – MpcOH]+, 108 (80) 
[Mpc]+, 95 (100) [C6H9N]+, 86 (95), 81 (35) [C5H7N]+ 
D/CI-MS m/z 358 [M+H]+ 
HRESMS m/z 358.1768 [M+H]+ (calculated for C19H24N3O4, 358.17627) 
 
Experimental part 
 
   
VI. 
212
 
 
 
Compound 23 
Structure 
N
CH3
O
O
O
H
N
H3C O
O
N
H3C
2''
5''
a''
2'
5'
a'
1
3
2
45
6
7
H3C
O
a'''
b'''
 
Chemical name 3α,6β-di-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]-7β-acetoxytropane 
Trivial name 7β-acetylcatuabine E 
Formula C22H27N3O6 
Exact Mass 429.1900 Da 
Molecular Weight 429.4664 Da 
Aspect amorphous white solid 
[ ]20Dα  -36.8 (c 0.56, EtOH) 
UV λmax (log ε) 268.5 nm (4.45, EtOH) 
IR νmax (KBr) 2945 (C–H), 1745 (C=O), 1700 (C=O), 1410, 1320, 1250, 1110, 745 
1H-NMR data see Table 0-10 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
429 (80) [M]+, 321 (15) [M – Mpc]+, 305 (100) [M – MpcO]+, 245 (73) [M – 
CH3COOH – MpcO]+, 196 (20) [M – Mpc – MpcOH]+, 180 (80) [M – MpcO – 
MpcOH]+, 138 (32) [M – CH3COO – Mpc – MpcO]+, 122 (16) [M – CH3COO 
– MpcO – MpcO]+, 108 (100) [Mpc]+, 94 (100) [C6H8N]+, 81 (15) [C5H7N]+ 
D/CI-MS m/z 430 [M+H]+ 
HRESMS m/z 430.1967 [M+H]+ (calculated for C22H28N3O6, 430.1973) 
 
Experimental part 
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Compound 24 
Structure 
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Chemical name 3α,6β-di-[(1-methyl-1H-pyrrol-2-yl)carbonyloxy]tropane 
Trivial name catuabine E 
Formula C20H25N3O4 
Exact Mass 371.1845 Da 
Molecular Weight 371.4303 Da 
Aspect amorphous white solid 
[ ]20Dα  -35.4 (c 0.57, EtOH) 
UV λmax (log ε) 267.6 nm (4.38, EtOH) 
IR νmax (KBr) 2945 (C–H), 1695 (C=O),1415, 1320, 1245, 1115, 740 
1H-NMR data see Table 0-10 
13C-NMR data see Table 0-11 
EIMS m/z (rel. int.) 
371 (30) [M]+, 263 (5) [M – Mpc]+, 247 (45) [M – MpcO]+, 138 (15) [M – Mpc 
– MpcOH]+, 122 (32) [M – MpcO – MpcOH]+, 108 (55) [Mpc]+, 95 (82) 
[C6H9N]+, 94 (100) [C6H8N]+, 86 (24), 81 (15) [C5H7N]+ 
D/CI-MS m/z 372 [M+H]+ 
HRESMS m/z 372.1924 [M+H]+ (calculated for C20H26N3O4, 372.1918) 
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Abstract 
 
Throughout the ages, men and women have incessantly pursued every means to increase, 
preserve or recapture their sexual capacity, or to stimulate the sexual desire of selected 
individuals. One of the most recurrent methods has been the use of natural aphrodisiacs. 
Nowadays, the commercialization of new synthetic “love drugs”, e.g. Viagra®, Cialis® and 
Levitra®, has fascinated the public interest and has led to a reassessment of classical 
aphrodisiacs and to the search for new ones. The practice of self-medication by an increasing 
number of patients, the incessant aggressive advertising of these herbal aphrodisiacs, the 
invasion of the medicinal market with uncontrolled dietary supplements and the absence of real 
directives amplifies the potential health hazards to the community. 
In order to evaluate the possible risks of commercialized aphrodisiac products on consumer 
health, the development and validation of a rapid qualitative and quantitative method for the 
analysis of yohimbine in these products, is reported in the first part of the present work. 
Yohimbine, a pharmacologically well-characterized α2-adrenoceptor antagonist with activity in 
the central and peripheral nervous system, has been used for over a century in the treatment of 
erectile dysfunction. The analytical method is based on liquid chromatography coupled with 
ultraviolet and mass spectrometry (LC-UV-MS) and in total, 20 commercially-available 
aphrodisiac preparations were analyzed. The amount of yohimbine measured and expressed as 
the maximal dose per day suggested on product labels ranged from 1.32 to 23.16 mg. 
The second part of this work involved the phytochemical and pharmacological investigation 
of Erythroxylum vacciniifolium Mart. (Erythroxylaceae), a plant used in Brazilian traditional 
medicine as an aphrodisiac and tonic, and locally known as catuaba. With the aim of obtaining 
preliminary structure information on-line, the alkaloid extract was analyzed by high 
performance liquid chromatography (HPLC) coupled to diode array UV detection (LC-UV-
DAD), to mass spectrometry (LC-MS) and to nuclear magnetic resonance spectroscopy (LC-
NMR). Interpretation of on-line spectroscopic data led to structure elucidation and partial 
identification of 24 potentially original alkaloids bearing the same tropane skeleton. 
Seventeen new tropane alkaloids were then isolated from the alkaloid extract of the plant, 
including catuabines D to I, their derivatives and vaccinines A and B. All compounds were 
elucidated as tropane-diol or -triol alkaloids esterified by at least one 1-methyl-1H-pyrrole-2-
carboxylic acid. One of the isolated compounds was identified as a tropane alkaloid N-oxide. 
Their structures were determined by high resolution mass spectrometry and multi-dimensional 
NMR spectroscopy. 
Among the numerous bioassays undertaken, only the cytotoxicity tests exhibited a weak 
positive activity of certain compounds. 
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Résumé 
 
De tout temps, hommes et femmes ont cherché par tous les moyens à développer, préserver ou 
recouvrer leurs propres capacités sexuelles mais également à stimuler le désir du partenaire. 
L’utilisation d’aphrodisiaques naturels a été l’un des recours les plus répandus. De nos jours, la 
commercialisation de nouvelles “love drugs” de synthèse, e.g. Viagra®, Cialis®, Levitra®, a 
remis au goût du jour les aphrodisiaques classiques et à relancer la recherche sur des molécules 
nouvelles. La pratique croissante de l’automédication, le matraquage publicitaire sur les 
aphrodisiaques naturels, la prolifération sur le marché de compléments alimentaires non 
contrôlés et l’absence de véritable législation accroissent les risques qui pèsent sur la santé 
publique.  
Dans le but d’évaluer les risques potentiels sur le consommateur de produits aphrodisiaques 
commercialisés, le développement et la validation d’une méthode rapide d’analyse qualitative et 
quantitative de la yohimbine dans ces préparations du marché sont exposés dans la première 
partie de ce travail. La yohimbine est un antagoniste α2-adrénocepteur du système nerveux 
central et périphérique, elle est employée depuis plus d’un siècle dans le traitement des 
dysfonctionnements érectiles. Cette méthode analytique utilise la chromatographie liquide 
couplée à l’ultraviolet et à la spectrométrie de masse (LC-UV-MS) et au total, vingt 
préparations aphrodisiaques ont été étudiées. La dose journalière de yohimbine mesurée s’est 
révélée très variable selon les produits puisqu’elle varie de 1.32 à 23.16 mg. 
La seconde partie de ce travail concerne l’étude phytochimique et pharmacologique 
d’Erythroxylum vacciniifolium Mart. (Erythroxylaceae), une plante, appelée localement catuaba, 
utilisée dans la médecine traditionnelle brésilienne comme tonique et aphrodisiaque. Dans un 
premier temps, l’extrait alcaloïdique a été analysé par chromatographie liquide haute 
performance (HPLC) couplée soit à un détecteur UV à barrette d’iode (LC-UV-DAD), soit à un 
spectromètre de masse (LC-MS), ou soit à un spectromètre de résonance magnétique nucléaire 
(LC-RMN). L’interprétation de ces données spectrales enregistrées en ligne a permis d’obtenir 
des informations structurales et d’identifier partiellement près de 24 alcaloïdes appartenant à la 
classe des tropanes et potentiellement originaux. 
Par des méthodes classiques de chromatographie liquide sur l’extrait alcaloïdique de la plante, 
dix sept tropanes nouveaux ont ensuite été isolés dont les catuabines et leurs dérivés, et les 
vaccinines. Tous ces composés sont des tropane-diols ou triols estérifiés par au moins un groupe 
acide 1-méthyl-1H-pyrrole-2-carboxylique. Un de ces composés a été identifié comme un 
tropane N-oxyde. Toutes les structures ont été déterminées par spectrométrie de masse haute 
résolution et spectroscopie RMN multi-dimensionnelle.  
Parmi les nombreux tests biologiques réalisés sur ces tropanes, seuls les tests de cytotoxicité 
se sont révélés faiblement positifs pour certains de ces composés. 
  
 
